DOW-Q3-9.30.2011
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended SEPTEMBER 30, 2011
Commission File Number: 1-3433
THE DOW CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
|
| | |
Delaware | | 38-1285128 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
2030 DOW CENTER, MIDLAND, MICHIGAN 48674
(Address of principal executive offices) (Zip Code)
989-636-1000
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
þ Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
þ Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
|
| | | | | | |
| Large accelerated filer | | þ | Accelerated filer | | ¨ |
| Non-accelerated filer | | ¨ | Smaller reporting company | | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
¨ Yes þ No
|
| | |
| | Outstanding at |
Class | | September 30, 2011 |
Common Stock, par value $2.50 per share | | 1,181,812,440 shares |
The Dow Chemical Company
QUARTERLY REPORT ON FORM 10-Q
For the quarterly period ended September 30, 2011
TABLE OF CONTENTS
|
| | |
| | PAGE |
| |
| |
| | |
Item 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Item 2. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Item 3. | | |
| | |
Item 4. | | |
| |
| |
| | |
Item 1. | | |
| | |
Item 1A. | | |
| | |
Item 2. | | |
| | |
Item 6. | | |
| |
| |
| |
| |
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Nine Months Ended |
In millions, except per share amounts (Unaudited) | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Net Sales | $ | 15,109 |
| | $ | 12,868 |
| | $ | 45,888 |
| | $ | 39,903 |
|
Cost of sales | 12,928 |
| | 10,841 |
| | 38,596 |
| | 33,962 |
|
Research and development expenses | 402 |
| | 403 |
| | 1,213 |
| | 1,217 |
|
Selling, general and administrative expenses | 691 |
| | 640 |
| | 2,086 |
| | 1,950 |
|
Amortization of intangibles | 125 |
| | 124 |
| | 373 |
| | 377 |
|
Restructuring charges | — |
| | — |
| | — |
| | 29 |
|
Acquisition and integration related expenses | — |
| | 35 |
| | 31 |
| | 98 |
|
Equity in earnings of nonconsolidated affiliates | 375 |
| | 251 |
| | 964 |
| | 799 |
|
Sundry income (expense) - net | 47 |
| | (10 | ) | | (322 | ) | | 168 |
|
Interest income | 9 |
| | 7 |
| | 26 |
| | 24 |
|
Interest expense and amortization of debt discount | 305 |
| | 362 |
| | 1,010 |
| | 1,105 |
|
Income Before Income Taxes | 1,089 |
| | 711 |
| | 3,247 |
| | 2,156 |
|
Provision for income taxes | 186 |
| | 114 |
| | 546 |
| | 348 |
|
Net Income | 903 |
| | 597 |
| | 2,701 |
| | 1,808 |
|
Net income attributable to noncontrolling interests | 3 |
| | — |
| | 24 |
| | 9 |
|
Net Income Attributable to The Dow Chemical Company | 900 |
| | 597 |
| | 2,677 |
| | 1,799 |
|
Preferred stock dividends | 85 |
| | 85 |
| | 255 |
| | 255 |
|
Net Income Available for The Dow Chemical Company Common Stockholders | $ | 815 |
| | $ | 512 |
| | $ | 2,422 |
| | $ | 1,544 |
|
| | | | | | | |
Per Common Share Data: | | | | | | | |
Earnings per common share - basic | $ | 0.70 |
| | $ | 0.45 |
| | $ | 2.08 |
| | $ | 1.37 |
|
Earnings per common share - diluted | $ | 0.69 |
| | $ | 0.45 |
| | $ | 2.07 |
| | $ | 1.35 |
|
|
|
| | | | | |
|
|
Common stock dividends declared per share of common stock | $ | 0.25 |
| | $ | 0.15 |
| | $ | 0.65 |
| | $ | 0.45 |
|
Weighted-average common shares outstanding - basic | 1,152.3 |
| | 1,128.0 |
| | 1,147.2 |
| | 1,123.6 |
|
Weighted-average common shares outstanding - diluted | 1,160.9 |
| | 1,145.5 |
| | 1,157.8 |
| | 1,140.7 |
|
|
|
| | | | | |
|
|
Depreciation | $ | 539 |
| | $ | 555 |
| | $ | 1,624 |
| | $ | 1,717 |
|
Capital Expenditures | $ | 651 |
| | $ | 497 |
| | $ | 1,620 |
| | $ | 1,188 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets
|
| | | | | | | |
In millions (Unaudited) | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Assets |
Current Assets | | | |
Cash and cash equivalents (variable interest entities restricted - 2011: $86; 2010: $145) | $ | 2,206 |
| | $ | 7,039 |
|
Accounts and notes receivable: | | | |
Trade (net of allowance for doubtful receivables - 2011: $124; 2010: $128) | 5,081 |
| | 4,616 |
|
Other | 5,035 |
| | 4,428 |
|
Inventories | 8,416 |
| | 7,087 |
|
Deferred income tax assets - current | 683 |
| | 611 |
|
Other current assets | 333 |
| | 349 |
|
Total current assets | 21,754 |
| | 24,130 |
|
Investments | | | |
Investment in nonconsolidated affiliates | 3,574 |
| | 3,453 |
|
Other investments (investments carried at fair value - 2011: $1,942; 2010: $2,064) | 2,426 |
| | 2,542 |
|
Noncurrent receivables | 333 |
| | 388 |
|
Total investments | 6,333 |
| | 6,383 |
|
Property | | | |
Property | 52,839 |
| | 51,648 |
|
Less accumulated depreciation | 35,046 |
| | 33,980 |
|
Net property (variable interest entities restricted - 2011: $1,855; 2010: $1,388) | 17,793 |
| | 17,668 |
|
Other Assets | | | |
Goodwill | 12,994 |
| | 12,967 |
|
Other intangible assets (net of accumulated amortization - 2011: $2,216; 2010: $1,805) | 5,212 |
| | 5,530 |
|
Deferred income tax assets - noncurrent | 2,001 |
| | 2,079 |
|
Asbestos-related insurance receivables - noncurrent | 206 |
| | 220 |
|
Deferred charges and other assets | 658 |
| | 611 |
|
Total other assets | 21,071 |
| | 21,407 |
|
Total Assets | $ | 66,951 |
| | $ | 69,588 |
|
Liabilities and Equity |
Current Liabilities | | | |
Notes payable | $ | 887 |
| | $ | 1,467 |
|
Long-term debt due within one year | 1,674 |
| | 1,755 |
|
Accounts payable: | | | |
Trade | 4,429 |
| | 4,356 |
|
Other | 2,260 |
| | 2,249 |
|
Income taxes payable | 427 |
| | 349 |
|
Deferred income tax liabilities - current | 110 |
| | 105 |
|
Dividends payable | 375 |
| | 257 |
|
Accrued and other current liabilities | 2,725 |
| | 3,358 |
|
Total current liabilities | 12,887 |
| | 13,896 |
|
Long-Term Debt (variable interest entities nonrecourse - 2011: $891; 2010: $167) | 17,042 |
| | 20,605 |
|
Other Noncurrent Liabilities | | | |
Deferred income tax liabilities - noncurrent | 1,298 |
| | 1,295 |
|
Pension and other postretirement benefits - noncurrent | 7,042 |
| | 7,492 |
|
Asbestos-related liabilities - noncurrent | 635 |
| | 663 |
|
Other noncurrent obligations | 2,906 |
| | 2,995 |
|
Total other noncurrent liabilities | 11,881 |
| | 12,445 |
|
Stockholders’ Equity | | | |
Preferred stock, series A | 4,000 |
| | 4,000 |
|
Common stock | 2,954 |
| | 2,931 |
|
Additional paid-in capital | 2,526 |
| | 2,286 |
|
Retained earnings | 19,400 |
| | 17,736 |
|
Accumulated other comprehensive loss | (4,290 | ) | | (4,399 | ) |
Unearned ESOP shares | (438 | ) | | (476 | ) |
Treasury stock at cost | — |
| | (239 | ) |
The Dow Chemical Company’s stockholders’ equity | 24,152 |
| | 21,839 |
|
Noncontrolling interests | 989 |
| | 803 |
|
Total equity | 25,141 |
| | 22,642 |
|
Total Liabilities and Equity | $ | 66,951 |
| | $ | 69,588 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Cash Flows
|
| | | | | | | |
| Nine Months Ended |
In millions (Unaudited) | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Operating Activities | | | |
Net Income | $ | 2,701 |
| | $ | 1,808 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
| |
|
Depreciation and amortization | 2,142 |
| | 2,207 |
|
Provision (Credit) for deferred income tax | (125 | ) | | 32 |
|
Earnings of nonconsolidated affiliates in excess of dividends received | (221 | ) | | (241 | ) |
Pension contributions | (712 | ) | | (177 | ) |
Net (gain) loss on sales of investments | (39 | ) | | 1 |
|
Net (gain) loss on sales of property, businesses and consolidated companies | (23 | ) | | 52 |
|
Other net gain | (19 | ) | | (16 | ) |
Net gain on sale of ownership interest in nonconsolidated affiliates | (61 | ) | | (25 | ) |
Restructuring charges | — |
| | 29 |
|
Loss on early extinguishment of debt | 482 |
| | — |
|
Excess tax benefits from share-based payment arrangements | (14 | ) | | (3 | ) |
Changes in assets and liabilities, net of effects of acquired and divested companies: | | | |
Accounts and notes receivable | (1,965 | ) | | (1,539 | ) |
Proceeds from interests in trade accounts receivable conduits | 1,444 |
| | 818 |
|
Inventories | (1,529 | ) | | (946 | ) |
Accounts payable | 17 |
| | (139 | ) |
Other assets and liabilities | (220 | ) | | 406 |
|
Cash provided by operating activities | 1,858 |
| | 2,267 |
|
Investing Activities | | | |
Capital expenditures | (1,620 | ) | | (1,188 | ) |
Construction of assets pending sale / leaseback | (113 | ) | | — |
|
Proceeds from sale / leaseback of assets | 119 |
| | — |
|
Proceeds from sales of property, businesses and consolidated companies | 149 |
| | 1,716 |
|
Acquisitions of businesses | (6 | ) | | (7 | ) |
Purchases of previously leased assets | (30 | ) | | (45 | ) |
Investments in consolidated companies, net of cash acquired | (218 | ) | | (167 | ) |
Investments in nonconsolidated affiliates | (126 | ) | | (101 | ) |
Distributions from nonconsolidated affiliates | 250 |
| | 24 |
|
Proceeds from sale of ownership interests in nonconsolidated affiliates | 93 |
| | 113 |
|
Change in restricted cash | — |
| | 436 |
|
Purchases of investments | (653 | ) | | (742 | ) |
Proceeds from sales and maturities of investments | 692 |
| | 742 |
|
Cash provided by (used in) investing activities | (1,463 | ) | | 781 |
|
Financing Activities | | | |
Changes in short-term notes payable | (485 | ) | | (740 | ) |
Proceeds from notes payable | — |
| | 84 |
|
Payments on notes payable | — |
| | (668 | ) |
Proceeds from issuance of long-term debt | 1,246 |
| | 539 |
|
Payments on long-term debt | (5,320 | ) | | (1,374 | ) |
Purchases of treasury stock | (19 | ) | | (14 | ) |
Proceeds from issuance of common stock | 184 |
| | 92 |
|
Proceeds from sales of common stock | 98 |
| | 70 |
|
Excess tax benefits from share-based payment arrangements | 14 |
| | 3 |
|
Contribution from noncontrolling interests | 20 |
| | — |
|
Distributions to noncontrolling interests | (34 | ) | | (7 | ) |
Dividends paid to stockholders | (885 | ) | | (760 | ) |
Cash used in financing activities | (5,181 | ) | | (2,775 | ) |
Effect of Exchange Rate Changes on Cash | (50 | ) | | 58 |
|
Cash Assumed in Initial Consolidation of Variable Interest Entities | 3 |
| | 46 |
|
Summary | | | |
Increase (Decrease) in cash and cash equivalents | (4,833 | ) | | 377 |
|
Cash and cash equivalents at beginning of year | 7,039 |
| | 2,846 |
|
Cash and cash equivalents at end of period | $ | 2,206 |
| | $ | 3,223 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Equity
|
| | | | | | | |
| Nine Months Ended |
In millions (Unaudited) | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Preferred Stock | | | |
Balance at beginning of year and end of period | $ | 4,000 |
| | $ | 4,000 |
|
Common Stock | | | |
Balance at beginning of year | 2,931 |
| | 2,906 |
|
Common stock issued | 23 |
| | 13 |
|
Balance at end of period | 2,954 |
| | 2,919 |
|
Additional Paid-in Capital | | | |
Balance at beginning of year | 2,286 |
| | 1,913 |
|
Common stock issued | 161 |
| | 79 |
|
Stock-based compensation and allocation of ESOP shares | 79 |
| | 124 |
|
Balance at end of period | 2,526 |
| | 2,116 |
|
Retained Earnings | | | |
Balance at beginning of year | 17,736 |
| | 16,704 |
|
Net income available for The Dow Chemical Company common stockholders | 2,422 |
| | 1,544 |
|
Dividends declared on common stock (per share: $0.65 in 2011, $0.45 in 2010) | (748 | ) | | (507 | ) |
Other | (10 | ) | | (15 | ) |
Impact of adoption of ASU 2009-17, net of tax | — |
| | (248 | ) |
Balance at end of period | 19,400 |
| | 17,478 |
|
Accumulated Other Comprehensive Loss | | | |
Unrealized Gains on Investments at beginning of year | 111 |
| | 79 |
|
Net change in unrealized gains (losses) | (78 | ) | | 35 |
|
Balance at end of period | 33 |
| | 114 |
|
Cumulative Translation Adjustments at beginning of year | 367 |
| | 624 |
|
Translation adjustments | (31 | ) | | (154 | ) |
Balance at end of period | 336 |
| | 470 |
|
Pension and Other Postretirement Benefit Plans at beginning of year | (4,871 | ) | | (4,587 | ) |
Adjustments to pension and other postretirement benefit plans | 209 |
| | 201 |
|
Balance at end of period | (4,662 | ) | | (4,386 | ) |
Accumulated Derivative Loss at beginning of year | (6 | ) | | (8 | ) |
Net hedging results | 6 |
| | (15 | ) |
Reclassification to earnings | 3 |
| | 15 |
|
Balance at end of period | 3 |
| | (8 | ) |
Total accumulated other comprehensive loss | (4,290 | ) | | (3,810 | ) |
Unearned ESOP Shares | | | |
Balance at beginning of year | (476 | ) | | (519 | ) |
Shares acquired | — |
| | (1 | ) |
Shares allocated to ESOP participants | 38 |
| | 36 |
|
Balance at end of period | (438 | ) | | (484 | ) |
Treasury Stock | | | |
Balance at beginning of year | (239 | ) | | (557 | ) |
Purchases | (19 | ) | | (14 | ) |
Issuance to employees and employee plans | 258 |
| | 258 |
|
Balance at end of period | — |
| | (313 | ) |
The Dow Chemical Company’s Stockholders’ Equity | 24,152 |
| | 21,906 |
|
Noncontrolling Interests | | | |
Balance at beginning of year | 803 |
| | 569 |
|
Net income attributable to noncontrolling interests | 24 |
| | 9 |
|
Distributions to noncontrolling interests | (34 | ) | | (7 | ) |
Capital contributions | 20 |
| | — |
|
Consolidation of a variable interest entity | 31 |
| | — |
|
Conversion of note payable to preferred shares of a subsidiary | 158 |
| | — |
|
Impact of adoption of ASU 2009-17 | — |
| | 100 |
|
Other | (13 | ) | | 27 |
|
Balance at end of period | 989 |
| | 698 |
|
Total Equity | $ | 25,141 |
| | $ | 22,604 |
|
See Notes to the Consolidated Financial Statements.
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Comprehensive Income
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Nine Months Ended |
In millions (Unaudited) | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Net Income | $ | 903 |
| | $ | 597 |
| | $ | 2,701 |
| | $ | 1,808 |
|
Other Comprehensive Income (Loss), Net of Tax | | | | | | | |
Net change in unrealized gains (losses) on investments | (84 | ) | | 54 |
| | (78 | ) | | 35 |
|
Translation adjustments | (631 | ) | | 868 |
| | (31 | ) | | (154 | ) |
Adjustments to pension and other postretirement benefit plans | 68 |
| | 52 |
| | 209 |
| | 201 |
|
Net gains (losses) on cash flow hedging derivative instruments | 4 |
| | (4 | ) | | 9 |
| | — |
|
Total other comprehensive income (loss) | (643 | ) | | 970 |
| | 109 |
| | 82 |
|
Comprehensive Income | 260 |
| | 1,567 |
| | 2,810 |
| | 1,890 |
|
Comprehensive income attributable to noncontrolling interests, net of tax | 3 |
| | — |
| | 24 |
| | 9 |
|
Comprehensive Income Attributable to The Dow Chemical Company | $ | 257 |
| | $ | 1,567 |
| | $ | 2,786 |
| | $ | 1,881 |
|
See Notes to the Consolidated Financial Statements.
|
| | |
(Unaudited) | | The Dow Chemical Company and Subsidiaries PART I – FINANCIAL INFORMATION, Item 1. Financial Statements. Notes to the Consolidated Financial Statements |
Table of Contents
|
| | |
Note | | Page |
A | | |
B | | |
C | | |
D | | |
E | | |
F | | |
G | | |
H | | |
I | | |
J | | |
K | | |
L | | |
M | | |
N | | |
O | | |
P | | |
Q | | |
NOTE A – CONSOLIDATED FINANCIAL STATEMENTS
The unaudited interim consolidated financial statements of The Dow Chemical Company and its subsidiaries (“Dow” or the “Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010.
A change to prior year balance sheet amounts has been made to properly classify the current portion of “Deferred charges and other assets” of $349 million to “Other current assets.”
NOTE B – RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
On September 30, 2011, the Company early adopted Accounting Standard Update (“ASU”) 2011-08, “Intangibles-Goodwill and Other (Topic 350): Testing Goodwill for Impairment.” This ASU simplifies how entities test goodwill for impairment and permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. This ASU is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 although early adoption is permitted. The Company has incorporated this guidance into its goodwill test for impairments.
On January 1, 2011, the Company adopted ASU 2009-13, “Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements – a consensus of the FASB Emerging Issues Task Force.” This ASU amended the criteria for when to evaluate individual delivered items in a multiple deliverable arrangement and how to allocate consideration received. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
Accounting Guidance Issued But Not Adopted as of September 30, 2011
In May 2011, the FASB issued ASU 2011-04, "Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS," which provides common requirements for measuring fair value and disclosing information about fair value measurements in accordance with U.S. GAAP and International Financial Reporting Standards ("IFRS"). This ASU is effective for fiscal years beginning on or after December 15, 2011. The Company is currently evaluating the impact of adopting the guidance.
In June 2011, the FASB issued ASU 2011-05, "Comprehensive Income (Topic 220): Presentation of Comprehensive Income," which improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income. This ASU is effective for fiscal years beginning on or after December 15, 2011 and early adoption is permitted. The Company is currently evaluating the impact of adopting the guidance.
NOTE C – RESTRUCTURING
2009 Restructuring
On June 30, 2009, the Company’s Board of Directors approved a restructuring plan related to the Company’s acquisition of Rohm and Haas Company (“Rohm and Haas”) as well as actions to advance the Company’s strategy and to respond to continued weakness in the global economy. The restructuring plan included the elimination of approximately 2,500 positions primarily resulting from synergies to be achieved as a result of the acquisition of Rohm and Haas. In addition, the plan included the shutdown of a number of manufacturing facilities. These actions were substantially complete at March 31, 2011. As a result of the restructuring activities, the Company recorded pretax restructuring charges of $677 million in the second quarter of 2009, consisting of asset write-downs and write-offs of $454 million, costs associated with exit or disposal activities of $68 million and severance costs of $155 million.
The severance component of the 2009 restructuring charges of $155 million was for the separation of approximately 2,500 employees under the terms of the Company’s ongoing benefit arrangements, primarily over two years. At December 31, 2010, severance of $149 million had been paid and a currency adjusted liability of $6 million remained for approximately 189 employees. In the first quarter of 2011, the remaining severance of $6 million was paid, bringing the program to a close.
The shutdowns related to the 2009 restructuring plan were substantially completed in the first quarter of 2011, with remaining liabilities primarily related to environmental remediation to be paid over time.
2010 Adjustments to the 2009 Restructuring Plan
In the first quarter of 2010, the Company recorded an additional $8 million charge to adjust the impairment of long-lived assets and other assets related to the United States Federal Trade Commission (“FTC”) required divestitures completed in the first quarter of 2010, and an additional $8 million charge related to the shutdown of a small manufacturing facility under the 2009 restructuring plan. The impact of these charges is shown as “Restructuring charges” in the consolidated statements of income and was reflected in the following operating segments: Electronic and Functional Materials ($8 million) and Coatings and Infrastructure Solutions ($8 million).
In the second quarter of 2010, the Company recorded additional restructuring charges of $13 million which included the write-off of other assets of $5 million, additional costs associated with exit or disposal activities of $7 million and additional severance of $1 million related to the FTC required divestitures that were included in the 2009 restructuring plan. The impact of these charges is shown as “Restructuring charges” in the consolidated statements of income and was reflected in Coatings and Infrastructure Solutions ($12 million) and Corporate ($1 million).
Restructuring Reserve Assumed from Rohm and Haas
Included in liabilities assumed in the April 1, 2009 acquisition of Rohm and Haas was a reserve for severance and employee benefits for the separation of employees under the terms of Rohm and Haas’ ongoing benefit arrangement. The separations resulted from plant shutdowns, production schedule adjustments, productivity improvements and reductions in support services. A currency adjusted liability of $12 million remained at December 31, 2010; $5 million for employees who had left the Company and would continue to receive annuity payments in early 2011, and $7 million for approximately 44 employees. In the first quarter of 2011, the Company decreased the restructuring reserve $6 million to adjust the reserve to the expected future severance payments. The impact of this adjustment is shown as “Cost of sales” in the consolidated statements of income and was reflected in Corporate. Severance payments of $7 million were made in the six-month period ended June 30, 2011, bringing the program to a close.
|
| | | |
Restructuring Reserve Assumed from Rohm and Haas In millions | Severance Costs |
|
Reserve balance at December 31, 2010 | $ | 12 |
|
Cash payments | (7 | ) |
Adjustments to reserve | (6 | ) |
Foreign currency impact | 1 |
|
Reserve balance at June 30, 2011 | $ | — |
|
NOTE D – ACQUISITIONS AND DIVESTITURES
Divestiture of Polypropylene Business
On July 27, 2011, the Company entered into a definitive agreement to sell its global Polypropylene business to Braskem SA. The definitive agreement specified the assets and liabilities related to the business to be included in the sale, which included the Company's polypropylene manufacturing facilities at Schkopau and Wesseling, Germany, and Freeport and Seadrift, Texas; railcars; inventory; receivables; business know-how; certain product and process technology; and customer contracts and lists. On September 30, 2011, the sale was completed for $459 million, net of working capital adjustments and costs to sell, with proceeds subject to customary post-closing adjustments, to be finalized in subsequent periods. The proceeds included a $474 million receivable, paid to the Company on October 3, 2011. Dow's Polypropylene Licensing and Catalyst business and related catalyst facilities were excluded from this sale. The transaction also resulted in several long-term supply, service and purchase agreements between Dow and Braskem SA, which are expected to generate significant ongoing cash flows. As a result, the divestiture of this business was not reported as discontinued operations.
Reclassification of Cumulative Translation Adjustments Resulting From the Sale of German Entities
On July 15, 2011, the Company sold assets and liabilities related to two legal entities in Germany. This asset sale qualified as a complete liquidation of an investment in a foreign entity. As a result of this asset sale, the Company transferred a $39 million cumulative translation adjustment gain from "Accumulated other comprehensive loss" into income. Including this gain, the sale resulted in a net immaterial loss, which was included in "Sundry income (expense) - net" and reflected in Corporate.
Rohm and Haas Acquisition and Integration Related Expenses
During the first quarter of 2011, pretax charges totaling $31 million were recorded for integration costs related to the April 1, 2009 acquisition of Rohm and Haas, which was substantially completed in the first quarter of 2011. During the third quarter of 2010, pretax charges totaling $35 million ($98 million during the first nine months of 2010) were recorded for integration costs related to the acquisition. These charges were recorded in “Acquisition and integration related expenses” and reflected in Corporate.
Divestitures Required as a Condition to the Acquisition of Rohm and Haas
As a condition of the FTC's approval of the April 1, 2009 acquisition of Rohm and Haas, the Company was required to divest a portion of its acrylic monomer business, a portion of its specialty latex business and its hollow sphere particle business. On July 31, 2009, the Company entered into a definitive agreement that included the sale of the portion of its acrylic monomer business and the portion of its specialty latex business. The sale was completed on January 25, 2010. Additional impairment charges of $8 million related to these assets were recognized in the first quarter of 2010. In the second quarter of 2010, additional severance costs of $1 million and the write-off of other assets of $5 million were recognized (see Note C).
The Company completed the sale of its hollow sphere particle business in the second quarter of 2010 and recognized additional costs associated with disposal activities of $7 million, related to contract termination fees (see Note C).
Divestiture of the Styron Business Unit
On March 2, 2010, the Company announced the entry into a definitive agreement to sell the Styron business unit (“Styron”) to an affiliate of Bain Capital Partners. The definitive agreement specified the assets and liabilities related to the businesses and products to be included in the sale. On June 17, 2010, the sale was completed for $1,561 million, net of working capital adjustments and costs to sell, with proceeds subject to customary post-closing adjustments. Post-closing adjustments were finalized in the fourth quarter of 2010. The proceeds included a $75 million long-term note receivable. In addition, the Company elected to acquire a 7.5 percent equity interest in the resulting privately held, global materials company.
The Company recognized a pretax gain of $51 million on the sale in the second quarter of 2010, included in “Sundry income (expense) - net” and reflected in the Performance Materials ($41 million) and Performance Plastics ($10 million) segments.
In the third quarter of 2010, a net $2 million pretax increase in the gain on the divestiture of Styron was recognized, related to a net gain on the sale of two small, related joint ventures, working capital adjustments and additional costs to sell. The adjustment was included in “Sundry income (expense) - net” and impacted the Performance Plastics segment.
On February 3, 2011, Styron repaid the $75 million long-term note receivable, plus interest. In the first quarter of 2011, the Company received dividend income of $25 million, recorded in “Sundry income (expense) - net” in the consolidated statements of income and reflected in Corporate. The Company continued to hold a 6.5 percent equity interest at September 30, 2011.
NOTE E – INVENTORIES
The following table provides a breakdown of inventories:
|
| | | | | | | |
Inventories In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Finished goods | $ | 4,796 |
| | $ | 4,289 |
|
Work in process | 2,017 |
| | 1,498 |
|
Raw materials | 845 |
| | 644 |
|
Supplies | 758 |
| | 656 |
|
Total inventories | $ | 8,416 |
| | $ | 7,087 |
|
The reserves reducing inventories from the first-in, first-out (“FIFO”) basis to the last-in, first-out (“LIFO”) basis amounted to $1,379 million at September 30, 2011 and $1,003 million at December 31, 2010.
NOTE F – NONCONSOLIDATED AFFILIATES
The table below presents summarized financial information for Dow Corning Corporation, a significant nonconsolidated affiliate (at 100 percent):
|
| | | | | | | | | | | | | | |
Summarized Income Statement Information | Three Months Ended | Nine Months Ended |
for Dow Corning Corporation In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales | $ | 1,660 |
| | $ | 1,515 |
| $ | 4,908 |
| | $ | 4,413 |
|
Gross profit | $ | 527 |
| | $ | 540 |
| $ | 1,599 |
| | $ | 1,599 |
|
Net income attributable to Dow Corning Corporation | $ | 177 |
| | $ | 176 |
| $ | 547 |
| | $ | 615 |
|
In the third quarter of 2011, the Company received $115 million on a previously impaired note receivable related to Equipolymers and recognized $86 million of income in "Equity in earnings of nonconsolidated affiliates," reflected in Performance Plastics.
NOTE G – GOODWILL AND OTHER INTANGIBLE ASSETS
The following table shows the carrying amount of goodwill by operating segment:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Goodwill | Electronic and Functional Materials |
| | Coatings and Infra- structure Solutions |
| | Ag Sciences |
| | Perf Materials |
| | Perf Plastics |
| | Feedstocks and Energy |
| | Total |
|
In millions | | | | | | |
Net goodwill at Dec. 31, 2010 | $ | 4,949 |
| | $ | 4,057 |
| | $ | 1,546 |
| | $ | 966 |
| | $ | 1,386 |
| | $ | 63 |
| | $ | 12,967 |
|
Acquisition of seed company | — |
| | — |
| | 12 |
| | — |
| | — |
| | — |
| | 12 |
|
Foreign currency impact | 3 |
| | 8 |
| | — |
| | 1 |
| | 3 |
| | — |
| | 15 |
|
Net goodwill at Sept. 30, 2011 | $ | 4,952 |
| | $ | 4,065 |
| | $ | 1,558 |
| | $ | 967 |
| | $ | 1,389 |
| | $ | 63 |
| | $ | 12,994 |
|
The following table provides information regarding the Company’s other intangible assets:
|
| | | | | | | | | | | | | | | | | | | | | | | |
Other Intangible Assets | At September 30, 2011 | | At December 31, 2010 |
In millions | Gross Carrying Amount |
| | Accumulated Amortization |
| | Net |
| | Gross Carrying Amount |
| | Accumulated Amortization |
| | Net |
|
Intangible assets with finite lives: | | | | | | | | | | | |
Licenses and intellectual property | $ | 1,686 |
| | $ | (554 | ) | | $ | 1,132 |
| | $ | 1,733 |
| | $ | (466 | ) | | $ | 1,267 |
|
Patents | 120 |
| | (97 | ) | | 23 |
| | 121 |
| | (95 | ) | | 26 |
|
Software | 1,044 |
| | (572 | ) | | 472 |
| | 965 |
| | (506 | ) | | 459 |
|
Trademarks | 696 |
| | (209 | ) | | 487 |
| | 693 |
| | (168 | ) | | 525 |
|
Customer related | 3,683 |
| | (679 | ) | | 3,004 |
| | 3,647 |
| | (492 | ) | | 3,155 |
|
Other | 147 |
| | (105 | ) | | 42 |
| | 122 |
| | (78 | ) | | 44 |
|
Total other intangible assets, finite lives | $ | 7,376 |
| | $ | (2,216 | ) | | $ | 5,160 |
| | $ | 7,281 |
| | $ | (1,805 | ) | | $ | 5,476 |
|
IPR&D (1), indefinite lives | 52 |
| | — |
| | 52 |
| | 54 |
| | — |
| | 54 |
|
Total other intangible assets | $ | 7,428 |
| | $ | (2,216 | ) | | $ | 5,212 |
| | $ | 7,335 |
| | $ | (1,805 | ) | | $ | 5,530 |
|
(1) Purchased in-process research and development (“IPR&D”).
The following table provides information regarding amortization expense related to intangible assets:
|
| | | | | | | | | | | | | | | |
Amortization Expense | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Other intangible assets, excluding software | $ | 125 |
| | $ | 124 |
| | $ | 373 |
| | $ | 377 |
|
Software, included in “Cost of sales” | $ | 23 |
| | $ | 21 |
| | $ | 68 |
| | $ | 64 |
|
Total estimated amortization expense related to intangible assets for 2011 and the five succeeding fiscal years is as follows:
|
| | | |
Estimated Amortization Expense In millions |
2011 | $ | 589 |
|
2012 | $ | 558 |
|
2013 | $ | 535 |
|
2014 | $ | 512 |
|
2015 | $ | 492 |
|
2016 | $ | 480 |
|
NOTE H – FINANCIAL INSTRUMENTS
Investments
The Company’s investments in marketable securities are primarily classified as available-for-sale.
|
| | | | | | | |
Investing Results | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Proceeds from sales of available-for-sale securities | $ | 631 |
| | $ | 680 |
|
Gross realized gains | $ | 39 |
| | $ | 31 |
|
Gross realized losses | $ | (13 | ) | | $ | (62 | ) |
The following table summarizes the contractual maturities of the Company’s investments in debt securities:
|
| | | | | | | |
Contractual Maturities of Debt Securities at September 30, 2011 |
In millions | Amortized Cost |
| | Fair Value |
|
Within one year | $ | 31 |
| | $ | 32 |
|
One to five years | 472 |
| | 514 |
|
Six to ten years | 462 |
| | 508 |
|
After ten years | 233 |
| | 274 |
|
Total | $ | 1,198 |
| | $ | 1,328 |
|
At September 30, 2011, the Company had no held-to-maturity securities classified as cash equivalents. At December 31, 2010, the Company had $3.2 billion in held-to-maturity securities (primarily Treasury Bills) classified as cash equivalents, as these securities had original maturities of three months or less. The Company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. At September 30, 2011, the Company had investments in money market funds of $302 million classified as cash equivalents ($35 million at December 31, 2010).
The net unrealized gain recognized during the nine-month period ended September 30, 2011 on trading securities held at September 30, 2011 was $25 million ($22 million during the nine-month period ended September 30, 2010).
The following table provides the fair value and gross unrealized losses of the Company’s investments that were deemed to be temporarily impaired at September 30, 2011 and December 31, 2010, aggregated by investment category:
|
| | | | | | | | | | | | | | | |
Temporarily Impaired Securities Less than 12 Months (1) |
| At September 30, 2011 | | At December 31, 2010 |
In millions | Fair Value | | Unrealized Losses |
| | Fair Value | | Unrealized Losses |
|
Debt securities: | | | | | | | |
Government debt (2,3) | $ | — |
| | $ | — |
| | $ | 62 |
| | $ | (2 | ) |
Corporate bonds | 57 |
| | (3 | ) | | 43 |
| | (1 | ) |
Total debt securities | $ | 57 |
| | $ | (3 | ) | | $ | 105 |
| | $ | (3 | ) |
Equity securities | 420 |
| | (70 | ) | | 52 |
| | (3 | ) |
Total temporarily impaired securities | $ | 477 |
| | $ | (73 | ) | | $ | 157 |
| | $ | (6 | ) |
| |
(1) | Unrealized losses of 12 months or more were less than $1 million. |
| |
(2) | U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations. |
| |
(3) | Unrealized losses of less than 12 months were less than $1 million at September 30, 2011. |
Portfolio managers regularly review the Company’s holdings to determine if any investments are other-than-temporarily impaired. The analysis includes reviewing the amount of a temporary impairment, as well as the length of time it has been impaired. In addition, specific guidelines for each instrument type are followed to determine if an other-than-temporary impairment has occurred.
For debt securities, the credit rating of the issuer, current credit rating trends, the trends of the issuer’s overall sector, the ability of the issuer to pay expected cash flows and the length of time the security has been in a loss position are considered in determining whether unrealized losses represent an other-than-temporary impairment. The Company did not have any credit-related losses on debt securities during the nine-month periods ended September 30, 2011 or September 30, 2010.
For equity securities, the Company’s investments are primarily in Standard & Poor’s (“S&P”) 500 companies; however, the Company’s policies allow investments in companies outside of the S&P 500. The largest holdings are Exchange Traded Funds that represent the S&P 500 index or an S&P sector or subset; the Company also has holdings in Exchange Traded Funds that represent emerging markets. The Company considers the evidence to support the recovery of the cost basis of a security including volatility of the stock, the length of time the security has been in a loss position, value and growth expectations, and overall market and sector fundamentals, as well as technical analysis, in determining whether unrealized losses represent an other-than-temporary impairment. In the nine-month period ended September 30, 2011, other-than-temporary impairment write-downs on investments still held by the Company were $6 million ($4 million in the nine-month period ended September 30, 2010).
The aggregate cost of the Company’s cost method investments totaled $177 million at September 30, 2011 and $171 million at December 31, 2010. Due to the nature of these investments, the fair market value is not readily determinable. These investments are reviewed for impairment indicators. In the nine-month period ended September 30, 2011, the Company's impairment analysis identified indicators that resulted in no reduction in the cost basis of these investments ($21 million reduction in the nine-month period ended September 30, 2010).
The following table summarizes the fair value of financial instruments at September 30, 2011 and December 31, 2010:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Fair Value of Financial Instruments |
| At September 30, 2011 | | At December 31, 2010 |
In millions | Cost |
| | Gain |
| | Loss |
| | Fair Value |
| | Cost |
| | Gain |
| | Loss |
| | Fair Value |
|
Marketable securities: (1) | | | | | | | | | | | | | | | |
Debt securities: | | | | | | | | | | | | | | | |
Government debt (2) | $ | 543 |
| | $ | 63 |
| | $ | — |
| | $ | 606 |
| | $ | 603 |
| | $ | 40 |
| | $ | (2 | ) | | $ | 641 |
|
Corporate bonds | 655 |
| | 70 |
| | (3 | ) | | 722 |
| | 760 |
| | 72 |
| | (1 | ) | | 831 |
|
Total debt securities | $ | 1,198 |
| | $ | 133 |
| | $ | (3 | ) | | $ | 1,328 |
| | $ | 1,363 |
| | $ | 112 |
| | $ | (3 | ) | | $ | 1,472 |
|
Equity securities | 652 |
| | 32 |
| | (70 | ) | | 614 |
| | 501 |
| | 94 |
| | (3 | ) | | 592 |
|
Total marketable securities | $ | 1,850 |
| | $ | 165 |
| | $ | (73 | ) | | $ | 1,942 |
| | $ | 1,864 |
| | $ | 206 |
| | $ | (6 | ) | | $ | 2,064 |
|
Long-term debt incl. debt due within one year (3) | $ | (18,716 | ) | | $ | 88 |
| | $ | (2,360 | ) | | $ | (20,988 | ) | | $ | (22,360 | ) | | $ | 175 |
| | $ | (2,530 | ) | | $ | (24,715 | ) |
Derivatives relating to: | | | | | | |
| | | | | | | |
|
Foreign currency | $ | — |
| | $ | 93 |
| | $ | (108 | ) | | $ | (15 | ) | | $ | — |
| | $ | 40 |
| | $ | (38 | ) | | $ | 2 |
|
Commodities | $ | — |
| | $ | 14 |
| | $ | (3 | ) | | $ | 11 |
| | $ | — |
| | $ | 14 |
| | $ | (4 | ) | | $ | 10 |
|
(1) Included in “Other investments” in the consolidated balance sheets.
(2) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.
(3) Cost includes fair value adjustments of $22 million at September 30, 2011 and $23 million at December 31, 2010.
Risk Management
Dow’s business operations give rise to market risk exposure due to changes in interest rates, foreign currency exchange rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies, which enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as cash flow, fair value or net foreign investment hedges where appropriate. The guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value. A secondary objective is to add value by creating additional nonspecific exposures within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not material to the Company’s results.
The Company’s risk management program for interest rate, foreign currency and commodity risks is based on fundamental, mathematical and technical models that take into account the implicit cost of hedging. Risks created by derivative instruments and the mark-to-market valuations of positions are strictly monitored at all times, using value at risk and stress tests. Counterparty credit risk arising from these contracts is not significant because the Company minimizes counterparty concentration, deals primarily with major financial institutions of solid credit quality, and the majority of its hedging transactions mature in less than three months. In addition, the Company minimizes concentrations of credit risk through its global orientation by transacting with large, internationally diversified financial counterparties. It is the Company’s policy not to have credit-risk-related contingent features in its derivative instruments. No significant concentration of counterparty credit risk existed at September 30, 2011. The Company does not anticipate losses from credit risk, and the net cash requirements arising from counterparty risk associated with risk management activities are not expected to be material in 2011.
The Company reviews its overall financial strategies and the impacts from using derivatives in its risk management program with the Company’s Board of Directors and revises its strategies as market conditions dictate.
Interest Rate Risk Management
The Company enters into various interest rate contracts with the objective of lowering funding costs or altering interest rate exposures related to fixed and variable rate obligations. In these contracts, the Company agrees with other parties to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated on an agreed-upon notional principal amount. At September 30, 2011, the Company had no open interest rate swaps.
Foreign Currency Risk Management
The Company’s global operations require active participation in foreign exchange markets. The Company enters into foreign exchange forward contracts and options, and cross-currency swaps to hedge various currency exposures or create desired exposures. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities. The primary business objective of the activity is to optimize the U.S. dollar value of the Company’s assets, liabilities and future cash flows with respect to exchange rate fluctuations. Assets and liabilities denominated in the same foreign currency are netted, and only the net exposure is hedged. At September 30, 2011, the Company had forward contracts, options and cross-currency swaps to buy, sell or exchange foreign currencies. These contracts had various expiration dates, primarily in the fourth quarter of 2011.
Commodity Risk Management
The Company has exposure to the prices of commodities in its procurement of certain raw materials. The primary purpose of commodity hedging activities is to manage the price volatility associated with these forecasted inventory purchases. At September 30, 2011, the Company had futures contracts, options and swaps to buy, sell or exchange commodities. These agreements had various expiration dates through 2012.
Accounting for Derivative Instruments and Hedging Activities
Cash Flow Hedges
For derivatives that are designated and qualify as cash flow hedging instruments, the effective portion of the gain or loss on the derivative is recorded in “Accumulated other comprehensive income (loss)” (“AOCI”); it is reclassified to “Cost of sales” in the same period or periods that the hedged transaction affects income. The unrealized amounts in AOCI fluctuate based on changes in the fair value of open contracts at the end of each reporting period. The Company anticipates volatility in AOCI and net income from its cash flow hedges. The amount of volatility varies with the level of derivative activities and market conditions during any period. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current period income.
The net loss from previously terminated interest rate cash flow hedges included in AOCI at September 30, 2011 was $1 million after tax ($2 million after tax at December 31, 2010). The Company had no open interest rate derivatives designated as cash flow hedges at September 30, 2011 or December 31, 2010.
Current open foreign currency forward contracts hedge the currency risk of forecasted feedstock purchase transactions until March 2012. The effective portion of the mark-to-market effects of the foreign currency forward contracts is recorded in AOCI; it is reclassified to income in the same period or periods that the underlying feedstock purchase affects income. The net gain from the foreign currency hedges included in AOCI at September 30, 2011 was $6 million after tax (net loss of $4 million after tax at December 31, 2010). At September 30, 2011, the Company had open forward contracts with various expiration dates to buy, sell or exchange foreign currencies with a notional U.S. dollar equivalent of $542 million ($827 million at December 31, 2010).
Commodity swaps, futures and option contracts with maturities of not more than 36 months are utilized and designated as cash flow hedges of forecasted commodity purchases. Current open contracts hedge forecasted transactions until December 2012. The effective portion of the mark-to-market effect of the cash flow hedge instrument is recorded in AOCI; it is reclassified to income in the same period or periods that the underlying commodity purchase affects income. The net gain from commodity hedges included in AOCI at September 30, 2011 was $1 million after tax ($3 million after tax at December 31, 2010). At September 30, 2011 and December 31, 2010, the Company had the following aggregate notionals of outstanding commodity forward contracts to hedge forecasted purchases:
|
| | | | | | | |
Commodity | Sep 30, 2011 |
| | Dec 31, 2010 |
| | Notional Volume Unit |
Crude Oil | 0.2 |
| | 0.1 |
| | million barrels |
Ethane | 0.3 |
| | 1.6 |
| | million barrels |
Natural Gas | 6.9 |
| | 2.7 |
| | million million British thermal units |
Fair Value Hedges
For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current period income and reflected as “Interest expense and amortization of debt discount” in the consolidated statements of income. The short-cut method is used when the criteria are met. The Company had no open interest rate swaps designated as fair value hedges of underlying fixed rate debt obligations at September 30, 2011 or December 31, 2010.
Net Foreign Investment Hedges
For derivative instruments that are designated and qualify as net foreign investment hedges, the effective portion of the gain or loss on the derivative is included in “Cumulative Translation Adjustments” in AOCI. The results of hedges of the Company’s net investment in foreign operations included in “Cumulative Translation Adjustments” in AOCI was a net loss of $59 million after tax at September 30, 2011 (net gain of $70 million after tax at December 31, 2010). At September 30, 2011 and December 31, 2010, the Company had no open forward contracts or outstanding options to buy, sell or exchange foreign currencies that were designated as net foreign investment hedges. At September 30, 2011, the Company had outstanding foreign-currency denominated debt designated as a hedge of net foreign investment of $602 million ($1,250 million at December 31, 2010).
Other Derivative Instruments
The Company utilizes futures, options and swap instruments that are effective as economic hedges of commodity price exposures, but do not meet the hedge accounting criteria in the accounting guidance for derivatives and hedging. At September 30, 2011 and December 31, 2010, the Company had the following aggregate notionals of outstanding commodity contracts:
|
| | | | | | | |
Commodity | Sep 30, 2011 |
| | Dec 31, 2010 |
| | Notional Volume Unit |
Crude Oil | 0.1 |
| | — |
| | million barrels |
Ethane | 2.3 |
| | 3.8 |
| | million barrels |
Naphtha | 53.0 |
| | — |
| | kilotons |
Natural Gas | 6.2 |
| | 12.0 |
| | million million British thermal units |
The Company also uses foreign exchange forward contracts, options, and cross-currency swaps that are not designated as hedging instruments primarily to manage foreign currency exposure. The Company had open foreign exchange contracts with various expiration dates to buy, sell or exchange foreign currencies with a notional U.S. dollar equivalent of $16,945 million at September 30, 2011 ($13,944 million at December 31, 2010).
The following table provides the fair value and gross balance sheet classification of derivative instruments at September 30, 2011 and December 31, 2010:
|
| | | | | | | | | |
Fair Value of Derivative Instruments In millions | Balance Sheet Classification | | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Asset Derivatives | | | | | |
Derivatives designated as hedges: | | | | | |
Foreign currency | Accounts and notes receivable – Other | | $ | 7 |
| | $ | 9 |
|
Commodities | Other current assets (1) | | 3 |
| | 7 |
|
Total derivatives designated as hedges | | | $ | 10 |
| | $ | 16 |
|
Derivatives not designated as hedges: | | | | | |
Foreign currency | Accounts and notes receivable – Other | | $ | 153 |
| | $ | 77 |
|
Commodities | Other current assets (1) | | 34 |
| | 23 |
|
Total derivatives not designated as hedges | | | $ | 187 |
| | $ | 100 |
|
Total asset derivatives | | | $ | 197 |
| | $ | 116 |
|
Liability Derivatives | | | | | |
Derivatives designated as hedges: | | | | | |
Foreign currency | Accounts payable – Other | | $ | 2 |
| | $ | 20 |
|
Commodities | Accounts payable – Other | | 3 |
| | 8 |
|
Total derivatives designated as hedges | | | $ | 5 |
| | $ | 28 |
|
Derivatives not designated as hedges: | | | | | |
Foreign currency | Accounts payable – Other | | $ | 173 |
| | $ | 64 |
|
Commodities | Accounts payable – Other | | 20 |
| | 16 |
|
Total derivatives not designated as hedges | | | $ | 193 |
| | $ | 80 |
|
Total liability derivatives | | | $ | 198 |
| | $ | 108 |
|
(1) Included in “Accounts and notes receivable – Other” in the consolidated balance sheet at December 31, 2010.
|
| | | | | | | | | | | | | |
Effect of Derivative Instruments for the three months ended September 30, 2011
In millions | Change in Unrealized Gain (Loss) in AOCI (1,2) |
| | Income Statement Classification | | Gain (Loss) Reclassified from AOCI to Income (3) |
| | Additional Gain (Loss) Recognized in Income (3,4) |
|
Derivatives designated as hedges: | | | | | | | |
Cash flow: | | | | | | | |
Commodities | $ | 2 |
| | Cost of sales | | $ | 8 |
| | $ | — |
|
Foreign currency | 7 |
| | Cost of sales | | (4 | ) | | — |
|
Total derivatives designated as hedges | $ | 9 |
| | | | $ | 4 |
| | $ | — |
|
Derivatives not designated as hedges: | | | | | | | |
Foreign currency (5) | $ | — |
| | Sundry income (expense) – net | | $ | — |
| | $ | (20 | ) |
Commodities | — |
| | Cost of sales | | — |
| | (5 | ) |
Total derivatives not designated as hedges | $ | — |
| | | | $ | — |
| | $ | (25 | ) |
Total derivatives | $ | 9 |
| | | | $ | 4 |
| | $ | (25 | ) |
| | | | | | | |
| | | | | | | |
Effect of Derivative Instruments for the three months ended September 30, 2010
In millions | Change in Unrealized Gain (Loss) in AOCI (1,2) |
| | Income Statement Classification | | Gain (Loss) Reclassified from AOCI to Income (3) |
| | Additional Gain (Loss) Recognized in Income (3,4) |
|
Derivatives designated as hedges: | | | | | | | |
Cash flow: | | | | | | | |
Commodities | $ | 4 |
| | Cost of sales | | $ | (10 | ) | | $ | — |
|
Foreign currency | (16 | ) | | Cost of sales | | 2 |
| | — |
|
Net foreign investment: | | | | | | | |
Foreign currency | 4 |
| | n/a | | — |
| | — |
|
Total derivatives designated as hedges | $ | (8 | ) | | | | $ | (8 | ) | | $ | — |
|
Derivatives not designated as hedges: | | | | | | | |
Foreign currency (5) | $ | — |
| | Sundry income (expense) – net | | $ | — |
| | $ | 44 |
|
Commodities | — |
| | Cost of sales | | — |
| | 5 |
|
Total derivatives not designated as hedges | $ | — |
| | | | $ | — |
| | $ | 49 |
|
Total derivatives | $ | (8 | ) | | | | $ | (8 | ) | | $ | 49 |
|
| |
(1) | Accumulated other comprehensive income (loss) (“AOCI”). |
| |
(2) | Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statements of equity. |
| |
(4) | Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness. |
| |
(5) | Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities. |
|
| | | | | | | | | | | | | |
Effect of Derivative Instruments for the nine months ended September 30, 2011
In millions | Change in Unrealized Gain (Loss) in AOCI (1,2) |
| | Income Statement Classification | | Gain (Loss) Reclassified from AOCI to Income (3) |
| | Additional Gain (Loss) Recognized in Income (3,4) |
|
Derivatives designated as hedges: | | | | | | | |
Fair value: | | | | | | | |
Interest rates | $ | — |
| | Interest expense (5) | | $ | (1 | ) | | $ | (1 | ) |
Cash flow: | | | | | | | |
Commodities | 12 |
| | Cost of sales | | 19 |
| | — |
|
Foreign currency | (9 | ) | | Cost of sales | | (21 | ) | | — |
|
Total derivatives designated as hedges | $ | 3 |
| | | | $ | (3 | ) | | $ | (1 | ) |
Derivatives not designated as hedges: | | | | | | | |
Foreign currency (6) | $ | — |
| | Sundry income (expense) – net | | $ | — |
| | $ | 21 |
|
Commodities | — |
| | Cost of sales | | — |
| | (18 | ) |
Total derivatives not designated as hedges | $ | — |
| | | | $ | — |
| | $ | 3 |
|
Total derivatives | $ | 3 |
| | | | $ | (3 | ) | | $ | 2 |
|
| | | | | | | |
| | | | | | | |
Effect of Derivative Instruments for the nine months ended September 30, 2010
In millions | Change in Unrealized Gain (Loss) in AOCI (1,2) |
| | Income Statement Classification | | Gain (Loss) Reclassified from AOCI to Income (3) |
| | Additional Gain (Loss) Recognized in Income (3,4) |
|
Derivatives designated as hedges: | | | | | | | |
Fair value: | | | | | | | |
Interest rates | $ | (1 | ) | | Interest expense (5) | | $ | — |
| | $ | (1 | ) |
Cash flow: | | | | | | | |
Commodities | (14 | ) | | Cost of sales | | (14 | ) | | — |
|
Foreign currency | 4 |
| | Cost of sales | | (1 | ) | | — |
|
Net foreign investment: | | | | | | | |
Foreign currency | (16 | ) | | n/a | | — |
| | — |
|
Total derivatives designated as hedges | $ | (27 | ) | | | | $ | (15 | ) | | $ | (1 | ) |
Derivatives not designated as hedges: | | | | | | | |
Foreign currency (6) | $ | — |
| | Sundry income (expense) – net | | $ | — |
| | $ | 157 |
|
Commodities | — |
| | Cost of sales | | — |
| | 1 |
|
Total derivatives not designated as hedges | $ | — |
| | | | $ | — |
| | $ | 158 |
|
Total derivatives | $ | (27 | ) | | | | $ | (15 | ) | | $ | 157 |
|
| |
(1) | Accumulated other comprehensive income (loss) (“AOCI”). |
| |
(2) | Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statements of equity. |
| |
(4) | Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness. |
| |
(5) | Interest expense and amortization of debt discount. |
| |
(6) | Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities. |
The net after-tax amounts to be reclassified from AOCI to income within the next 12 months are a $1 million loss for interest rate contracts, a $1 million gain for commodity contracts and a $6 million gain for foreign currency contracts.
NOTE I – FAIR VALUE MEASUREMENTS
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis in the consolidated balance sheets:
|
| | | | | | | | | | | | | | | | | | | |
Basis of Fair Value Measurements on a Recurring Basis at September 30, 2011
In millions | Quoted Prices in Active Markets for Identical Items (Level 1) |
| | Significant Other Observable Inputs (Level 2) |
| | Significant Unobservable Inputs (Level 3) |
| | Counterparty and Cash Collateral Netting (1) |
| | Total |
|
Assets at fair value: | | | | | | | | | |
Interests in trade accounts receivable conduits (2) | $ | — |
| | $ | — |
| | $ | 1,245 |
| | $ | — |
| | $ | 1,245 |
|
Equity securities (3) | 583 |
| | 31 |
| | — |
| | — |
| | 614 |
|
Debt securities: (3) |
| |
| |
| |
| | |
Government debt (4) | — |
| | 606 |
| | — |
| | — |
| | 606 |
|
Corporate bonds | — |
| | 722 |
| | — |
| | — |
| | 722 |
|
Derivatives relating to: (5) |
| |
| |
| |
| | |
Foreign currency | — |
| | 160 |
| | — |
| | (67 | ) | | 93 |
|
Commodities | 13 |
| | 24 |
| | — |
| | (23 | ) | | 14 |
|
Total assets at fair value | $ | 596 |
| | $ | 1,543 |
| | $ | 1,245 |
| | $ | (90 | ) | | $ | 3,294 |
|
Liabilities at fair value: | | | | | | | | | |
Derivatives relating to: (5) | | | | | | | | | |
Foreign currency | $ | — |
| | $ | 175 |
| | $ | — |
| | $ | (67 | ) | | $ | 108 |
|
Commodities | 5 |
| | 18 |
| | — |
| | (20 | ) | | 3 |
|
Total liabilities at fair value | $ | 5 |
| | $ | 193 |
| | $ | — |
| | $ | (87 | ) | | $ | 111 |
|
|
| | | | | | | | | | | | | | | | | | | |
Basis of Fair Value Measurements on a Recurring Basis at December 31, 2010
In millions | Quoted Prices in Active Markets for Identical Items (Level 1) |
| | Significant Other Observable Inputs (Level 2) |
| | Significant Unobservable Inputs (Level 3) |
| | Counterparty and Cash Collateral Netting (1) |
| | Total |
|
Assets at fair value: | | | | | | | | | |
Interests in trade accounts receivable conduits (2) | $ | — |
| | $ | — |
| | $ | 1,267 |
| | $ | — |
| | $ | 1,267 |
|
Equity securities (3) | 556 |
| | 36 |
| | — |
| | — |
| | 592 |
|
Debt securities: (3) |
| |
| |
| |
| | |
Government debt (4) | — |
| | 641 |
| | — |
| | — |
| | 641 |
|
Corporate bonds | — |
| | 831 |
| | — |
| | — |
| | 831 |
|
Derivatives relating to: (5) |
| |
| |
| |
| | |
Foreign currency | — |
| | 86 |
| | — |
| | (46 | ) | | 40 |
|
Commodities | 12 |
| | 18 |
| | — |
| | (16 | ) | | 14 |
|
Total assets at fair value | $ | 568 |
| | $ | 1,612 |
| | $ | 1,267 |
| | $ | (62 | ) | | $ | 3,385 |
|
Liabilities at fair value: | | | | | | | | | |
Derivatives relating to: (5) | | | | | | | | | |
Foreign currency | $ | — |
| | $ | 84 |
| | $ | — |
| | $ | (46 | ) | | $ | 38 |
|
Commodities | 7 |
| | 17 |
| | — |
| | (20 | ) | | 4 |
|
Total liabilities at fair value | $ | 7 |
| | $ | 101 |
| | $ | — |
| | $ | (66 | ) | | $ | 42 |
|
| |
(1) | Cash collateral is classified as “Accounts and notes receivable – Other” in the consolidated balance sheets. Amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. |
| |
(2) | Included in “Accounts and notes receivable – Other” in the consolidated balance sheets. See Note K for additional information on transfers of financial assets. |
| |
(3) | The Company’s investments in equity and debt securities are primarily classified as available-for-sale and are included in “Other investments” in the consolidated balance sheets. |
| |
(4) | U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations. |
| |
(5) | See Note H for the classification of derivatives in the consolidated balance sheets. |
Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets and liabilities. The Company borrowed $2 million of cash collateral against $8 million of unrealized gains at September 30, 2011 (posted $4 million of cash collateral at December 31, 2010). The net $6 million at September 30, 2011 and the $4 million at December 31, 2010 were classified as “Accounts and notes receivable – Other” in the consolidated balance sheets.
For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange in which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.
For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.
For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note H for further information on the types of instruments used by the Company for risk management.
There were no significant transfers between Levels 1 and 2 in the nine-month period ended September 30, 2011 or the year ended December 31, 2010.
For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests. See Note K for further information on assets classified as Level 3 measurements.
The following table summarizes the changes in fair value measurements using Level 3 inputs for the three- and nine-month periods ended September 30, 2011 and 2010:
|
| | | | | | | | | | | | | | | |
Fair Value Measurements Using Level 3 Inputs | Three Months Ended | | Nine Months Ended |
Interests Held in Trade Receivable Conduits (1) In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Balance at beginning of period | $ | 1,389 |
| | $ | 1,206 |
| | $ | 1,267 |
| | $ | — |
|
Gain (Loss) included in earnings (2) | (1 | ) | | (2 | ) | | (6 | ) | | 7 |
|
Purchases – North America | 117 |
| | 155 |
| | 1,215 |
| | 1,976 |
|
Purchases – Europe | 32 |
| | 16 |
| | 285 |
| | 160 |
|
Settlements – North America | (229 | ) | | (55 | ) | | (1,229 | ) | | (823 | ) |
Settlements – Europe | (63 | ) | | (8 | ) | | (287 | ) | | (8 | ) |
Balance at September 30 | $ | 1,245 |
| | $ | 1,312 |
| | $ | 1,245 |
| | $ | 1,312 |
|
| |
(1) | Included in “Accounts and notes receivable – Other” in the consolidated balance sheets. |
| |
(2) | Included in “Selling, general and administrative expenses” in the consolidated statements of income. |
NOTE J – COMMITMENTS AND CONTINGENT LIABILITIES
Litigation
Breast Implant Matters
On May 15, 1995, Dow Corning Corporation (“Dow Corning”), in which the Company is a 50 percent shareholder, voluntarily filed for protection under Chapter 11 of the Bankruptcy Code to resolve litigation related to Dow Corning’s breast implant and other silicone medical products. On June 1, 2004, Dow Corning’s Joint Plan of Reorganization (the “Joint Plan”) became effective and Dow Corning emerged from bankruptcy. The Joint Plan contains release and injunction provisions resolving all tort claims brought against various entities, including the Company, involving Dow Corning’s breast implant and other silicone medical products.
To the extent not previously resolved in state court actions, cases involving Dow Corning’s breast implant and other silicone medical products filed against the Company were transferred to the U.S. District Court for the Eastern District of Michigan (the “District Court”) for resolution in the context of the Joint Plan. On October 6, 2005, all such cases then pending in the District Court against the Company were dismissed. Should cases involving Dow Corning’s breast implant and other silicone medical products be filed against the Company in the future, they will be accorded similar treatment. It is the opinion of the Company’s management that the possibility is remote that a resolution of all future cases will have a material adverse impact on the Company’s consolidated financial statements.
As part of the Joint Plan, Dow and Corning Incorporated agreed to provide a credit facility to Dow Corning in an aggregate amount of $300 million, which was reduced to $150 million effective June 1, 2011. The Company’s share of the credit facility was originally $150 million, but was reduced to $75 million effective June 1, 2011, and is subject to the terms and conditions stated in the Joint Plan. At September 30, 2011, no draws had been taken against the credit facility.
DBCP Matters
Numerous lawsuits have been brought against the Company and other chemical companies, both inside and outside of the United States, alleging that the manufacture, distribution or use of pesticides containing dibromochloropropane (“DBCP”) has caused personal injury and property damage, including contamination of groundwater. It is the opinion of the Company’s management that the possibility is remote that the resolution of such lawsuits will have a material adverse impact on the Company’s consolidated financial statements.
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At September 30, 2011, the Company had accrued obligations of $666 million for probable environmental remediation and restoration costs, including $64 million for the remediation of Superfund sites. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although the ultimate cost with respect to these particular matters could range up to approximately twice that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material adverse impact on the Company’s results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material adverse impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. At December 31, 2010, the Company had accrued obligations of $607 million for probable environmental remediation and restoration costs, including $59 million for the remediation of Superfund sites.
Midland Off-Site Environmental Matters
On June 12, 2003, the Michigan Department of Environmental Quality ("MDEQ") issued a Hazardous Waste Operating License (the “License”) to the Company’s Midland, Michigan manufacturing site (the “Midland site”), which included provisions requiring the Company to conduct an investigation to determine the nature and extent of off-site contamination in the City of Midland soils; the Tittabawassee River and Saginaw River sediment and floodplain soils; and the Saginaw Bay; and, if necessary, undertake remedial action.
City of Midland
Matters related to the City of Midland remain under the primary oversight of the State of Michigan (the “State”) under the License, and the Company and the State are in ongoing discussions regarding the implementation of the requirements of the License.
Tittabawassee and Saginaw Rivers, Saginaw Bay
The Company, the U.S. Environmental Protection Agency (“EPA”) and the State entered into an administrative order on consent (“AOC”), effective January 21, 2010, that requires the Company to conduct a remedial investigation, a feasibility study and a remedial design for the Tittabawassee River, the Saginaw River and the Saginaw Bay, and pay the oversight costs of the EPA and the State under the authority of the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”). These actions, to be conducted under the lead oversight of the EPA, will build upon the investigative work completed under the State Resource Conservation Recovery Act (“RCRA”) program from 2005 through 2009. The Tittabawassee River, beginning at the Midland Site and extending down to the first six miles of the Saginaw River, are designated as the first Operable Unit for purposes of conducting the remedial investigation, feasibility study and remedial design work. This work will be performed in a largely upriver to downriver sequence for eight geographic segments of the Tittabawassee and upper Saginaw Rivers. The remainder of the Saginaw River and the Saginaw Bay are designated as a second Operable Unit and the work associated with that unit may also be geographically segmented. The AOC does not obligate the Company to perform removal or remedial action; that action can only be required by a separate order. The Company and the EPA will be negotiating orders separate from the AOC that will obligate the Company to perform remedial actions under the scope of work of the AOC. The Company and the EPA have entered into two separate orders to perform limited remedial actions to implement early actions. In addition, the Company and the EPA have entered into the first order to address remedial actions in the first of the eight geographic segments in the first Operable Unit.
Alternative Dispute Resolution Process
The Company; the EPA; the U.S. Department of Justice; and the natural resource damage trustees (the Michigan Office of the Attorney General; the MDEQ; the U.S. Fish and Wildlife Service; the U.S. Bureau of Indian Affairs and the Saginaw-Chippewa tribe), have been engaged in negotiations to seek to resolve potential governmental claims against the Company related to historical off-site contamination associated with the City of Midland, the Tittabawassee and Saginaw Rivers and the Saginaw Bay. The Company and the governmental parties started meeting in the fall of 2005 and entered into a Confidentiality Agreement in December 2005. The Company continues to conduct negotiations under the Federal Alternative Dispute Resolution Act with all of the governmental parties, except the EPA which withdrew from the alternative dispute resolution process on September 12, 2007.
On September 28, 2007, the Company and the natural resource damage trustees entered into a Funding and Participation Agreement that addressed the Company’s payment of past costs incurred by the natural resource damage trustees, payment of the costs of a trustee coordinator and a process to review additional cooperative studies that the Company might agree to fund or conduct with the natural resource damage trustees. On March 18, 2008, the Company and the natural resource damage trustees entered into a Memorandum of Understanding to provide a mechanism for the Company to fund cooperative studies related to the assessment of natural resource damages. This Memorandum of Understanding has been amended and extended until March 2013. On April 7, 2008, the natural resource damage trustees released their “Natural Resource Damage Assessment Plan for the Tittabawassee River System Assessment Area.”
At September 30, 2011, the accrual for these off-site matters was $42 million (included in the total accrued obligation of $666 million at September 30, 2011). At December 31, 2010, the Company had an accrual for these off-site matters of $32 million (included in the total accrued obligation of $607 million).
Asbestos-Related Matters of Union Carbide Corporation
Union Carbide Corporation (“Union Carbide”), a wholly owned subsidiary of the Company, is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.
Influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation and the prospects of various forms of state and national legislative reform, the rate at which plaintiffs filed asbestos-related suits against various companies, including Union Carbide and Amchem, increased in 2001, 2002 and the first half of 2003. Since then, the rate of filing has significantly abated. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.
Based on a study completed by Analysis, Research & Planning Corporation (“ARPC”) in January 2003, Union Carbide increased its December 31, 2002 asbestos-related liability for pending and future claims for the 15-year period ending in 2017 to $2.2 billion, excluding future defense and processing costs. Since then, Union Carbide has compared current asbestos claim and resolution activity to the results of the most recent ARPC study at each balance sheet date to determine whether the accrual continues to be appropriate. In addition, Union Carbide has requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity each November since 2004 to determine the appropriateness of updating the most recent ARPC study.
In November 2009, Union Carbide requested ARPC to review Union Carbide’s 2009 asbestos claim and resolution activity and determine the appropriateness of updating its then most recent study completed in December 2008. In response to that request, ARPC reviewed and analyzed data through October 31, 2009. In December 2009, ARPC stated that an update of its study would not provide a more likely estimate of future events than the estimate reflected in its study of the previous year and, therefore, the estimate in that study remained applicable. Based on Union Carbide’s own review of the asbestos claim and resolution activity and ARPC’s response, Union Carbide determined that no change to the accrual was required. At December 31, 2009, Union Carbide’s asbestos-related liability for pending and future claims was $839 million.
In November 2010, Union Carbide requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity and determine the appropriateness of updating its December 2008 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2010. The resulting study, completed by ARPC in December 2010, stated that the undiscounted cost of resolving pending and future asbestos-related claims against Union Carbide and Amchem, excluding future defense and processing costs, through 2025 was estimated to be between $744 million and $835 million. As in its earlier studies, ARPC provided estimates for a longer period of time in its December 2010 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time.
In December 2010, based on ARPC’s December 2010 study and Union Carbide’s own review of the asbestos claim and resolution activity, Union Carbide decreased its asbestos-related liability for pending and future claims to $744 million, which covered the 15-year period ending 2025, excluding future defense and processing costs. The reduction was $54 million and was shown as “Asbestos-related credits” in the consolidated statements of income. At December 31, 2010, the asbestos-related liability for pending and future claims was $728 million. At December 31, 2010, approximately 21 percent of the recorded liability related to pending claims and approximately 79 percent related to future claims.
Based on Union Carbide’s review of 2011 activity, Union Carbide determined that no adjustment to the accrual was required at September 30, 2011. Union Carbide’s asbestos-related liability for pending and future claims was $690 million at September 30, 2011. Approximately 18 percent of the recorded liability related to pending claims and approximately 82 percent related to future claims.
At December 31, 2002, Union Carbide increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion, substantially exhausting its asbestos product liability coverage. The insurance receivable related to the asbestos liability was determined by Union Carbide after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which Union Carbide and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The Wellington Agreement and other agreements with insurers are designed to facilitate an orderly resolution and collection of Union Carbide’s insurance policies and to resolve issues that the insurance carriers may raise.
In September 2003, Union Carbide filed a comprehensive insurance coverage case, now proceeding in the Supreme Court of the State of New York, County of New York, seeking to confirm its rights to insurance for various asbestos claims and to facilitate an orderly and timely collection of insurance proceeds (the “Insurance Litigation”). The Insurance Litigation was filed against insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place with Union Carbide regarding their asbestos-related insurance coverage, in order to facilitate an orderly resolution and collection of such insurance policies and to resolve issues that the insurance carriers may raise. Since the filing of the case, Union Carbide has reached settlements with several of the carriers involved in the Insurance Litigation, including settlements reached with two significant carriers in the fourth quarter of 2009. The Insurance Litigation is ongoing.
Union Carbide’s receivable for insurance recoveries related to its asbestos liability was $50 million at September 30, 2011 and $50 million at December 31, 2010. At September 30, 2011 and December 31, 2010, all of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.
In addition to the receivable for insurance recoveries related to its asbestos liability, Union Carbide had receivables for defense and resolution costs submitted to insurance carriers that have settlement agreements in place regarding their asbestos-related insurance coverage.
The following table summarizes Union Carbide’s receivables related to its asbestos-related liability:
|
| | | | | | | |
Receivables for Asbestos-Related Costs In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Receivables for defense costs – carriers with settlement agreements | $ | 20 |
| | $ | 12 |
|
Receivables for resolution costs – carriers with settlement agreements | 166 |
| | 236 |
|
Receivables for insurance recoveries – carriers without settlement agreements | 50 |
| | 50 |
|
Total | $ | 236 |
| | $ | 298 |
|
Union Carbide expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $30 million in the third quarter of 2011 ($22 million in the third quarter of 2010) and $58 million in the first nine months of 2011 ($58 million in the first nine months of 2010 ), and was reflected in “Cost of sales.”
After a review of its insurance policies, with due consideration given to applicable deductibles, retentions and policy limits, after taking into account the solvency and historical payment experience of various insurance carriers; existing insurance settlements; and the advice of outside counsel with respect to the applicable insurance coverage law relating to the terms and conditions of its insurance policies, Union Carbide continues to believe that its recorded receivable for insurance recoveries from all insurance carriers is probable of collection.
The amounts recorded by Union Carbide for the asbestos-related liability and related insurance receivable described above were based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of disposing of each such claim, coverage issues among insurers, and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries for Union Carbide to be higher or lower than those projected or those recorded.
Because of the uncertainties described above, Union Carbide’s management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. Union Carbide’s management believes that it is reasonably possible that the cost of disposing of Union Carbide’s asbestos-related claims, including future defense costs, could have a material adverse impact on Union Carbide’s results of operations and cash flows for a particular period and on the consolidated financial position of Union Carbide.
It is the opinion of Dow’s management that it is reasonably possible that the cost of Union Carbide disposing of its asbestos-related claims, including future defense costs, could have a material adverse impact on the Company’s results of operations and cash flows for a particular period and on the consolidated financial position of the Company.
Synthetic Rubber Industry Matters
In 2003, the U.S., Canadian and European competition authorities initiated separate investigations into alleged anticompetitive behavior by certain participants in the synthetic rubber industry. Certain subsidiaries of the Company (but as to the investigation in Europe only) have responded to requests for documents and are otherwise cooperating in the investigations.
On June 10, 2005, the Company received a Statement of Objections from the European Commission (the “EC”) stating that it believed that the Company and certain subsidiaries of the Company (the “Dow Entities”), together with other participants in the synthetic rubber industry, engaged in conduct in violation of European competition laws with respect to the butadiene rubber and emulsion styrene butadiene rubber businesses. In connection therewith, on November 29, 2006, the EC issued its decision alleging infringement of Article 81 of the Treaty of Rome and imposed a fine of Euro 64.575 million (approximately $85 million at that time) on the Dow Entities; several other companies were also named and fined. As a result, the Company recognized a loss contingency of $85 million related to the fine in the fourth quarter of 2006. The Company appealed the EC’s decision and a hearing was held before the Court of First Instance on October 13, 2009. On July 13, 2011, the General Court issued a decision that partly affirmed the EC's decision with regard to the amount of the fine and the liability of the parent company, but rejected the EC's decision regarding the length of the conspiracy and determined that it was of a shorter duration. The Dow Entities have filed an appeal of this decision to the Court of Justice of the European Union. Subsequent to the imposition of the fine in 2006, the Company and/or certain subsidiaries of the Company became named parties in various related U.S., United Kingdom and Italian civil actions. The U.S. matter was settled in March 2010 through a confidential settlement agreement, with an immaterial impact on the Company’s consolidated financial statements. The United Kingdom and Italian civil actions are still pending.
Additionally, on March 10, 2007, the Company received a Statement of Objections from the EC stating that it believed that DuPont Dow Elastomers L.L.C. (“DDE”), a former 50:50 joint venture with E.I. du Pont de Nemours and Company (“DuPont”), together with other participants in the synthetic rubber industry, engaged in conduct in violation of European competition laws with respect to the polychloroprene business. This Statement of Objections specifically names the Company, in its capacity as a former joint venture owner of DDE. On December 5, 2007, the EC announced its decision to impose a fine on the Company, among others, in the amount of Euro 48.675 million (approximately $66 million). The Company previously transferred its joint venture ownership interest in DDE to DuPont in 2005, and DDE then changed its name to DuPont Performance Elastomers L.L.C. (“DPE”). In February 2008, DuPont, DPE and the Company each filed an appeal of the December 5, 2007 decision of the EC. Based on the Company’s allocation agreement with DuPont, the Company’s share of this fine, regardless of the outcome of the appeals, will not have a material adverse impact on the Company’s consolidated financial statements.
Rohm and Haas Pension Plan Matters
In December 2005, a federal judge in the U.S. District Court for the Southern District of Indiana (the “District Court”) issued a decision granting a class of participants in the Rohm and Haas Pension Plan (the “Rohm and Haas Plan”) who had retired from Rohm and Haas, now a wholly owned subsidiary of the Company, and who elected to receive a lump sum benefit from the Rohm and Haas Plan, the right to a cost-of-living adjustment (“COLA”) as part of their retirement benefit. In August 2007, the Seventh Circuit Court of Appeals (the "Seventh Circuit") affirmed the District Court’s decision, and in March 2008, the U.S. Supreme Court denied the Rohm and Haas Plan’s petition to review the Seventh Circuit’s decision. The case was returned to the District Court for further proceedings. In October 2008 and February 2009, the District Court issued rulings that have the effect of including in the class all Rohm and Haas retirees who received a lump sum distribution without a COLA from the Rohm and Haas Plan since January 1976. These rulings are subject to appeal, and the District Court has not yet determined the amount of the COLA benefits that may be due to the class participants. The Rohm and Haas Plan and the plaintiffs entered into a settlement agreement that, in addition to settling the litigation with respect to the Rohm and Haas retirees, provides for the amendment of the complaint and amendment of the Rohm and Haas Plan to include active employees in the settlement benefits. The District Court preliminarily approved the settlement on November 24, 2009 and, following a hearing on March 12, 2010, issued a final order approving the settlement on April 12, 2010. A group of objectors to the settlement filed an appeal from the final order. In November 2010, the District Court issued an order approving class counsel’s fee award petition in an amount consistent with the terms of the settlement. The same objectors also appealed this order. On September 2, 2011, the Seventh Circuit affirmed the approval of the settlement and the award of attorneys' fees. A lone objector filed a petition for rehearing, which was denied on October 17, 2011.
A pension liability associated with this matter of $185 million was recognized as part of the acquisition of Rohm and Haas on April 1, 2009. The liability, which was determined in accordance with the accounting guidance for contingencies, recognized the estimated impact of the above described judicial decisions on the long-term Rohm and Haas Plan obligations owed to the applicable Rohm and Haas retirees and active employees. The Company had a liability associated with this matter of $186 million at September 30, 2011 and $186 million at December 31, 2010.
Other Litigation Matters
In addition to breast implant, DBCP, environmental and synthetic rubber industry matters, the Company is party to a number of other claims and lawsuits arising out of the normal course of business with respect to commercial matters, including product liability, governmental regulation and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. Dow has an active risk management program consisting of numerous insurance policies secured from many carriers at various times. These policies provide coverage that will be utilized to minimize the impact, if any, of the contingencies described above.
Summary
Except for the possible effect of Union Carbide’s asbestos-related liability described above, it is the opinion of the Company’s management that the possibility is remote that the aggregate of all claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company.
Purchase Commitments
The Company has numerous agreements for the purchase of ethylene-related products globally. The purchase prices are determined primarily on a cost-plus basis. Total purchases under these agreements were $714 million in 2010, $784 million in 2009 and $1,502 million in 2008. The Company’s take-or-pay commitments associated with these agreements at December 31, 2010 are included in the table below. There have been no material changes to purchase commitments since December 31, 2010.
The Company also has various commitments for take-or-pay and throughput agreements. Such commitments are at prices not in excess of current market prices. The terms of all but two of these agreements extend from one to 25 years. One agreement has terms extending to 35 years and another has terms extending to 80 years. The determinable future commitments for these agreements are included for 10 years in the following table which presents the fixed and determinable portion of obligations under the Company’s purchase commitments at December 31, 2010:
|
| | | |
Fixed and Determinable Portion of Take-or-Pay and Throughput Obligations at December 31, 2010 In millions |
2011 | $ | 3,603 |
|
2012 | 3,261 |
|
2013 | 2,647 |
|
2014 | 2,055 |
|
2015 | 1,341 |
|
2016 - 2020 | 8,203 |
|
Total | $ | 21,110 |
|
In addition to the take-or-pay obligations at December 31, 2010, the Company had outstanding commitments which ranged from one to ten years for materials, services and other items used in the normal course of business of approximately $180 million. Such commitments were at prices not in excess of current market prices.
Guarantees
The Company provides a variety of guarantees as described more fully in the following sections.
Guarantees
Guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to ten years, and trade financing transactions in Latin America, which typically expire within one year of their inception. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered unlikely.
Residual Value Guarantees
The Company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.
The following tables provide a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for each type of guarantee:
|
| | | | | | | | | |
Guarantees at September 30, 2011 In millions | Final Expiration | | Maximum Future Payments (1) |
| | Recorded Liability |
|
Guarantees | 2020 | | $ | 431 |
| | $ | 19 |
|
Residual value guarantees | 2021 | | 508 |
| | 23 |
|
Total guarantees | | | $ | 939 |
| | $ | 42 |
|
| |
(1) | The Company was indemnified by a third party for $52 million if required to perform under a $105 million guarantee. |
|
| | | | | | | | | |
Guarantees at December 31, 2010 In millions | Final Expiration | | Maximum Future Payments (1) |
| | Recorded Liability |
|
Guarantees | 2020 | | $ | 445 |
| | $ | 80 |
|
Residual value guarantees | 2020 | | 391 |
| | 17 |
|
Total guarantees | | | $ | 836 |
| | $ | 97 |
|
| |
(1) | The Company was indemnified by a third party for $53 million if required to perform under a $106 million guarantee. |
Asset Retirement Obligations
The Company has recognized asset retirement obligations for the following activities: demolition and remediation activities at manufacturing sites in the United States, Canada, Brazil, Chile, China and Europe; capping activities at landfill sites in the United States, Canada, Brazil and Europe; and asbestos encapsulation as a result of planned demolition and remediation activities at manufacturing and administrative sites in the United States, Canada, Brazil, Chile, China and Europe.
The aggregate carrying amount of asset retirement obligations recognized by the Company was $87 million at September 30, 2011 and $99 million at December 31, 2010. The discount rate used to calculate the Company’s asset retirement obligations was 1.78 percent at September 30, 2011 and 1.78 percent at December 31, 2010. These obligations are included in the consolidated balance sheets as “Other noncurrent obligations.”
The Company has not recognized conditional asset retirement obligations for which a fair value cannot be reasonably estimated in its consolidated financial statements. It is the opinion of the Company’s management that the possibility is remote that such conditional asset retirement obligations, when estimable, will have a material adverse impact on the Company’s consolidated financial statements based on current costs.
NOTE K – TRANSFERS OF FINANCIAL ASSETS
Sale of Trade Accounts Receivable in North America
The Company sells trade accounts receivable of select North America entities on a revolving basis to certain multi-seller commercial paper conduit entities. The Company maintains servicing responsibilities and the related costs are insignificant. The proceeds received are comprised of cash and interests in specified assets (the receivables sold by the Company) of the conduits that entitle the Company to the residual cash flows of such specified assets in the conduits after the commercial paper has been repaid. Neither the conduits nor the investors in those entities have recourse to other assets of the Company in the event of nonpayment by the debtors.
During the three months ended September 30, 2011, the Company recognized a loss of $3 million on the sale of these receivables ($5 million during the three months ended September 30, 2010), which was classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. During the nine months ended September 30, 2011, the Company recognized a loss of $7 million on the sale of receivables ($14 million during the nine months ended September 30, 2010).
The Company classifies its interests in the conduits as “Accounts and notes receivable – Other” on the consolidated balance sheets and those interests are carried at fair value. Fair value of the interests is determined by calculating the expected amount of cash to be received and is based on unobservable inputs (a Level 3 measurement). The key input in the valuation is percentage of anticipated credit losses, which was 1.52 percent at September 30, 2011 (1.42 percent at December 31, 2010), in the portfolio of receivables sold that had not yet been collected. Given the short-term nature of the underlying receivables, discount rates and prepayments are not factors in determining the fair value of the interests. Credit losses, net of any recoveries, on receivables sold were insignificant for the three-month period ended September 30, 2011 ($1 million for the three-month period ended September 30, 2010) and insignificant for the nine-month period ended September 30, 2011 ($2 million for the nine-month period ended September 30, 2010). At September 30, 2011, the carrying value of the interests held was $1,090 million ($1,110 million at December 31, 2010), which is the Company’s maximum exposure to loss related to the receivables sold.
The sensitivity of the fair value of the interests held to hypothetical adverse changes in the anticipated credit losses assumption are as follows (amounts shown are the corresponding hypothetical decreases in the carrying value of the interests):
|
| | | | | | | |
Impact to Carrying Value In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
10% adverse change | $ | 2 |
| | $ | 2 |
|
20% adverse change | $ | 5 |
| | $ | 5 |
|
Following is an analysis of certain cash flows between the Company and the North American conduits:
|
| | | | | | | | | | | | | | | |
Cash Proceeds | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sale of receivables | $ | — |
| | $ | — |
| | $ | — |
| | $ | 264 |
|
Collections reinvested in revolving receivables | $ | 5,704 |
| | $ | 4,893 |
| | $ | 15,422 |
| | $ | 12,611 |
|
Interests in conduits (1) | $ | 157 |
| | $ | 55 |
| | $ | 1,157 |
| | $ | 810 |
|
(1) Presented in "Operating Activities" in the consolidated statements of cash flows.
Delinquencies on the sold receivables that were still outstanding at September 30, 2011 were $117 million ($127 million at December 31, 2010). Trade accounts receivable outstanding and derecognized from the Company’s consolidated balance sheets at September 30, 2011 were $2,224 million ($1,930 million at December 31, 2010). In September 2011, the Company repurchased $71 million of previously sold receivables related to a divestiture ($13 million related to another divestiture in May 2010).
Sale of Trade Accounts Receivable in Europe
Since June 2010, the Company sold qualifying trade accounts receivable of select European entities on a revolving basis to certain multi-seller commercial paper conduit entities. The Company maintains servicing responsibilities and the related costs are insignificant. The proceeds received are comprised of cash and interests in specified assets (the receivables sold by the Company) of the conduits that entitle the Company to the residual cash flows of such specified assets in the conduits after the commercial paper has been repaid. Neither the conduits nor the investors in those entities have recourse to other assets of the Company in the event of nonpayment by the debtors.
During the three months ended September 30, 2011, the Company recognized a loss of $9 million on the sale of these receivables ($3 million during the three months ended September 30, 2010), which was classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. During the nine months ended September 30, 2011, the Company recognized a loss of $11 million on the sale of receivables ($4 million during the nine months ended September 30, 2010).
The Company classifies its interests in the conduits as “Accounts and notes receivable – Other” on the consolidated balance sheets and those interests are carried at fair value. Fair value of the interests is determined by calculating the expected amount of cash to be received and is based on unobservable inputs (a Level 3 measurement). The key input in the valuation is percentage of anticipated credit losses, which was zero at September 30, 2011 (zero at December 31, 2010), in the portfolio of receivables sold that had not yet been collected. Given the short-term nature of the underlying receivables, discount rates and prepayments are not factors in determining the fair value of the interests. There were no credit losses on receivables sold during the three- and nine-month periods ended September 30, 2011 and September 30, 2010. At September 30, 2011, the carrying value of the interests held was $155 million ($157 million at December 31, 2010), which is the Company’s maximum exposure to loss related to the receivables sold.
Following is an analysis of certain cash flows between the Company and the European conduits:
|
| | | | | | | | | | | | | | | |
Cash Proceeds | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sale of receivables | $ | 13 |
| | $ | 70 |
| | $ | 16 |
| | $ | 582 |
|
Collections reinvested in revolving receivables | $ | 2,020 |
| | $ | 1,851 |
| | $ | 6,079 |
| | $ | 2,018 |
|
Interests in conduits (1) | $ | 63 |
| | $ | 8 |
| | $ | 287 |
| | $ | 8 |
|
(1) Presented in "Operating Activities" in the consolidated statements of cash flows.
Delinquencies on the sold receivables still outstanding at September 30, 2011 were $19 million ($42 million at December 31, 2010). Trade accounts receivable outstanding and derecognized from the Company’s consolidated balance sheets at September 30, 2011 were $354 million ($405 million at December 31, 2010).
Sale of Trade Accounts Receivable in Asia Pacific
The Company sells participating interests in trade accounts receivable of select Asia Pacific entities for which the Company maintains servicing responsibilities and the related costs are insignificant. The third-party holders of the participating interests do not have recourse to the Company’s assets in the event of nonpayment by the debtors.
During the nine-month periods ended September 30, 2011 and 2010, the Company recognized insignificant losses on the sale of the participating interests in the receivables, which are classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. The Company receives cash upon the sale of the participating interests in the receivables.
Following is an analysis of certain cash flows between the Company and the third-party holders of the participating interests:
|
| | | | | | | | | | | | | | | |
Cash Proceeds | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sale of participating interests | $ | 42 |
| | $ | 61 |
| | $ | 129 |
| | $ | 163 |
|
Collections reinvested in revolving receivables | $ | 27 |
| | $ | 49 |
| | $ | 106 |
| | $ | 145 |
|
Following is additional information related to the sale of participating interests in the receivables under this facility:
|
| | | | | | | |
Trade Accounts Receivable In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Derecognized from the consolidated balance sheet | $ | 13 |
| | $ | 25 |
|
Outstanding in the consolidated balance sheet | 277 |
| | 281 |
|
Total accounts receivable in select Asia Pacific entities | $ | 290 |
|
| $ | 306 |
|
There were no credit losses on receivables relating to the participating interests sold during the three- and nine-month periods ended September 30, 2011 and September 30, 2010. There were no delinquencies on the outstanding receivables related to the participating interests sold at September 30, 2011 or December 31, 2010.
NOTE L – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES
|
| | | | | | | |
Notes Payable In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Notes payable to banks | $ | 773 |
| | $ | 1,310 |
|
Notes payable to related companies | 99 |
| | 157 |
|
Notes payable trade | 15 |
| | — |
|
Total notes payable | $ | 887 |
| | $ | 1,467 |
|
Period-end average interest rates | 3.06 | % | | 2.64 | % |
|
| | | | | | | | | | | | | |
Long-Term Debt
In millions | 2011 Average Rate |
| | Sep 30, 2011 |
| | 2010 Average Rate |
| | Dec 31, 2010 |
|
Promissory notes and debentures: | | | | | | | |
Final maturity 2011 | 9.80 | % | | $ | 3 |
| | 5.30 | % | | $ | 1,057 |
|
Final maturity 2012 | 5.35 | % | | 2,159 |
| | 5.33 | % | | 2,154 |
|
Final maturity 2013 | 6.11 | % | | 395 |
| | 6.05 | % | | 389 |
|
Final maturity 2014 | 7.29 | % | | 2,103 |
| | 7.27 | % | | 2,096 |
|
Final maturity 2015 | 5.92 | % | | 1,257 |
| | 5.90 | % | | 1,250 |
|
Final maturity 2016 | 2.57 | % | | 757 |
| | 2.57 | % | | 757 |
|
Final maturity 2017 and thereafter | 6.98 | % | | 9,090 |
| | 6.78 | % | | 10,503 |
|
Other facilities: |
| |
| |
| |
|
U.S. dollar loans, various rates and maturities | 2.63 | % | | 236 |
| | 1.67 | % | | 20 |
|
Foreign currency loans, various rates and maturities | 3.39 | % | | 1,422 |
| | 2.95 | % | | 998 |
|
Medium-term notes, varying maturities through 2022 | 4.90 | % | | 807 |
| | 5.96 | % | | 2,005 |
|
Euro medium-term notes, final maturity 2011 | — |
| | — |
| | 4.63 | % | | 665 |
|
Pollution control/industrial revenue bonds, varying maturities through 2038 | 5.70 | % | | 872 |
| | 5.68 | % | | 907 |
|
Capital lease obligations | — |
| | 17 |
| | — |
| | 17 |
|
Unamortized debt discount | — |
| | (402 | ) | | — |
| | (458 | ) |
Long-term debt due within one year | — |
| | (1,674 | ) | | — |
| | (1,755 | ) |
Total long-term debt | — |
| | $ | 17,042 |
| | — |
| | $ | 20,605 |
|
|
| | | |
Annual Installments on Long-Term Debt For Next Five Years at September 30, 2011 In millions |
2011 | $ | 37 |
|
2012 | $ | 2,800 |
|
2013 | $ | 671 |
|
2014 | $ | 2,348 |
|
2015 | $ | 1,444 |
|
2016 | $ | 965 |
|
On March 22, 2011, the Company concluded cash tender offers for $1.5 billion aggregate principal amount of certain notes issued by the Company. As a result of the tender offers, the Company redeemed $1.5 billion of the notes and recognized a $472 million pretax loss on early extinguishment of debt, included in “Sundry income (expense) – net” in the consolidated statements of income and reflected in Corporate.
In the first nine months of 2011, the Company redeemed $800 million of notes that matured on February 1, 2011; Euro 500 million of notes that matured on May 27, 2011 ($707 million equivalent); $250 million of floating rate notes that matured on August 8, 2011; and $1,538 million of InterNotes, and recognized a $10 million pretax loss on early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and reflected in Corporate.
In the first nine months of 2011, the Company issued $341 million of InterNotes; and approximately $895 million of long-term debt was entered into by consolidated variable interest entities, including the refinancing of short-term notes payable.
The Company’s outstanding debt of $18.7 billion has been issued under indentures which contain, among other provisions, covenants with which the Company must comply while the underlying notes are outstanding. Such covenants include obligations to not allow liens on principal U.S. manufacturing facilities, enter into sale and lease-back transactions with respect to principal U.S. manufacturing facilities, or merge or consolidate with any other corporation, or sell or convey all or substantially all of the Company’s assets. The outstanding debt also contains customary default provisions. Failure of the Company to comply with any of these covenants could result in a default under the applicable indenture, which would allow the note holders to accelerate the due date of the outstanding principal and accrued interest on the subject notes.
The Company’s primary credit agreements contain covenant and default provisions in addition to the covenants set forth above with respect to the Company’s debt. Significant other covenants and default provisions related to these agreements include:
| |
(a) | the obligation to maintain the ratio of the Company’s consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Three Year Competitive Advance and Revolving Credit Facility Agreement dated June 4, 2010 exceeds $500 million, |
| |
(b) | a default if the Company or an applicable subsidiary fails to make any payment on indebtedness of $50 million or more when due, or any other default under the applicable agreement permits or results in the acceleration of $200 million or more of principal, and |
| |
(c) | a default if the Company or any applicable subsidiary fails to discharge or stay within 30 days after the entry of a final judgment of more than $200 million. |
Failure of the Company to comply with any of the covenants or default provisions could result in a default under the applicable credit agreement which would allow the lenders to not fund future loan requests and to accelerate the due date of the outstanding principal and accrued interest on any outstanding loans.
At September 30, 2011, management believes the Company was in compliance with all of the covenants and default provisions referred to above.
NOTE M – VARIABLE INTEREST ENTITIES
Consolidated Variable Interest Entities
The Company holds variable interests in six joint ventures for which the Company is the primary beneficiary.
Three of the joint ventures own and operate manufacturing and logistics facilities, which produce certain chemicals and provide certain services in Asia Pacific. The Company’s variable interest in these joint ventures relates to arrangements between the joint ventures and the Company, involving the majority of the output on take-or-pay terms with pricing ensuring a guaranteed return to the joint ventures.
Another joint venture will construct, own and operate a membrane chlor-alkali facility to be located at the Company’s Freeport, Texas integrated manufacturing complex. The Company’s variable interests relate to equity options between the partners and a cost-plus off-take arrangement involving proportional purchase commitments on take-or-pay terms and ensuring a guaranteed return to the joint venture. The Company will provide the joint venture with operation and maintenance services, utilities and raw materials; market the joint venture’s co-products; and toll convert the other partner’s proportional purchase commitments into ethylene dichloride. The joint venture is expected to begin operations in mid-2013.
The fifth joint venture was acquired through the acquisition of Rohm and Haas on April 1, 2009. This joint venture manufactures products in Japan for the semiconductor industry. Each joint venture partner holds several equivalent variable interests, with the exception of a royalty agreement held exclusively between the joint venture and the Company. In addition, the entire output of the joint venture is sold to the Company for resale to third-party customers.
The sixth joint venture is an existing ethylene storage joint venture located in Alberta, Canada. Previously accounted for as an equity method investment, the Company became the primary beneficiary upon execution of new storage cavern agreements in the second quarter of 2011. The Company's variable interests relate to arrangements involving a majority of the joint venture's storage capacity on take-or-pay terms with pricing ensuring a guaranteed return to the joint venture; and favorably priced leases provided to the joint venture. The Company provides the joint venture with operation and maintenance services and utilities.
The Company also holds a variable interest in an owner trust, for which the Company is the primary beneficiary. The owner trust leases an ethylene facility in The Netherlands to the Company, whereby substantially all of the rights and obligations of ownership are transferred to the Company. The Company’s variable interest in the owner trust relates to a residual value guarantee provided to the owner trust. Upon expiration of the lease, which matures in 2014, the Company may purchase the facility for an amount based on a fair market value determination. At September 30, 2011, the Company had provided to the owner trust a residual value guarantee of $363 million, which represents the Company’s maximum exposure to loss under the lease.
As the primary beneficiary of these variable interest entities ("VIEs"), the entities’ assets, liabilities and results of operations are included in the Company’s consolidated financial statements. The other equity holders’ interests are reflected in “Net income attributable to noncontrolling interests” in the consolidated statements of income and “Noncontrolling interests” in the consolidated balance sheets. The following table summarizes the carrying amounts of the entities’ assets and liabilities included in the Company’s consolidated balance sheets at September 30, 2011 and December 31, 2010:
|
| | | | | | | |
Assets and Liabilities of Consolidated VIEs In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Cash and cash equivalents (1) | $ | 86 |
| | $ | 145 |
|
Other current assets | 131 |
| | 83 |
|
Property | 1,855 |
| | 1,388 |
|
Other noncurrent assets | 140 |
| | 122 |
|
Total assets (2) | $ | 2,212 |
| | $ | 1,738 |
|
Current liabilities (nonrecourse 2011: $229; 2010: $190) | $ | 310 |
| | $ | 837 |
|
Long-term debt (nonrecourse 2011: $891; 2010: $167) | 1,238 |
| | 513 |
|
Other noncurrent liabilities (nonrecourse 2011: $84; 2010: $64) | 84 |
| | 64 |
|
Total liabilities | $ | 1,632 |
| | $ | 1,414 |
|
| |
(1) | Included $6 million at September 30, 2011 restricted for the construction of a specific manufacturing facility. |
| |
(2) | All assets were restricted at September 30, 2011 and December 31, 2010. |
The Company holds a variable interest in an entity created in June 2010 to monetize accounts receivable of select European entities. The Company is the primary beneficiary of this entity as a result of holding subordinated notes while maintaining servicing responsibilities for the accounts receivable. The carrying amounts of assets and liabilities included in the Company’s consolidated balance sheets pertaining to this entity, were current assets of $156 million (zero restricted) at September 30, 2011 ($158 million, zero restricted, at December 31, 2010) and current liabilities of $4 million ($4 million nonrecourse) at September 30, 2011 ($1 million, $1 million nonrecourse, at December 31, 2010).
Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at September 30, 2011 and December 31, 2010 are adjusted for intercompany eliminations, parental guarantees and residual value guarantees.
Nonconsolidated Variable Interest Entity
The Company holds a variable interest in a joint venture accounted for under the equity method of accounting, acquired through the acquisition of Rohm and Haas on April 1, 2009. The joint venture manufactures crude acrylic acid in the United States and Germany on behalf of the Company and the other joint venture partner. The variable interest relates to a cost-plus arrangement between the joint venture and each joint venture partner. The Company is not the primary beneficiary, as a majority of the joint venture’s output is sold to the other joint venture partner, and therefore the entity is not consolidated. At September 30, 2011, the Company’s investment in the joint venture was $140 million ($144 million at December 31, 2010), classified as “Investment in nonconsolidated affiliates” in the consolidated balance sheets, representing the Company’s maximum exposure to loss.
NOTE N – PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS
|
| | | | | | | | | | | | | | | |
Net Periodic Benefit Cost for All Significant Plans | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Defined Benefit Pension Plans: | | | | | | | |
Service cost | $ | 88 |
| | $ | 76 |
| | $ | 260 |
| | $ | 232 |
|
Interest cost | 282 |
| | 272 |
| | 842 |
| | 821 |
|
Expected return on plan assets | (329 | ) | | (301 | ) | | (978 | ) | | (907 | ) |
Amortization of prior service cost | 7 |
| | 7 |
| | 21 |
| | 21 |
|
Amortization of net loss | 94 |
| | 67 |
| | 280 |
| | 201 |
|
Curtailment cost | — |
| | — |
| | — |
| | 8 |
|
Net periodic benefit cost | $ | 142 |
| | $ | 121 |
| | $ | 425 |
| | $ | 376 |
|
| | | | | | | |
Other Postretirement Benefits: | | | | | | | |
Service cost | $ | 4 |
| | $ | 4 |
| | $ | 10 |
| | $ | 12 |
|
Interest cost | 25 |
| | 28 |
| | 75 |
| | 84 |
|
Expected return on plan assets | (1 | ) | | (3 | ) | | (3 | ) | | (9 | ) |
Curtailment cost | — |
| | — |
| | — |
| | 3 |
|
Net periodic benefit cost | $ | 28 |
| | $ | 29 |
| | $ | 82 |
| | $ | 90 |
|
As a result of the divestiture of Styron on June 17, 2010, the Company recognized a curtailment loss of $11 million and improved the funded status (plan assets less benefit obligations) by $99 million due to settlements, remeasurements and curtailments (see Note D).
The Company's funding policy is to contribute to its pension plans when pension laws and/or economics either require or encourage funding. In the nine-month period ended September 30, 2011, the Company contributed $712 million to its pension plans, including contributions to fund benefit payments for its non-qualified supplemental plans. The Company expects to contribute approximately $200 million to its pension plans in the fourth quarter of 2011.
NOTE O – STOCK-BASED COMPENSATION
The Company grants stock-based compensation to employees under the Employees' Stock Purchase Plan (“ESPP”) and the 1988 Award and Option Plan (the “1988 Plan”) and to non-employee directors under the 2003 Non-Employee Directors' Stock Incentive Plan. Most of the Company's stock-based compensation awards are granted in the first quarter of each year. Details for awards granted in the first quarter of 2011 are included in the following paragraphs. There was minimal grant activity in the second and third quarters of 2011.
During the first quarter of 2011, employees subscribed to the right to purchase 10.8 million shares with a weighted-average exercise price of $23.00 per share and a weighted-average fair value of $11.39 per share under the ESPP.
During the first quarter of 2011, the Company granted the following stock-based compensation awards to employees under the 1988 Plan:
| |
• | 10.5 million stock options with a weighted-average exercise price of $38.38 per share and a weighted-average fair value of $10.67 per share; |
| |
• | 3.0 million shares of deferred stock with a weighted-average fair value of $38.35 per share; and |
| |
• | 1.1 million shares of performance deferred stock with a weighted-average fair value of $48.94 per share. |
During the first quarter of 2011, the Company granted the following stock-based compensation awards to non-employee directors under the 2003 Non-Employee Directors' Stock Incentive Plan:
| |
• | 31,350 shares of restricted stock with a weighted-average fair value of $37.26 per share. |
Total unrecognized compensation cost at September 30, 2011 is provided in the following table:
|
| | | | | | |
Total Unrecognized Compensation Cost at September 30, 2011 |
In millions | Unrecognized Compensation Cost |
| | Weighted-average Recognition Period (Years) |
|
ESPP purchase rights | $ | 8 |
| | 0.13 |
|
Unvested stock options | $ | 65 |
| | 0.77 |
|
Deferred stock awards | $ | 108 |
| | 0.81 |
|
Performance deferred stock awards | $ | 20 |
| | 0.50 |
|
NOTE P – EARNINGS PER SHARE CALCULATIONS
The following tables provide the earnings per share calculations for the three- and nine-month periods ended September 30, 2011:
|
| | | | | | | |
Net Income | Three Months Ended |
| | Nine Months Ended |
|
In millions | Sep 30, 2011 |
| | Sep 30, 2011 |
|
Net income | $ | 903 |
| | $ | 2,701 |
|
Net income attributable to noncontrolling interests | (3 | ) | | (24 | ) |
Net income attributable to The Dow Chemical Company | $ | 900 |
| | $ | 2,677 |
|
Preferred stock dividends | (85 | ) | | (255 | ) |
Net income attributable to participating securities (1) | (11 | ) | | (31 | ) |
Net income attributable to common stockholders | $ | 804 |
| | $ | 2,391 |
|
|
| | | | | | | |
Earnings Per Share Calculations - Basic | Three Months Ended |
| | Nine Months Ended |
|
Dollars per share | Sep 30, 2011 |
| | Sep 30, 2011 |
|
Net income | $ | 0.78 |
| | $ | 2.35 |
|
Net income attributable to noncontrolling interests | — |
| | (0.02 | ) |
Net income attributable to The Dow Chemical Company | $ | 0.78 |
| | $ | 2.33 |
|
Preferred stock dividends | (0.07 | ) | | (0.22 | ) |
Net income attributable to participating securities (1) | (0.01 | ) | | (0.03 | ) |
Net income attributable to common stockholders | $ | 0.70 |
| | $ | 2.08 |
|
|
| | | | | | | |
Earnings Per Share Calculations - Diluted | Three Months Ended |
| | Nine Months Ended |
|
Dollars per share | Sep 30, 2011 |
| | Sep 30, 2011 |
|
Net income | $ | 0.77 |
| | $ | 2.33 |
|
Net income attributable to noncontrolling interests | — |
| | (0.02 | ) |
Net income attributable to The Dow Chemical Company | $ | 0.77 |
| | $ | 2.31 |
|
Preferred stock dividends (2) | (0.07 | ) | | (0.22 | ) |
Net income attributable to participating securities (1) | (0.01 | ) | | (0.02 | ) |
Net income attributable to common stockholders | $ | 0.69 |
| | $ | 2.07 |
|
|
| | | | | |
Shares in millions | | | |
Weighted-average common shares - basic | 1,152.3 |
| | 1,147.2 |
|
Plus dilutive effect of stock options and awards | 8.6 |
| | 10.6 |
|
Weighted-average common shares - diluted | 1,160.9 |
| | 1,157.8 |
|
Stock options and deferred stock awards excluded from EPS calculations (3) | 42.5 |
| | 41.1 |
|
Conversion of preferred stock excluded from EPS calculations (4) | 96.8 |
| | 96.8 |
|
| |
(1) | Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial. |
| |
(2) | Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive. |
| |
(3) | These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. |
| |
(4) | Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. |
The following tables provide the earnings per share calculations for the three- and nine-month periods ended September 30, 2010:
|
| | | | | | | | |
Net Income | Three Months Ended | | | Nine Months Ended |
|
In millions | | Sep 30, 2010 |
| | Sep 30, 2010 |
|
Net income | | $ | 597 |
| | $ | 1,808 |
|
Net income attributable to noncontrolling interests | | — |
| | (9 | ) |
Net income attributable to The Dow Chemical Company | | $ | 597 |
| | $ | 1,799 |
|
Preferred stock dividends | | (85 | ) | | (255 | ) |
Net income available for common stockholders | | $ | 512 |
| | $ | 1,544 |
|
|
| | | | | | | | |
Earnings Per Share Calculations - Basic | Three Months Ended | | | Nine Months Ended |
|
Dollars per share | | Sep 30, 2010 |
| | Sep 30, 2010 |
|
Net income | | $ | 0.53 |
| | $ | 1.61 |
|
Net income attributable to noncontrolling interests | | — |
| | (0.01 | ) |
Net income attributable to The Dow Chemical Company | | $ | 0.53 |
| | $ | 1.60 |
|
Preferred stock dividends | | (0.08 | ) | | (0.23 | ) |
Net income available for common stockholders | | $ | 0.45 |
| | $ | 1.37 |
|
|
| | | | | | | | |
Earnings Per Share Calculations - Diluted | Three Months Ended | | | Nine Months Ended |
|
Dollars per share | | Sep 30, 2010 |
| | Sep 30, 2010 |
|
Net income | | $ | 0.52 |
| | $ | 1.58 |
|
Net income attributable to noncontrolling interests | | — |
| | (0.01 | ) |
Net income attributable to The Dow Chemical Company | | $ | 0.52 |
| | $ | 1.57 |
|
Preferred stock dividends (1) | | (0.07 | ) | | (0.22 | ) |
Net income available for common stockholders | | $ | 0.45 |
| | $ | 1.35 |
|
|
| | | | | | |
Shares in millions | | | | |
Weighted-average common shares - basic | | 1,128.0 |
| | 1,123.6 |
|
Plus dilutive effect of stock options and awards | | 17.5 |
| | 17.1 |
|
Weighted-average common shares - diluted | | 1,145.5 |
| | 1,140.7 |
|
Stock options and deferred stock awards excluded from EPS calculations (2) | | 52.7 |
| | 49.1 |
|
Conversion of preferred stock excluded from EPS calculations (3) | | 96.8 |
| | 96.8 |
|
| |
(1) | Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive. |
| |
(2) | These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. |
| |
(3) | Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. |
NOTE Q – OPERATING SEGMENTS AND GEOGRAPHIC AREAS
Beginning in the third quarter of 2011, the Company changed its reportable segments due to recent changes in the Company's organization. Following are the new segments:
| |
• | Electronic and Functional Materials |
| |
• | Coatings and Infrastructure Solutions |
The reporting changes are reflected in the following Corporate Profile and segment information for all periods presented.
Corporate Profile
Dow combines the power of science and technology with the “Human Element” to passionately innovate what is essential to human progress. The Company connects chemistry and innovation with the principles of sustainability to help address many of the world's most challenging problems such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity. Dow's diversified industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses deliver a broad range of technology-based products and solutions to customers in approximately 160 countries and in high growth sectors such as electronics, water, energy, coatings and agriculture. In 2010, Dow had annual sales of $53.7 billion and employed approximately 50,000 people worldwide. The Company's more than 5,000 products are manufactured at 188 sites in 35 countries across the globe. The following descriptions of the Company's six operating segments include a representative listing of products for each business.
ELECTRONIC AND FUNCTIONAL MATERIALS
Applications: chemical mechanical planarization pads and slurries chemical processing aids and intermediates electronic displays food and pharmaceutical processing and ingredients home and personal care ingredients hygiene and infection control photolithography materials printed circuit board materials process and materials preservation semiconductor packaging, connectors and industrial finishing
Dow Electronic Materials is a leading global supplier of materials for chemical mechanical planarization (CMP); materials used in the production of electronic displays, including brightness films, diffusers, metalorganic light emitting diode (LED) precursors and organic light emitting diode (OLED) materials; products and technologies that drive leading edge semiconductor design; materials used in the fabrication of printed circuit boards; and integrated metallization processes critical for interconnection, corrosion resistance, metal finishing and decorative applications. These enabling materials are found in applications such as consumer electronics, flat panel displays and telecommunications. Dow Electronic Materials includes Display Technologies, Growth Technologies, Interconnect Technologies and Semiconductor Technologies.
| |
• | Products: ACuPLANE™ CMP slurries; AR™ antireflective coatings; AUROLECTROLESS™ immersion gold process; COPPER GLEAM™ acid copper plating products; CYCLOTENE™ advanced electronics resins; DURAPOSIT™ electroless nickel process; ENLIGHT™ products for photovoltaic manufacturers; EPIC™ immersion photoresists; INTERVIA™ photodielectrics for advanced packaging; LITHOJET™ digital imaging processes; OPTOGRADE™ metalorganic precursors; VISIONPAD™ CMP pads |
Functional Materials is a portfolio of businesses characterized by a vast global footprint, a broad array of unique chemistries, multi-functional ingredients and technology capabilities, combined with key positions in the pharmaceuticals; food, home and personal care; and industrial specialty industries. These technology capabilities and market platforms enable the businesses to develop innovative solutions that address modern societal needs for clean water and air; material preservation; and improved health care, disease prevention, nutrition and wellness. Functional Materials includes Dow Home and Personal Care, Dow Microbial Control, Dow Wolff Cellulosics and Performance Additives.
| |
• | Products and Services: Acrolein derivatives; ACUDYNE™ hair fixative resins; ACULYN™ rheology modifiers; ACUMER™ scale inhibitors and dispersants; ACUSOL™ detergent polymers, dispersants, opacifiers and rheology modifiers; AMBERCHROM™ chromatography resins; ANGUS™ nitroalkanes and derivatives; AQUCAR™ water treatment microbiocides; ASC METATIN™ dimethyltin catalyst; AUTOMATE™ liquid dyes; BIOBAN™ biocide for material preservation; CELLOSIZE™ hydroxyethyl cellulose; CLEAR+STABLE™ |
carboxymethyl cellulose; Divinylbenzene; DUOLITE™ pharmaceutical grade resins; DURAGREEN™ and DURAPLUS™ floor care polymers; ECOSMOOTH™ silk conditioning polymers; ECOSURF™ biodegradable surfactants; ETHOCEL™ ethylcellulose polymers; GLUTEX™ sanitizers and cleaners; KATHON™ preservatives; KLARIX™ algicides; METHOCEL™ cellulose ethers; NEOLONE™ preservatives for personal care; OPULYN™ opacifiers; POLYOX™ water-soluble resins; PRIMENE™ amines; Quaternaries; SATISFIT™ Weight Care Technology; SILVADUR™ antimicrobial; Sodium borohydride products; SOFTCAT™ polymers; SOLTERRA™ Boost inorganic SPF booster; SOLTEX™ waterproofing polymer; SUNSPHERES™ SPF boosters; UCARE™ polymers; UCARHIDE™ opacifier; UCON™ fluids; VENPURE™ reducing agents; VERSENE™ chelating agents; Vinylbenzyl chloride; VINYZENE™ antimicrobials for plastics; WALOCEL™ cellulose polymers; WALSRODER™ nitrocellulose; ZinClear™ IM zinc oxide dispersions
The Electronic and Functional Materials segment also includes a portion of the Company's share of the results of Dow Corning Corporation, a joint venture of the Company.
COATINGS AND INFRASTRUCTURE SOLUTIONS
Applications: building and construction, insulation and weatherization, roofing membrane systems, adhesives and sealants cellulosic-based construction additives construction materials (vinyl siding, vinyl windows, vinyl fencing) flexible and rigid packaging general mortars and concrete, cement modifiers and plasters, tile adhesives and grouts house and traffic paints metal coatings pipeline coatings transportation and corrosion protection water purification
Dow Building and Construction is comprised of three global businesses - Dow Building Solutions, Dow Construction Chemicals and Dow Solar Solutions - that offer extensive lines of industry-leading insulation, housewrap, sealant and adhesive products and systems, as well as construction chemical solutions and building-integrated photovoltaics. Through its strong sales support, customer service and technical expertise, Dow Building Solutions provides meaningful solutions for improving the energy efficiency in homes and buildings today, while also addressing the industry's emerging needs and demands. Dow Construction Chemicals provides solutions for increased durability, greater water resistance and lower systems costs. As a leader in insulation solutions, the business' products help curb escalating utility bills, reduce a building's carbon footprint and provide a more comfortable indoor environment. Dow Solar Solutions is focused on developing the next generation of solar energy products to help solve global energy challenges.
| |
• | Products: AQUASET™ acrylic thermosetting resins; CELLOSIZE™ hydroxyethyl cellulose; DOW™ latex powders; FROTH-PAK™ polyurethane spray foam; GREAT STUFF™ polyurethane foam sealant; INSTA-STIK™ roof insulation adhesive; METHOCEL™ cellulose ethers; POWERHOUSE™ solar shingle; RHOPLEX™ aqueous acrylic polymer emulsions; STYROFOAM™ brand insulation products (including extruded polystyrene and polyisocyanurate rigid foam sheathing products); THERMAX™ insulation; TILE BOND™ roof tile adhesive; WEATHERMATE™ weather barrier solutions (housewraps, sill pans, flashings and tapes) |
Dow Coating Materials is the largest coatings supplier in the world and a premier supplier of raw materials for architectural paints and industrial coatings. The business manufactures and delivers solutions that leverage high quality, technologically advanced product offerings for paint and coatings. The business also offers technologies used in industrial coatings applications, including packaging, pipelines, wood, automotive, marine, maintenance and protective industries. The business is also the leader in the conversion of solvent to water-based technologies, which enable customers to offer more environmentally friendly products, including low volatile organic compound (VOC) paints and other sustainable coatings.
| |
• | Products: ACRYSOL™ rheology modifiers; AVANSE™, ELASTENE™, PRIMAL™ and RHOPLEX™ acrylics; CELLOSIZE™ hydroxyethyl cellulose; D.E.H.™ curing agent and intermediates; D.E.N.™ and D.E.R.™ liquid and epoxy resins; DOWFAX™, ECOSURF™ SA, TERGITOL™ and TRITON™ surfactants; EVOQUE™ Pre-Composite Polymer Technology; FORTEGRA™ epoxy tougheners; OROTAN™ and TAMOL™ dispersants; ROPAQUE™ opaque polymers |
Dow Water and Process Solutions is a leading water purification and separation technology supplier, developing cost-effective technologies for water purification, desalination and separation solutions for specialty applications that make water safer, cleaner and more available; food better tasting; and pharmaceuticals more effective.
| |
• | Products: ADSORBSIA™ titanium-based media; AMBERJET™, AMBERLITE™, AMBERLYST™ and DOWEX™ ion exchange resins; AMBERLYST™ and DOWEX™ catalysts; DOW™ electrodeionization; |
DOW™ ultrafiltration; DOWEX™ OPTIPORE™ polymeric adsorbent resins; FILMTEC™ reverse osmosis and nanofiltration membrane elements
The Performance Monomers business produces specialty monomer products that are sold externally as well as consumed internally as building blocks used in downstream polymer businesses. The business' products are used in several applications, including cleaning materials, personal care products, paints, coatings and inks.
| |
• | Products: Acrylic acid/acrylic esters; ACUMER™, ACUSOL™, DURAMAX™, OPTIDOSE™, ROMAX™ and TAMOL™ dispersants; Methyl methacrylate |
The Coatings and Infrastructure Solutions segment also includes a portion of the Company's share of the results of Dow Corning Corporation, a joint venture of the Company.
AGRICULTURAL SCIENCES
Applications: agricultural seeds, traits (genes) and oils control of weeds, insects and plant diseases for agriculture and pest management
Dow AgroSciences is a global leader in providing agricultural and plant biotechnology products, pest management solutions and healthy oils. The business invents, develops, manufactures and markets products for use in agriculture, industrial and commercial pest management, and food service.
| |
• | Products: AGROMEN™ seeds; BRODBECK™ seed; CLINCHER™ herbicide; DAIRYLAND™ seed; DELEGATE™ insecticide; DITHANE™ fungicide; SmartStax™; FORTRESS™ fungicide; GARLON™ herbicide; GLYPHOMAX™ herbicide; GRANITE™ herbicide; HERCULEX™ I, HERCULEX™ RW and HERCULEX™ XTRA insect protection; KEYSTONE™ herbicides; LAREDO™ fungicide; LONTREL™ herbicide; LORSBAN™ insecticides; MILESTONE™ herbicide; MUSTANG™ herbicide; MYCOGEN™ seeds; NEXERA™ canola and sunflower seeds; PHYTOGEN™ cottonseeds; PROFUME™ gas fumigant; RENZE™ seeds; SENTRICON™ termite colony elimination system; SIMPLICITY™ herbicide; STARANE™ herbicide; TELONE™ soil fumigant; TORDON™ herbicide; TRACER™ NATURALYTE™ insect control; TRIUMPH™ seed; VIKANE™ structural fumigant; WIDESTRIKE™ insect protection |
The Agricultural Sciences segment also includes the results of the AgroFresh business, providing a portfolio of products used for maintaining the freshness of fruits, vegetables and flowers.
PERFORMANCE MATERIALS
Applications: adhesives aircraft and runway deicing fluids appliances automotive interiors, exteriors, under-the-hood and body engineered systems bedding caps and closures carpeting chelating agents chemical intermediates civil engineering cleaning products composites construction corrosion inhibitors detergents, cleaners and fabric softeners electrical castings, potting and encapsulation and tooling electrical laminates electronics flavors and fragrances flooring footwear furniture gas treatment gaskets and sealing components heat transfer fluids home and office furnishings industrial coatings manufactured housing and modular construction mattresses medical equipment metalworking fluids mining packaging pipe treatment pressure sensitive adhesives sealants surfactants transportation vinyl exteriors waterproofing membranes
The Amines business is the world's largest producer of ethanolamines and a leading global provider of ethyleneamines, isopropanolamines and chelants. These products are used in a wide variety of applications, including lube oil additives, wet-strength resins, metalworking fluids, liquid detergents, personal care products, and herbicide and fungicide formulations for the agricultural industry.
| |
• | Products: Alkyl alkanolamines; Ethanolamines; Ethyleneamines; Isopropanolamines; VERSENE™ chelating agents |
The Chlorinated Organics business is the world's largest supplier of chlorinated organic products and services for intermediates, which are used in the production of fluoropolymers, refrigerants, methyl cellulose, quaternary ammonium compounds and silicones; and solvents, which are used as process agents in chemicals manufacturing, surface preparation, dry cleaning and pharmaceuticals.
| |
• | Products: Chloroform; Methyl chloride; Methylene chloride; Perchloroethylene; Trichloroethylene; Vinylidene chloride |
Dow Automotive Systems is a leading global provider of technology-driven solutions that meet consumer demands for vehicles that are safer, stronger, quieter, lighter, and more comfortable and stylish. The business provides adhesives, glass bonding systems, emissions control technology, performance plastics, polyurethane products and systems, films, fluids and acoustical management solutions to original equipment manufacturers and tier, aftermarket and commercial transportation customers. With offices and application development centers around the world, Dow Automotive Systems provides materials science expertise and comprehensive technical capabilities to its customers worldwide.
| |
• | Products: AERIFY™ diesel particulate filters; BETAFOAM™ NVH acoustical foams; BETAFORCE™ structural composite bonding systems; BETAMATE™ structural adhesives; BETASEAL™ glass bonding systems; BETATECH™ high performance elastic adhesive sealer; DOW™ polyethylene resins; ENGAGE™ polyolefin elastomers; IMPAXX™ energy management foam; INTEGRAL™ adhesive films; NORDEL™ hydrocarbon rubber; Premium brake fluids; ROBOND™ acrylic adhesives; SPECFLEX™ semi-flexible polyurethane foam systems; UCON™ fluids; VORAFORCE™ composite systems |
Dow Formulated Systems manufactures and markets custom formulated, rigid and semi-rigid, flexible, integral skin and microcellular polyurethane foams and systems and tailor-made epoxy solutions and systems. These products are used in a broad range of applications, including appliances, athletic equipment, automotive, bedding, construction, decorative molding, furniture, shoe soles and wind turbines.
| |
• | Products: AIRSTONE™ epoxy systems; COMPAXX™ foam core systems; DIPRANE™ polyurethane elastomers; ENFORCER™ Technology and ENHANCER™ Technology for carpet and turf backing; HYPERKOTE™, TRAFFIDECK™ and VERDISEAL™ waterproofing systems; HYPERLAST™, DURAMOULD™ and DURELAST™ polyurethane systems; HYPOL™ hydrophilic polyurethane prepolymers; VORACOR™ rigid foam systems; VORATHERM™ polyisocyanurate; VORATRON™ electrical encapsulation systems |
Dow Plastic Additives is a worldwide supplier of additives and solutions used in a large variety of applications ranging from construction materials and packaging containers to consumer appliances and electronics, business machines and automotive parts. These additives and solutions improve impact strength, clarity, chemical and heat resistance, weather resistance and color retention properties of base polymers. They also aid in the processing of plastics by increasing melt strength, heat stability and lubricity, thereby enabling plastics processors to achieve greater output rates and increased efficiency without loss of quality.
| |
• | Products: ACRYLIGARD™ CS capstock polymers; ADVALUBE™ specialty lubricants; ADVAPAK™ lubricant/stabilizer one-packs for vinyl pipe processing; ADVASTAB™ and ADVASTAB™ NEO thermal stabilizer; PARALOID™ and PARALOID™ EXL impact modifiers and processing aids; SURECEL™ foam cell promoters; TYRIN™ chlorinated polyethylene |
The Epoxy business is a supplier of epoxy resins and intermediates that serves a diverse array of end-markets and applications, including electrical laminates, civil engineering, composites, infrastructure and consumer goods. The business is one of the most vertically-integrated epoxy suppliers in the world. This position helps provide cost advantages and economies of scale across the value chain, as well as dependable product and service delivery around the globe.
| |
• | Products: D.E.H.™ epoxy curing agents or hardeners; D.E.N.™ epoxy novolac resins; D.E.R.™ epoxy resins (liquids, solids and solutions); Epoxy intermediates (acetone, allyl chloride, epichlorohydrin and phenol); FORTEGRA™ epoxy tougheners; PROLOGIC™ epoxy specialty materials |
The Oxygenated Solvents business is the world's largest producer of oxygenated solvents, with the leading position in butanol, E- and P-series glycol ethers, as well as several other products in its portfolio. The business offers the broadest range of solvents for servicing a diverse mix of end-use markets and applications, including paints and coatings, cleaning products, inks, electronics, pharmaceuticals, mining, personal care and other applications.
| |
• | Products: Acetic esters; Acetone derivatives; Aldehydes; Butyl CARBITOL™ and Butyl CELLOSOLVE™ solvents; Carboxylic acids; DOWANOL™ glycol ethers; ECOSOFT™ IK solvent; Oxo alcohols and acids; PROGLYDE™ DMM solvent; UCAR™ propionates |
The Polyglycols, Surfactants and Fluids business is one of the world's leading suppliers of polyglycols and surfactants, with a broad range of products and technology and a proven record of performance and economy. The business also produces a broad line of lubricants, hydraulic fluids, aircraft deicing fluids and thermal fluids, with some of the most recognized brand names in the industry. Product applications include chemical processing, cleaning, heating, cooling, food and beverage processing, fuel additives, paints and coatings, pharmaceuticals and silicone surfactants.
| |
• | Products: CARBOWAX™ and CARBOWAX SENTRY™ polyethylene glycols and methoxypolyethylene glycols; DOW™ polypropylene glycols; DOW SYMBIO™ base fluid; DOWFAX™, TERGITOL™ and TRITON™ surfactants; DOWFROST™ and DOWTHERM™ heat transfer fluids; ECOSURF™ biodegradable surfactants; SYNALOX™ lubricants; UCAR™ deicing fluids; UCON™ fluids |
The Polyurethanes business is a leading global producer of polyurethane raw materials. Dow's polyurethane products offer a broad range of solutions for flexible foam, rigid foam, coating, adhesive, sealant, and elastomer applications and are used in a variety of end-markets, including appliances, automotive, bedding, construction, electronics, flooring, footwear, furniture and packaging. The business is the leading global producer of propylene oxide (PO) and propylene glycol (PG) - offering PO via both a traditional process and a sustainable hydrogen peroxide to propylene oxide (HPPO) manufacturing technology, and a portfolio of PG products for a wide variety of applications.
| |
• | Products: ECHELON™ polyurethane prepolymer; ISONATE™ modified, pure and polymeric methylene diphenyl diisocyanate (MDI); PAPI™ polymeric MDI; Propylene glycol portfolio, including DOW PURAGUARD™ PG USP/EP, propylene glycol USP/EP, PG industrial grade, dipropylene glycol regular and LO+ grades, and tripropylene glycol regular and acrylate grades; Propylene oxide; VORALUX™, VORAMER™, VORANOL™, VORANOL™ VORACTIV™ and VORATEC™ polyether and copolymer polyols; VORANATE™ isocyanate; VORASURF™ surfactants |
The Performance Materials segment also includes the results of Dow Fiber Solutions, providing differentiated fibers and process improvements to the textile industry; Dow Haltermann, a provider of world-class contract manufacturing services to companies in the fine and specialty chemicals and polymers industries; Dow Oil and Gas, providing products for use in exploration and production, refining and gas processing, transportation, and fuel and lubricant performance; and SAFECHEM, a wholly owned subsidiary that manufactures closed-loop systems to manage the risks associated with chlorinated solvents. The segment also includes a portion of the results of the SCG‑Dow Group, joint ventures of the Company.
Divestiture:
| |
• | On June 17, 2010, Dow sold Styron to an affiliate of Bain Capital Partners. Businesses and products sold within the Performance Materials segment included Emulsion Polymers (styrene-butadiene latex), supporting customers in paper and paperboard applications, as well as carpet and artificial turf backings; Synthetic Rubber; and certain products from Dow Automotive Systems; all of which were reported in the Performance Materials segment through the date of the divestiture. |
PERFORMANCE PLASTICS
Applications: adhesives agricultural films appliances and appliance housings automotive parts and trim beverage bottles bins, crates, pails and pallets building and construction coatings consumer and durable goods consumer electronics disposable diaper liners fibers and nonwovens food and specialty packaging hoses and tubing household and industrial bottles housewares hygiene and medical films industrial and consumer films and foams information technology leather, textile, graphic arts and paper oil tanks and road equipment plastic pipe processing aids for plastic production tapes and labels toys, playground equipment and recreational products wire and cable insulation and jacketing materials for power utility and telecommunications
Dow Elastomers offers a unique set of elastomer products for customers worldwide. The business is focused on delivering innovative solutions that allow for differentiated participation in multiple industries and applications. The business offers a broad range of performance elastomers and plastomers, specialty copolymers and synthetic rubber. Key applications include adhesives, automotive, building and construction, hygiene and medical, and consumer solutions.
| |
• | Products: AFFINITY™ polyolefin plastomers; ENGAGE™ polyolefin elastomers; INFUSE™ olefin block copolymers; NORDEL™ hydrocarbon rubber; VERSIFY™ plastomers and elastomers |
Dow Electrical and Telecommunications is a leading global provider of products, technology, solutions and expertise that set standards for reliability, longevity, efficiency, ease of installation and protection used by the power and telecommunications industries in the transmission, distribution and consumption of power, voice and data. Dow Electrical and Telecommunications collaborates with cable makers, other industry suppliers, utilities, municipalities, testing institutes and other organizations around the world to develop solutions and create mutual value that will sustain these industries for years to come.
| |
• | Products: ENGAGE™ polyolefin elastomers; NORDEL™ hydrocarbon rubber; SI-LINK™ and REDI-LINK™ moisture crosslinkable polyethylene-based wire and cable insulation compounds; TYRIN™ chlorinated polyethylene; UNIGARD™ flame retardant compound for specialty wire and cable applications |
Dow Packaging and Converting is a portfolio of businesses that primarily manufacture sticking and bonding solutions and specialty films for a wide range of applications, including adhesive tapes and paper labels, flexible packaging, film substrates, industrial and consumer films and foams, leather, rigid packaging, and textile and imaging. These products are supported with market recognized best-in-class technical support and end-use application knowledge. Many of the businesses' water-borne technologies are well-positioned to support environmentally preferred applications.
| |
• | Products: ADCOTE™ and AQUA-LAM™ laminating adhesives; AMPLIFY™ functional polymers; DOW™ Adhesive Film; DOW™ Medical Packaging Film; DOW™ very low density polyethylene; ENLIGHT™ polyolefin encapsulant films; INTEGRAL™ adhesive films; MOR-FREE™ solventless adhesives; NYLOPAK™ nylon barrier films; OPTICITE™ films; PRIMACOR™ copolymers; PROCITE™ window envelope films; ROBOND™ acrylic adhesives; SARAN™ barrier resins; SARANEX™ barrier films; SEALUTION™ peel polymers; SERFENE™ barrier coatings; Solvent-based polyurethanes and polyesters; TRENCHCOAT™ protective films; TRYCITE™ polystyrene film; TYBRITE™ clear packaging film; TYMOR™ tie resins |
The Polyethylene business is the world's leading supplier of polyethylene-based solutions through sustainable product differentiation. With multiple catalyst and process technologies, the business offers customers one of the industry's broadest ranges of polyethylene resins. With its industry-leading portfolio of product and technology solutions, the business primarily serves performance packaging and hygiene and medical end-markets.
| |
• | Products: ASPUN™ fiber grade resins; ATTANE™ ultra low density polyethylene (ULDPE) resins; CONTINUUM™ bimodal polyethylene resins; DOW™ high density polyethylene (HDPE) resins; DOW™ low density polyethylene (LDPE) resins; DOWLEX™ polyethylene resins; ELITE™ enhanced polyethylene (EPE) resins; TUFLIN™ linear low density polyethylene (LLDPE) resins; UNIVAL™ HDPE resins |
The Performance Plastics segment also includes the results of the Plastics Licensing and Catalyst business. The segment also includes the results of Equipolymers (consolidated with MEGlobal effective July 1, 2011) and Univation Technologies, LLC (which licenses the UNIPOL™ polyethylene process and sells related catalysts, including metallocene catalysts), as well as a portion of the results of EQUATE Petrochemical Company K.S.C., The Kuwait Olefins Company K.S.C. and the SCG‑Dow Group, all joint ventures of the Company.
Divestitures:
| |
• | On June 17, 2010, Dow sold Styron to an affiliate of Bain Capital Partners. Businesses sold within the Performance Plastics segment included Styrenics (polystyrene, acrylonitrile butadiene styrene, styrene acrylonitrile and expandable polystyrene), a global leader in the production of polystyrene resins; Polycarbonate and Compounds and Blends; and the Company's 50-percent ownership interest in Americas Styrenics LLC, a nonconsolidated affiliate; all of which were reported in the Performance Plastics segment through the date of the divestiture. |
| |
• | On July 27, 2011, the Company entered into a definitive agreement to sell its global Polypropylene business to Braskem SA; the transaction closed on September 30, 2011. The transaction did not include Dow's Polypropylene Licensing and Catalyst business. The Polypropylene business was reported in the Performance Plastics segment through the date of the divestiture. |
FEEDSTOCKS AND ENERGY
Applications: agricultural products alumina automotive antifreeze and coolant systems carpet and textiles chemical processing dry cleaning household cleaners and plastic products inks metal cleaning packaging, food and beverage containers paints, coatings and adhesives personal care products petroleum refining pharmaceuticals plastic pipe polymer and chemical production power protective packaging pulp and paper manufacturing soaps and detergents water treatment
The Chlor-Alkali/Chlor-Vinyl business focuses on the production of chlorine for consumption by Dow's downstream derivative businesses, as well as production, marketing and supply of ethylene dichloride, vinyl chloride monomer and caustic soda. These products are used for applications such as alumina production, pulp and paper manufacturing, soaps and detergents, and building and construction. Dow is the world's largest producer of both chlorine and caustic soda.
| |
• | Products: Caustic soda; Chlorine; Ethylene dichloride (EDC); Hydrochloric acid; Vinyl chloride monomer (VCM) |
The Energy business supplies power, steam and other utilities, principally for use in Dow's global operations.
| |
• | Products: Power, steam and other utilities |
The Ethylene Oxide/Ethylene Glycol business is the world's largest producer of purified ethylene oxide, principally used in Dow's downstream performance derivatives. Dow is also a key supplier of ethylene glycol to MEGlobal, a 50:50 joint venture and a world leader in the manufacture and marketing of merchant monoethylene glycol and diethylene glycol. Ethylene glycol is used in polyester fiber, polyethylene terephthalate (PET) for food and beverage container applications, polyester film, and aircraft and runway deicers.
| |
• | Products: Ethylene oxide (EO); Ethylene glycol (EG); METEOR™ EO/EG process technology and catalysts |
The Hydrocarbons business encompasses the procurement of natural gas liquids and crude oil-based raw materials, as well as the supply of monomers, principally for use in Dow's global operations. The business regularly sells its by-products and buys and sells products in order to balance regional production capabilities and derivative requirements. The business also sells products to certain Dow joint ventures. Dow is the world leader in the production of olefins and aromatics.
| |
• | Products: Benzene; Butadiene; Butylene; Cumene; Ethylene; Propylene; Styrene |
The Feedstocks and Energy segment also includes the results of Compañía Mega S.A., MEGlobal and a portion of the results of EQUATE Petrochemical Company K.S.C., The Kuwait Olefins Company K.S.C. and the SCG-Dow Group, all joint ventures of the Company.
Divestiture:
| |
• | On June 17, 2010, Dow sold Styron to an affiliate of Bain Capital Partners. Businesses and products sold within the Feedstocks and Energy segment included certain styrene monomer assets, which were reported in the Feedstocks and Energy segment through the date of the divestiture. |
Corporate includes the results of Ventures (which includes new business incubation platforms focused on identifying and pursuing new commercial opportunities); Venture Capital; non-business aligned technology licensing and catalyst activities; the Company's insurance operations and environmental operations; enterprise level mega project activities; and certain corporate overhead costs and cost recovery variances not allocated to the operating segments.
|
| | | | | | | | | | | | | | | |
Operating Segments | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales by operating segment | | | | | | | |
Electronic and Functional Materials | $ | 1,205 |
| | $ | 1,087 |
| | $ | 3,536 |
| | $ | 3,144 |
|
Coatings and Infrastructure Solutions | 1,905 |
| | 1,734 |
| | 5,639 |
| | 5,049 |
|
Agricultural Sciences | 1,205 |
| | 948 |
| | 4,311 |
| | 3,593 |
|
Performance Materials | 3,698 |
| | 3,311 |
| | 11,097 |
| | 10,552 |
|
Performance Plastics | 4,114 |
| | 3,540 |
| | 12,598 |
| | 11,381 |
|
Feedstocks and Energy | 2,905 |
| | 2,176 |
| | 8,456 |
| | 5,951 |
|
Corporate | 77 |
| | 72 |
| | 251 |
| | 233 |
|
Total | $ | 15,109 |
| | $ | 12,868 |
| | $ | 45,888 |
| | $ | 39,903 |
|
EBITDA (1) by operating segment | | | | | | | |
Electronic and Functional Materials | $ | 306 |
| | $ | 277 |
| | $ | 850 |
| | $ | 775 |
|
Coatings and Infrastructure Solutions | 372 |
| | 382 |
| | 990 |
| | 979 |
|
Agricultural Sciences | 75 |
| | (12 | ) | | 768 |
| | 568 |
|
Performance Materials | 478 |
| | 513 |
| | 1,523 |
| | 1,377 |
|
Performance Plastics | 834 |
| | 900 |
| | 2,773 |
| | 2,623 |
|
Feedstocks and Energy | 263 |
| | 154 |
| | 765 |
| | 319 |
|
Corporate | (229 | ) | | (432 | ) | | (1,296 | ) | | (1,197 | ) |
Total | $ | 2,099 |
| | $ | 1,782 |
| | $ | 6,373 |
| | $ | 5,444 |
|
Equity in earnings (losses) of nonconsolidated affiliates by operating segment (included in EBITDA) | | |
Electronic and Functional Materials | $ | 23 |
| | $ | 23 |
| | $ | 72 |
| | $ | 76 |
|
Coatings and Infrastructure Solutions | 72 |
| | 75 |
| | 219 |
| | 247 |
|
Agricultural Sciences | — |
| | 2 |
| | 3 |
| | 3 |
|
Performance Materials | (11 | ) | | (4 | ) | | (20 | ) | | 9 |
|
Performance Plastics | 150 |
| | 58 |
| | 271 |
| | 182 |
|
Feedstocks and Energy | 153 |
| | 98 |
| | 446 |
| | 294 |
|
Corporate | (12 | ) | | (1 | ) | | (27 | ) | | (12 | ) |
Total | $ | 375 |
| | $ | 251 |
| | $ | 964 |
| | $ | 799 |
|
| |
(1) | The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. A reconciliation of EBITDA to “Income Before Income Taxes” is provided below. |
|
| | | | | | | | | | | | | | | |
Reconciliation of EBITDA to “Income Before Income Taxes” | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
EBITDA | $ | 2,099 |
| | $ | 1,782 |
| | $ | 6,373 |
| | $ | 5,444 |
|
- Depreciation and amortization | 714 |
| | 716 |
| | 2,142 |
| | 2,207 |
|
+ Interest income | 9 |
| | 7 |
| | 26 |
| | 24 |
|
- Interest expense and amortization of debt discount | 305 |
| | 362 |
| | 1,010 |
| | 1,105 |
|
Income Before Income Taxes | $ | 1,089 |
| | $ | 711 |
| | $ | 3,247 |
| | $ | 2,156 |
|
Transfers of products between operating segments are generally valued at cost. However, transfers of products to Agricultural Sciences from other segments are generally valued at market-based prices; the revenues generated by these transfers in the first nine months of 2011 and 2010 were immaterial and eliminated in consolidation.
|
| | | | | | | | | | | | | | | |
Geographic Areas | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales by geographic area | | | | | | | |
United States | $ | 4,930 |
| | $ | 4,271 |
| | $ | 14,950 |
| | $ | 13,116 |
|
Europe, Middle East and Africa | 5,125 |
| | 4,293 |
| | 16,196 |
| | 13,761 |
|
Rest of World | 5,054 |
| | 4,304 |
| | 14,742 |
| | 13,026 |
|
Total | $ | 15,109 |
| | $ | 12,868 |
| | $ | 45,888 |
| | $ | 39,903 |
|
|
| | |
(Unaudited) | | The Dow Chemical Company and Subsidiaries PART I – FINANCIAL INFORMATION, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
DISCLOSURE REGARDING FORWARD-LOOKING INFORMATION
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements made by or on behalf of The Dow Chemical Company and its subsidiaries (“Dow” or the “Company”). This section covers the current performance and outlook of the Company and each of its operating segments. The forward-looking statements contained in this section and in other parts of this document involve risks and uncertainties that may affect the Company’s operations, markets, products, services, prices and other factors as more fully discussed elsewhere and in filings with the U.S. Securities and Exchange Commission (“SEC”). These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that the Company’s expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.
OVERVIEW
| |
• | The Company reported sales in the third quarter of 2011 of $15.1 billion, up 17 percent from $12.9 billion in the third quarter of 2010, with double-digit increases in all geographic areas and all operating segments. Price was up 17 percent compared with the same period last year, with double-digit increases in all geographic areas and most operating segments. |
| |
• | Compared with the same quarter of 2010, volume was flat, as volume improvements in Latin America (up 7 percent) and Asia Pacific (up 5 percent) were offset by volume declines in North America (down 3 percent) and Europe, Middle East and Africa ("EMEA") (down 2 percent). |
| |
• | Purchased feedstock and energy costs, which account for more than one-third of Dow’s total costs, increased 38 percent or $1.7 billion compared with the third quarter of 2010. |
| |
• | Research and development expenses totaled $402 million in the third quarter of 2011, essentially flat with $403 million in the third quarter of last year. Selling, general and administrative expenses increased $51 million, primarily due to growth initiatives in the Electronic and Functional Materials and Agricultural Sciences segments. |
| |
• | Equity earnings were $375 million in the third quarter of 2011, up $124 million from $251 million in the third quarter of last year. Equity earnings in the third quarter of 2011 include an $86 million gain related to cash collected on a previously impaired note receivable related to Equipolymers (reflected in Performance Plastics). |
| |
• | The Company retired additional debt in the third quarter of 2011. Total gross debt at September 30, 2011 was down $4.2 billion compared with total gross debt at December 31, 2010. These debt retirement actions will reduce annual interest expense by more than $250 million going forward. |
|
| | | | | | | | | | | | | | | |
Selected Financial Data | Three Months Ended | | Nine Months Ended |
In millions, except per share amounts | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Net sales | $ | 15,109 |
| | $ | 12,868 |
| | $ | 45,888 |
| | $ | 39,903 |
|
| | | | | | | |
Cost of sales | $ | 12,928 |
| | $ | 10,841 |
| | $ | 38,596 |
| | $ | 33,962 |
|
Percent of net sales | 85.6 | % | | 84.2 | % | | 84.1 | % | | 85.1 | % |
| | | | | | | |
Research and development expenses | $ | 402 |
| | $ | 403 |
| | $ | 1,213 |
| | $ | 1,217 |
|
Percent of net sales | 2.7 | % | | 3.1 | % | | 2.6 | % | | 3.0 | % |
| | | | | | | |
Selling, general and administrative expenses | $ | 691 |
| | $ | 640 |
| | $ | 2,086 |
| | $ | 1,950 |
|
Percent of net sales | 4.6 | % | | 5.0 | % | | 4.5 | % | | 4.9 | % |
| | | | | | | |
Effective tax rate | 17.1 | % | | 16.0 | % | | 16.8 | % | | 16.1 | % |
| | | | | | | |
Net income available for common stockholders | $ | 815 |
| | $ | 512 |
| | $ | 2,422 |
| | $ | 1,544 |
|
| | | | | | | |
Earnings per common share – basic | $ | 0.70 |
| | $ | 0.45 |
| | $ | 2.08 |
| | $ | 1.37 |
|
Earnings per common share – diluted | $ | 0.69 |
| | $ | 0.45 |
| | $ | 2.07 |
| | $ | 1.35 |
|
| | | | | | | |
Operating rate percentage | 83 | % | | 86 | % | | 83 | % | | 83 | % |
RESULTS OF OPERATIONS
Net sales in the third quarter of 2011 were $15.1 billion, up 17 percent from $12.9 billion in the third quarter of last year, with double-digit increases in all geographic areas and all operating segments. Compared with the same quarter of 2010, price increased 17 percent (with approximately one-quarter of the increase due to currency) and volume was flat. Price increases were broad-based with gains in all operating segments and double-digit increases in all geographic areas, led by EMEA (up 21 percent) and North America (up 17 percent). Price increases were most pronounced in Feedstocks and Energy (up 36 percent), Performance Materials and Performance Plastics (each up 15 percent) and Coatings and Infrastructure Solutions (up 14 percent), driven by price initiatives in response to a 38 percent increase ($1.7 billion) in purchased feedstock and energy costs. Volume improvements were noted in Latin America (up 7 percent) and Asia Pacific (up 5 percent), but were offset by volume declines in North America (down 3 percent) and EMEA (down 2 percent).
Net sales for the first nine months of 2011 were $45.9 billion, up 15 percent from $39.9 billion in the same period last year. Compared with the first nine months of 2010, price increased 16 percent and volume decreased 1 percent. The decline in volume reflects the impact of recent divestitures. Excluding these divestitures,(1) sales increased 22 percent compared with the first nine months of 2010, with price up 17 percent and volume up 5 percent. Price increases were recognized in all operating segments and all geographic areas, largely in response to a 26 percent increase ($3.9 billion) in purchased feedstock and energy costs compared with year-to-date 2010. Excluding the impact of divestitures, volume improved in all geographic areas and all operating segments (except Coatings and Infrastructure Solutions, unchanged from last year) with the most pronounced increases in Latin America (up 11 percent), Agricultural Sciences (up 15 percent), and Feedstocks and Energy (up 10 percent). For additional details regarding the change in net sales, see the Sales Volume and Price tables at the end of the section entitled “Segment Results.”
Gross margin was $2,181 million in the third quarter of 2011, up from $2,027 million in the third quarter of last year. Gross margin increased due to the impact of higher selling prices and lower freight costs, which more than offset the increase in purchased feedstock and energy costs, as well as increases in other raw material costs and the unfavorable impact of currency on costs. In the third quarter of 2010, gross margin was reduced by $50 million related to a labor-related litigation matter that was included in “Cost of Sales” and reflected in Corporate. Year to date, gross margin was $7,292 million, compared with $5,941 million in the first nine months of 2010. The improvement in the year-to-date gross margin reflected higher selling prices, increased margin on product mix and lower freight costs, which more than offset the increase in purchased feedstock and energy costs, increases in other raw material costs and the unfavorable impact of currency on costs.
| |
(1) | Excludes sales of the acrylic monomer business and a portion of the specialty latex business divested on January 25, 2010, sales of the Powder Coatings business divested on June 1, 2010, and sales of the Styron business unit divested on June 17, 2010. |
The Company’s global plant operating rate was 83 percent of capacity in the third quarter of 2011, down from 86 percent in the third quarter of 2010, as the Company reduced production levels due to the softer economy and planned turnarounds. For the first nine months of 2011, the Company's global plant operating rate was 83 percent, unchanged from the first nine months of 2010.
The Company has operations at several locations in Japan, including a manufacturing site located in Soma, Japan, that manufactures product primarily for the Dow Water and Process Solutions business, part of the Coatings and Infrastructure Solutions operating segment. The site is located in the area of Japan that was heavily impacted by the March 11, 2011 earthquakes and tsunami, and near the Fukushima Daiichi nuclear power plant. Based on an assessment of the site, the Company wrote off an immaterial amount of property and inventory in the first quarter of 2011. The Soma manufacturing site returned to operations on a limited basis late in the third quarter of 2011 and is anticipated to return to full production capacity by year-end 2011. The financial impact of the disaster, net of insurance recoveries, did not have a material adverse impact on the Company’s results of operations, financial condition and cash flows.
Personnel count was 51,732 at September 30, 2011, up from 49,505 at December 31, 2010 and up from 49,191 at September 30, 2010. Headcount increased from September 30, 2010 and from year-end 2010 primarily due to the hiring of additional employees to support the Company’s growth initiatives.
Research and development (“R&D”) expenses totaled $402 million in the third quarter of 2011, essentially flat with $403 million in the third quarter of last year, as the Company’s spending on strategic growth initiatives in the Electronic and Functional Materials and Agricultural Sciences segments and continued investment in POWERHOUSETM solar shingle, were offset by cost reduction initiatives. For the first nine months of 2011, R&D expenses totaled $1,213 million, down slightly from $1,217 million in the first nine months of 2010.
Selling, general and administrative (“SG&A”) expenses totaled $691 million in the third quarter of 2011, up $51 million (8 percent) from $640 million in the third quarter of last year, primarily due to growth initiatives in the Electronic and Functional Materials and Agricultural Sciences segments. For the first nine months of 2011, SG&A expenses totaled $2,086 million, up $136 million (7 percent) from $1,950 million in the first nine months of 2010.
Amortization of intangibles was $125 million in the third quarter of 2011, up slightly from $124 million in the third quarter of last year. In the first nine months of 2011, amortization of intangibles was $373 million, down from $377 million in the same period last year. See Note G to the Consolidated Financial Statements for additional information on intangible assets.
In June 2009, the Company’s Board of Directors approved a restructuring plan that incorporated actions related to the Company’s acquisition of Rohm and Haas, as well as additional actions to advance the Company’s strategy and to respond to continued weakness in the global economy. The restructuring plan included the shutdown of a number of facilities and a global workforce reduction. In the first quarter of 2010, the Company recorded pretax adjustments of $16 million to the 2009 restructuring charge for additional asset impairment costs, which were reflected in Electronic and Functional Materials ($8 million) and Coatings and Infrastructure Solutions ($8 million). In the second quarter of 2010, the Company recorded pretax adjustments of $13 million to the 2009 restructuring charge for additional exit or disposal activities, which were reflected in Coatings and Infrastructure Solutions ($12 million) and Corporate ($1 million). The impact of these adjustments is shown as “Restructuring charges” in the consolidated statements of income. See Note C to the Consolidated Financial Statements for details on the Company’s restructuring activities.
In the first quarter of 2011, pretax charges totaling $31 million were recorded for integration costs related to the April 1, 2009 acquisition of Rohm and Haas. In the third quarter of 2010, pretax charges totaling $35 million ($98 million for the first nine months of 2010) were recorded for integration costs related to the acquisition. These charges were reflected in Corporate.
Dow’s share of the earnings of nonconsolidated affiliates was $375 million in the third quarter of 2011, up $124 million from $251 million in the third quarter of last year, driven by an $86 million gain related to cash collected on a previously impaired note receivable related to Equipolymers (reflected in Performance Plastics), and improved earnings at The Kuwait Olefins Company K.S.C., MEGlobal and Univation Technologies, LLC that more than offset decreased earnings at Dow Corning Corporation (“Dow Corning”) and the SCG-Dow Group. For the first nine months of 2011, Dow's share of the earnings of nonconsolidated affiliates was $964 million, an increase of $165 million from $799 million for the same period last year, with the same joint ventures, as well as the collection of the note receivable, driving the increase in earnings.
Sundry income (expense) – net includes a variety of income and expense items such as the gain or loss on foreign currency exchange, dividends from investments, and gains and losses on sales of investments and assets. Sundry income (expense) – net in the third quarter of 2011 was net income of $47 million, an increase of $57 million compared with net expense of $10 million in the same quarter of 2010. The third quarter of 2011 included a small gain on the divestiture of the Polypropylene business (reflected in Performance Plastics) and gains from the mark-to-market of trading securities, that more than offset losses on foreign currency exchange. The third quarter of 2010 included a loss of $46 million related to the early extinguishment of debt (reflected in Corporate), and a net $2 million increase (reflected in Performance Plastics) to the second quarter 2010 net gain of $51 million on the divestiture of the Styron business unit ("Styron") ($41 million reflected in Performance Materials and $10 million reflected in Performance Plastics). Year to date, sundry income (expense) - net was net expense of $322 million, which included a $482 million loss on the early extinguishment of debt (reflected in Corporate) (see Note L to the Consolidated Financial Statements), gains on the divestiture of the Polypropylene business (reflected in Performance Plastics) and other small divestitures, $25 million of dividend income received from the Company's ownership interest in the divested Styron business unit (reflected in Corporate), gains from the mark-to-market of trading securities, working capital adjustments from prior divestitures, a gain from the consolidation of a joint venture, as well as losses on foreign currency exchange. This compared with net sundry income of $168 million in the first nine months of 2010, which included gains on several small divestitures as well as the gain on the divestiture of Styron.
On July 27, 2011, the Company entered into a definitive agreement to sell its global Polypropylene business to Braskem SA. The definitive agreement specified the assets and liabilities related to the business to be included in the sale, which included the Company's polypropylene manufacturing facilities at Schkopau and Wesseling, Germany, and Freeport and Seadrift, Texas; railcars; inventory; receivables; business know-how; certain product and process technology; and customer contracts and lists. On September 30, 2011, the sale was completed for $459 million, net of working capital adjustments and costs to sell, with proceeds subject to customary post-closing adjustments, to be finalized in subsequent periods. The proceeds included a $474 million receivable, paid to the Company on October 3, 2011. Dow's Polypropylene Licensing and Catalyst business and related catalyst facilities were excluded from this sale. The transaction also resulted in several long-term supply, service and purchase agreements between Dow and Braskem SA.
Net interest expense (interest expense less capitalized interest and interest income) was $296 million in the third quarter of 2011, compared with $355 million in the third quarter of last year. Year to date, net interest expense was $984 million, compared with $1,081 million in the first nine months of 2010. The decrease in net interest expense in the third quarter of 2011 as well as year-to-date 2011 reflected the Company's redemption of certain notes and InterNotes during the first nine months of 2011 (see Note L to the Consolidated Financial Statements). Interest income was $9 million in the third quarter of 2011, compared with $7 million in the third quarter of 2010, and $26 million for the first nine months of 2011, compared with $24 million in the first nine months of 2010.
The effective tax rate for the third quarter of 2011 was 17.1 percent compared with 16.0 percent for the third quarter of 2010. For the first nine months of 2011 the effective tax rate was 16.8 percent compared with 16.1 percent for the first nine months of 2010. The Company's effective tax rate fluctuates based on, among other factors, where income is earned, reinvestment assertions regarding earned income and the level of income relative to tax credits available. The Company's tax rate is also influenced by the level of equity earnings, since most of the earnings from the Company's equity company investments are taxed at the joint venture level. Similar to the third quarter of 2010, the tax rate for the third quarter of 2011 was favorably impacted by continued earnings growth outside of the United States, primarily in Europe, and strong equity earnings. The tax rate for the first nine months of 2011 was also favorably impacted by tax benefits from the early extinguishment of debt in the United States, reorganization of a joint venture and accrual-to-return adjustments related to the filing of tax returns during 2011. The tax rate in the first nine months of 2010 was also favorably impacted by audit settlements and the closure of tax years.
Net income attributable to noncontrolling interests was $3 million in the third quarter of 2011, up from zero in the third quarter of 2010. Net income attributable to noncontrolling interests was $24 million in the first nine months of 2011, compared with $9 million in the first nine months of 2010, reflecting improved results in certain affiliates, primarily in the Electronic and Functional Materials and Agricultural Sciences segments.
Preferred stock dividends of $85 million were recognized in the third quarters of 2011 and 2010 ($255 million in the first nine months of 2011 and 2010), related to the Company’s Cumulative Convertible Perpetual Preferred Stock, Series A.
Net income available for common stockholders was $815 million, or $0.69 per share, in the third quarter of 2011, compared with $512 million, or $0.45 per share, in the third quarter of 2010. Net income available for common stockholders for the first nine months of 2011 was $2,422 million, or $2.07 per share, compared with $1,544 million, or $1.35 per share, for the same period of 2010.
On July 25, 2011, the Company and Saudi Arabian Oil Company (“Saudi Aramco”) announced that the Board of Directors of both companies had approved the formation of a joint venture, Sadara Chemical Company (“Sadara”), to build and operate a world-scale, fully integrated chemicals complex in Jubail Industrial City, Kingdom of Saudi Arabia. On October 8, 2011, the Shareholders' Agreement was signed. Comprised of 26 manufacturing units, building on Saudi Aramco's project management and execution expertise, and utilizing many of Dow's industry leading technologies, the complex will be one of the world's largest integrated chemical facilities, and the largest ever built in one single phase. The complex will possess flexible cracking capabilities and will produce over 3 million metric tons of high value-added chemical products and performance plastics, capitalizing on rapidly growing end-markets in energy, transportation, infrastructure and consumer products. Construction began immediately and the first production units are expected to come on line in the second half of 2015, with all units expected to be up and running in 2016. Once operational, Sadara is expected to deliver annual revenues of approximately $10 billion within a few years of operations. Total project investment, including third-party investments, is expected to be approximately $20 billion. Sadara will become an equal joint venture between Saudi Aramco and Dow after an initial public offering. In addition to equity from the partners, Export Credit Agencies and financial institutions will provide project financing to Sadara.
The following table summarizes the impact of certain items recorded in the three- and nine-month periods ended September 30, 2011 and September 30, 2010, and previously described in this section:
|
| | | | | | | | | | | | | | | | | | | | | | | |
Certain Items Impacting Results | Pretax Impact (1) | | Impact on Net Income (2) | | Impact on EPS (3) |
| Three Months Ended | | Three Months Ended | | Three Months Ended |
In millions, except per share amounts | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Labor-related litigation matter | $ | — |
| | $ | (50 | ) | | $ | — |
| | $ | (33 | ) | | $ | — |
| | $ | (0.03 | ) |
Acquisition-related integration expenses | — |
| | (35 | ) | | — |
| | (23 | ) | | — |
| | (0.02 | ) |
Gain on collection of impaired note receivable | 86 |
| | — |
| | 86 |
| | — |
| | 0.07 |
| | — |
|
Gain (Loss) on divestiture of Styron | — |
| | 2 |
| | — |
| | (23 | ) | | — |
| | (0.02 | ) |
Loss on early extinguishment of debt | — |
| | (46 | ) | | — |
| | (29 | ) | | — |
| | (0.02 | ) |
Total | $ | 86 |
| | $ | (129 | ) | | $ | 86 |
| | $ | (108 | ) | | $ | 0.07 |
| | $ | (0.09 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | |
Certain Items Impacting Results | Pretax Impact (1) | | Impact on Net Income (2) | | Impact on EPS (3) |
| Nine Months Ended | | Nine Months Ended | | Nine Months Ended |
In millions, except per share amounts | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Labor-related litigation matter | $ | — |
| | $ | (50 | ) | | $ | — |
| | $ | (33 | ) | | $ | — |
| | $ | (0.03 | ) |
Restructuring charges | — |
| | (29 | ) | | — |
| | (16 | ) | | — |
| | (0.02 | ) |
Acquisition-related integration expenses | (31 | ) | | (98 | ) | | (20 | ) | | (64 | ) | | (0.02 | ) | | (0.05 | ) |
Gain on collection of impaired note receivable | 86 |
| | — |
| | 86 |
| | — |
| | 0.07 |
| | — |
|
Gain (Loss) on divestiture of Styron | — |
| | 53 |
| | — |
| | (39 | ) | | — |
| | (0.03 | ) |
Loss on early extinguishment of debt | (482 | ) | | (46 | ) | | (314 | ) | | (29 | ) | | (0.27 | ) | | (0.02 | ) |
Total | $ | (427 | ) | | $ | (170 | ) | | $ | (248 | ) | | $ | (181 | ) | | $ | (0.22 | ) | | $ | (0.15 | ) |
| |
(1) | Impact on “Income Before Income Taxes” |
| |
(2) | Impact on “Net Income Attributable to The Dow Chemical Company” |
| |
(3) | Impact on “Earnings per common share – diluted” |
SEGMENT RESULTS
Beginning in the third quarter of 2011, the Company changed its reportable segments due to recent changes in the Company's organization. Following are the new segments:
| |
• | Electronic and Functional Materials |
| |
• | Coatings and Infrastructure Solutions |
The reporting changes are reflected in the following discussion of segment results for all periods presented.
The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. Additional information regarding the Company’s operating segments and a reconciliation of EBITDA to “Income Before Income Taxes” can be found in Note Q to the Consolidated Financial Statements.
Due to the completion of several divestitures (see Note D to the Consolidated Financial Statements), the change in sales volume from 2010 excluding divestitures is provided by operating segment, where applicable. Sales excluding divestitures exclude the sales of the acrylic monomer business and a portion of the specialty latex business divested on January 25, 2010, sales of the Powder Coatings business divested on June 1, 2010, and sales of Styron divested on June 17, 2010.
ELECTRONIC AND FUNCTIONAL MATERIALS
The Electronic and Functional Materials segment consists of two businesses – Dow Electronic Materials and Functional Materials – and includes a portion of the Company’s share of the results of Dow Corning Corporation, a joint venture of the Company. Dow Electronic Materials is a leading global supplier of materials for chemical mechanical planarization; materials used in the production of electronic displays, including brightness films, diffusers, metalorganic light emitting diode precursors and organic light emitting diode materials; products and technologies that drive leading edge semiconductor design; materials used in the fabrication of printed circuit boards; and integrated metallization processes critical for interconnection, corrosion resistance, metal finishing and decorative applications. These enabling materials are found in applications such as consumer electronics, flat panel displays and telecommunications. Dow Electronic Materials includes Display Technologies, Growth Technologies, Interconnect Technologies and Semiconductor Technologies. Functional Materials is a portfolio of businesses characterized by a vast global footprint, a broad array of unique chemistries, multi-functional ingredients and technology capabilities, combined with key positions in the pharmaceuticals; food, home and personal care; and industrial specialty industries. These technology capabilities and market platforms enable the businesses to develop innovative solutions that address modern societal needs for clean water and air; material preservation; and improved health care, disease prevention, nutrition and wellness. Functional Materials includes Dow Home and Personal Care, Dow Microbial Control, Dow Wolff Cellulosics and Performance Additives.
|
| | | | | | | | | | | | | | | |
Electronic and Functional Materials | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales | $ | 1,205 |
| | $ | 1,087 |
| | $ | 3,536 |
| | $ | 3,144 |
|
Price change from comparative period | 8 | % | | N/A |
| | 7 | % | | N/A |
|
Volume change from comparative period | 3 | % | | N/A |
| | 5 | % | | N/A |
|
Equity earnings | $ | 23 |
| | $ | 23 |
| | $ | 72 |
| | $ | 76 |
|
EBITDA | $ | 306 |
| | $ | 277 |
| | $ | 850 |
| | $ | 775 |
|
Certain items impacting EBITDA | $ | — |
| | $ | — |
| | $ | — |
| | $ | (8 | ) |
Electronic and Functional Materials sales were $1,205 million in the third quarter of 2011, up 11 percent from $1,087 million in the third quarter of 2010 with double-digit sales increases in all geographic areas, except Asia Pacific. Compared with last year, price increased 8 percent (with approximately half of the increase due to currency) and volume increased 3 percent. Price increased in all geographic areas and most major business units in response to increasing raw material costs. Volume also increased in all geographic areas and most business units, driven by strong demand for consumer electronics, specialty polymers and specialty cellulosics used in food and pharmaceutical applications. EBITDA in the third quarter of 2011
was $306 million, up from $277 million in the third quarter of 2010. EBITDA improved from last year as higher prices and volume more than offset increased raw material costs, the unfavorable impact of currency on costs, increased investment in R&D and higher SG&A expenses.
Dow Electronic Materials sales in the third quarter of 2011 increased 8 percent from the same quarter last year, with significant sales growth in Asia Pacific and EMEA. Volume increased 6 percent, driven by higher demand for materials used in flat panel displays, especially in organic light emitting diodes, and chemical mechanical planarization pads and slurries.
Functional Materials sales in the third quarter of 2011 increased 14 percent from the third quarter of 2010, as price improved 13 percent and volume increased 1 percent. The increase in price was broad-based, with gains across all geographic areas and business units, driven by higher raw material costs. Volume increased in all geographic areas, except EMEA, and in most business units. Volume increased due to higher demand for specialty cellulosics used in food and pharmaceutical applications and specialty polymers used in nutrition and wellness applications.
Electronic and Functional Materials sales were $3,536 million for the first nine months of 2011, up 12 percent from $3,144 million in the first nine months of 2010. Compared with year-to-date sales in 2010, price increased 7 percent (with approximately one-third of the increase due to currency) and volume increased 5 percent. EBITDA for the first nine months of 2011 was $850 million, up from $775 million in the first nine months of 2010. EBITDA improved from last year as price increases and volume growth more than offset higher raw material costs, the unfavorable impact of currency on costs, higher SG&A expenses and increased investment in growth initiatives. EBITDA in the first nine months of 2010 was negatively impacted by an $8 million adjustment to the 2009 restructuring charge related to the closure of a small manufacturing facility.
COATINGS AND INFRASTRUCTURE SOLUTIONS
The Coatings and Infrastructure Solutions segment consists of the following businesses: Dow Building and Construction, Dow Coating Materials, Dow Water and Process Solutions, and Performance Monomers; and includes a portion of the Company's share of the results of Dow Corning Corporation, a joint venture of the Company. These businesses produce a wide variety of products with a broad range of applications – adhesives and sealants, construction materials (insulation, weatherization and vinyl applications), cellulosic-based construction additives, raw materials for architectural paints and industrial coatings, and technologies used for water purification.
|
| | | | | | | | | | | | | | | |
Coatings and Infrastructure Solutions | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales | $ | 1,905 |
| | $ | 1,734 |
| | $ | 5,639 |
| | $ | 5,049 |
|
Price change from comparative period | 14 | % | | N/A |
| | 15 | % | | N/A |
|
Volume change from comparative period | (4 | )% | | N/A |
| | (3 | )% | | N/A |
|
Volume change, excluding divestitures | (4 | )% | | N/A |
| | — | % | | N/A |
|
Equity earnings | $ | 72 |
| | $ | 75 |
| | $ | 219 |
| | $ | 247 |
|
EBITDA | $ | 372 |
| | $ | 382 |
| | $ | 990 |
| | $ | 979 |
|
Certain items impacting EBITDA | $ | — |
| | $ | — |
| | $ | — |
| | $ | (20 | ) |
Coatings and Infrastructure Solutions sales were $1,905 million in the third quarter of 2011, up from $1,734 million in the third quarter of 2010. Sales increased 10 percent with price improving 14 percent (with approximately one-third of the price increase due to currency) and volume decreasing 4 percent. The price increase was broad-based, with double-digit gains across all geographic areas and businesses, except Dow Water and Process Solutions, driven by higher feedstock and energy and other raw material costs. Volume declined due to continued weak demand in the housing and construction industry, especially in North America. Architectural and industrial coatings volume decreased, especially in North America and Asia Pacific, driven by weaker end-market conditions. Dow Water and Process Solutions sales were higher in EMEA, North America and Asia Pacific (most notably in China), driven by increased demand for ion exchange resins and reverse osmosis membranes used in industrial water purification projects.
EBITDA in the third quarter of 2011 was $372 million, down from $382 million in the third quarter of 2010. EBITDA decreased slightly from the same quarter last year as price increases did not offset higher feedstock and energy costs and other raw material costs, lower sales volume and increased expenses related to ongoing investment in POWERHOUSE™ solar shingle, for which the business recently announced its commercial launch.
Coatings and Infrastructure Solutions sales were $5,639 million for the first nine months of 2011, up 12 percent from $5,049 million in 2010. Compared with the first nine months of 2010, price rose 15 percent and volume declined 3 percent. The increase in price was broad-based, with increases across all geographic areas, primarily driven by higher feedstock and energy and other raw material costs. Volume was down due to the United States Federal Trade Commission (“FTC”) required divestiture of certain specialty latex assets on January 25, 2010 (related to the April 1, 2009 acquisition of Rohm and Haas) and the June 1, 2010 divestiture of the Powder Coatings business. Excluding these divestitures, volume was flat as higher demand for ion exchange resins and reverse osmosis membranes was offset by lower demand for architectural and industrial coatings.
EBITDA for the first nine months of 2011 was $990 million, compared with $979 million in the first nine months of 2010. EBITDA improved slightly from last year as price increases and lower freight costs more than offset higher raw material costs, ongoing investment in the POWERHOUSE™ solar shingle, lower equity earnings from Dow Corning, and the absence of earnings from divested businesses. Results in the first nine months of 2010 were negatively impacted by $15 million in adjustments to the 2009 restructuring plan and $5 million in restructuring charges related to the divestiture of the specialty latex assets.
AGRICULTURAL SCIENCES
Dow AgroSciences is a global leader in providing agricultural and plant biotechnology products, pest management solutions and healthy oils. The business invents, develops, manufactures and markets products for use in agriculture, industrial and commercial pest management, and food service.
|
| | | | | | | | | | | | | | | |
Agricultural Sciences | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales | $ | 1,205 |
| | $ | 948 |
| | $ | 4,311 |
| | $ | 3,593 |
|
Price change from comparative period | 9 | % | | N/A |
| | 5 | % | | N/A |
|
Volume change from comparative period | 18 | % | | N/A |
| | 15 | % | | N/A |
|
Equity earnings | $ | — |
| | $ | 2 |
| | $ | 3 |
| | $ | 3 |
|
EBITDA | $ | 75 |
| | $ | (12 | ) | | $ | 768 |
| | $ | 568 |
|
Certain items impacting EBITDA | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
|
Agricultural Sciences sales were $1,205 million in the third quarter of 2011, up 27 percent from $948 million in the third quarter of 2010, a third quarter sales record for the segment. Compared with the third quarter of 2010, volume increased 18 percent and price increased 9 percent, with approximately one-third of the price increase due to currency. Double-digit sales growth was reported across all geographic areas and all businesses. Agricultural chemicals had strong sales growth in the quarter due to new product sales, which increased 32 percent, and sales of herbicides for range and pasture, cereal, corn and soybeans. Seeds, Traits and Oils benefited from new seed technologies, especially in Latin America, where customer demand for high-yield varieties as well as a portfolio shift to more products with seed traits generated strong volume and price growth in the corn seed business. EBITDA for the third quarter of 2011 was $75 million, up from a loss of $12 million in the third quarter of 2010, driven by sales growth, which more than offset increased R&D and SG&A expenses related to growth initiatives and the negative impact of currency on costs.
For the first nine months of 2011, sales for Agricultural Sciences were $4,311 million, up 20 percent from $3,593 million in 2010, with double-digit sales growth in all geographic areas and all businesses. This represents a new sales record for the segment for the first nine months of the year. Compared with the same period last year, volume increased 15 percent and price increased 5 percent, with approximately half of the price increase due to currency. For 2011, year-to-date EBITDA for the segment was $768 million, up from $568 million recorded in the first nine months of 2010. EBITDA increased in the first nine months of 2011 as favorable global agricultural and food industry conditions, new product sales and new seed technologies led to strong sales increases across all geographic areas, more than offsetting increased R&D and SG&A expenses related to ongoing growth initiatives, and the unfavorable impact of currency on costs.
PERFORMANCE MATERIALS
The Performance Materials segment consists of the following businesses: Amines; Chlorinated Organics; Dow Automotive Systems; Dow Formulated Systems; Dow Plastic Additives; Epoxy; Oxygenated Solvents; Polyglycols, Surfactants and Fluids; Polyurethanes; Dow Fiber Solutions; Dow Haltermann; Dow Oil and Gas; and SAFECHEM. These businesses produce a wide variety of products with a broad range of applications – adhesives, aircraft and runway deicing fluids, automotive interiors and exteriors, carpeting, footwear, home furnishings, mattresses, personal care products, transportation, waterproofing membranes and wind turbines. The segment also includes a portion of the results of the SCG-Dow Group, joint ventures of the Company.
On June 17, 2010, Dow sold Styron to an affiliate of Bain Capital Partners. Businesses and products sold within the Performance Materials segment included Emulsion Polymers (styrene-butadiene latex); Synthetic Rubber; and certain products from Dow Automotive Systems; all of which were reported in the Performance Materials segment through the date of the divestiture. See Note D to the Consolidated Financial Statements for additional information on this divestiture.
|
| | | | | | | | | | | | | | | |
Performance Materials | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales | $ | 3,698 |
| | $ | 3,311 |
| | $ | 11,097 |
| | $ | 10,552 |
|
Price change from comparative period | 15 | % | | N/A |
| | 14 | % | | N/A |
|
Volume change from comparative period | (3 | )% | | N/A |
| | (9 | )% | | N/A |
|
Volume change, excluding divestitures | (3 | )% | | N/A |
| | 1 | % | | N/A |
|
Equity earnings (losses) | $ | (11 | ) | | $ | (4 | ) | | $ | (20 | ) | | $ | 9 |
|
EBITDA | $ | 478 |
| | $ | 513 |
| | $ | 1,523 |
| | $ | 1,377 |
|
Certain items impacting EBITDA | $ | — |
| | $ | — |
| | $ | — |
| | $ | 41 |
|
Performance Materials sales were $3,698 million in the third quarter of 2011, up 12 percent from $3,311 million in the third quarter of 2010. Price increased 15 percent (with approximately one-quarter of the increase due to currency) as increases in feedstock and energy and other raw material costs drove double-digit price increases in all geographic areas and most businesses. Volume decreased 3 percent as modest volume gains in Latin America and North America were more than offset by lower demand in EMEA and Asia Pacific. Dow Plastic Additives and Dow Formulated Systems reported lower volume due to weak global demand in the building and construction industries. For Epoxy and Chlorinated Organics, volume declined due to planned maintenance turnarounds and softer demand. Volume improved across all geographic areas for Dow Automotive Systems as the automotive industry continued its recovery.
EBITDA for the third quarter of 2011 was $478 million, down from $513 million in the third quarter of 2010. Compared with the same period last year, EBITDA declined as higher feedstock and energy and other raw material costs, increased spending for planned maintenance turnarounds, the negative impact of currency on costs, and lower equity earnings from joint ventures more than offset the favorable impact from price increases and lower freight costs.
Performance Materials sales in the first nine months of 2011 were $11,097 million, an increase of 5 percent from $10,552 million in the same period last year. Compared with the first nine months of 2010, price was up 14 percent while volume declined 9 percent, reflecting the divestiture of Emulsion Polymers, Synthetic Rubber and certain products from Dow Automotive Systems as part of the June 17, 2010 divestiture of Styron. Excluding the impact of this divestiture, volume increased 1 percent compared with the first nine months of 2010, with volume gains in the Epoxy, Dow Automotive Systems, Polyurethanes and Dow Oil and Gas businesses offset by declines in some of the other businesses.
EBITDA for the first nine months of 2011 was $1,523 million, up from $1,377 million in the first nine months of 2010. Compared with the same period last year, EBITDA improved as price increases, reduced freight costs and lower R&D spending more than offset higher feedstock and energy and other raw material costs, the absence of earnings from divested businesses and lower equity earnings. Results in the first nine months of 2010 were favorably impacted by a $41 million net gain on the sale of Styron.
PERFORMANCE PLASTICS
The Performance Plastics segment includes the following businesses: Dow Elastomers; Dow Electrical and Telecommunications; Dow Packaging and Converting; Plastics Licensing and Catalyst; and Polyethylene. These world-leading businesses provide a broad range of products and solutions by leveraging Dow’s leading manufacturing and application technology, research and product development expertise, extensive market knowledge and strong customer relationships. Product applications include adhesives, beverage bottles, disposable diaper liners, flexible and rigid packaging, toys, plastic pipe, oil tanks, road equipment, and wire and cable insulation and jacketing materials for power utility and telecommunications. The Performance Plastics segment also includes the results of Americas Styrenics LLC (through the June 17, 2010 divestiture of Styron), Equipolymers (consolidated with MEGlobal effective July 1, 2011) and Univation Technologies, LLC, as well as a portion of the results of EQUATE Petrochemical Company K.S.C., The Kuwait Olefins Company K.S.C. and the SCG-Dow Group, all joint ventures of the Company.
On June 17, 2010, Dow sold Styron to an affiliate of Bain Capital Partners. Businesses sold within the Performance Plastics segment included Styrenics (polystyrene, acrylonitrile butadiene styrene, styrene acrylonitrile and expandable polystyrene), a global leader in the production of polystyrene resins; Polycarbonate and Compounds and Blends; and the Company’s 50-percent ownership interest in Americas Styrenics LLC, a nonconsolidated affiliate; all of which were reported in the Performance Plastics segment through the date of the divestiture.
On July 27, 2011, the Company entered into a definitive agreement to sell its global Polypropylene business to Braskem SA; the transaction closed on September 30, 2011. The transaction did not include Dow's Polypropylene Licensing and Catalyst business. The Polypropylene business was reported in the Performance Plastics segment through the date of the divestiture. See Note D to the Consolidated Financial Statements for additional information on these divestitures.
|
| | | | | | | | | | | | | | | |
Performance Plastics | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales | $ | 4,114 |
| | $ | 3,540 |
| | $ | 12,598 |
| | $ | 11,381 |
|
Price change from comparative period | 15 | % | | N/A |
| | 15 | % | | N/A |
|
Volume change from comparative period | 1 | % | | N/A |
| | (4 | )% | | N/A |
|
Volume change, excluding divestitures | 1 | % | | N/A |
| | 5 | % | | N/A |
|
Equity earnings | $ | 150 |
| | $ | 58 |
| | $ | 271 |
| | $ | 182 |
|
EBITDA | $ | 834 |
| | $ | 900 |
| | $ | 2,773 |
| | $ | 2,623 |
|
Certain items impacting EBITDA | $ | 86 |
| | $ | 2 |
| | $ | 86 |
| | $ | 12 |
|
Performance Plastics sales in the third quarter of 2011 were $4,114 million, up 16 percent from $3,540 million in the third quarter of 2010. Compared with the same quarter last year, price increased 15 percent (with approximately 30 percent of the increase due to currency). Double-digit price increases were reported in all geographic areas and most businesses, largely due to significant increases in feedstock and energy costs. Volume increased 1 percent with gains reported in all geographic areas, except North America. Modest volume growth was reported for the segment in EMEA, reflecting economic concerns in the region. In EMEA, polypropylene availability was impacted by a planned maintenance turnaround at the Company's Wesseling, Germany manufacturing facility. Volume grew modestly in Latin America where limited ethylene supply due to a planned maintenance turnaround at the Company's ethylene facility in Bahia Blanca, Argentina impacted product availability. Volume was down in North America due to the slowing U.S. economic recovery as well as planned maintenance turnarounds at the Company's St. Charles, Louisiana and Freeport, Texas polyethylene manufacturing facilities. Dow Elastomers reported double-digit volume growth due to increased demand, especially in Asia Pacific, due to the continuing recovery from the March 2011 earthquakes and tsunami in Japan. Polyethylene and Dow Packaging and Converting also reported volume gains. Dow Electrical and Telecommunication volume declined, especially in Asia Pacific, due to low demand in the construction, manufacturing and public utility sectors.
EBITDA in the third quarter of 2011 was $834 million, down from $900 million in the third quarter of 2010. EBITDA declined due to significantly higher feedstock and energy and other raw material costs, and increased turnaround costs. EBITDA in the third quarter of 2011 included an $86 million gain related to cash collected on a previously impaired note receivable related to Equipolymers, and a small gain on the sale of the Polypropylene business. EBITDA in the third quarter of 2010 included a net $2 million increase in the gain on the divestiture of Styron.
Performance Plastics sales for the first nine months of 2011 were $12,598 million, up 11 percent from $11,381 million in the first nine months of 2010. Compared with the first nine months of 2010, prices were up 15 percent while volume declined 4 percent. The decline in volume for the segment reflected the divestiture of the Styrenics and Polycarbonate and Compounds and Blends businesses as part of the June 17, 2010 divestiture of Styron. Excluding the impact of the Styron divestiture, volume improved 5 percent. EBITDA for the first nine months of 2011 was $2,773 million, up from $2,623 million in the first nine months of 2010. EBITDA improved as the increase in sales, and lower freight costs more than offset the unfavorable impact of higher feedstock and energy and other raw material costs, increased costs related to turnarounds, and the absence of earnings from divested businesses. EBITDA for the first nine months of 2011 included an $86 million gain related to cash collected on a previously impaired note receivable related to Equipolymers. EBITDA for the first nine months of 2010 included a $12 million net gain related to the divestiture of Styron.
FEEDSTOCKS AND ENERGY
The Feedstocks and Energy segment includes the following businesses: Chlor-Alkali/Chlor-Vinyl; Energy; Ethylene Oxide/Ethylene Glycol; and Hydrocarbons. The Chlor-Alkali/Chlor-Vinyl business focuses on the production of chlorine for consumption by downstream Dow derivatives, as well as production, marketing and supply of ethylene dichloride, vinyl chloride monomer and caustic soda. These products are used for applications such as alumina production, pulp and paper manufacturing, soaps and detergents, and building and construction. The Energy business supplies power, steam and other utilities, principally for use in Dow’s global operations. The Ethylene Oxide/Ethylene Glycol business is the world’s largest producer of purified ethylene oxide, principally used in Dow’s downstream performance derivatives. Dow is also a key supplier of ethylene glycol to MEGlobal, a 50:50 joint venture and world leader in the manufacture and marketing of merchant monoethylene glycol and diethylene glycol. Ethylene glycol is used in polyester fiber, polyethylene terephthalate (PET) for food and beverage container applications, polyester film, and aircraft and runway deicers. The Hydrocarbons business encompasses the procurement of natural gas liquids and crude oil-based raw materials, as well as the supply of monomers, principally for use in Dow's global operations. The business regularly sells its by-products and buys and sells products in order to balance regional production capabilities and derivative requirements. The business also sells products to certain Dow joint ventures. Also included in the Feedstocks and Energy segment are the results of Compañia Mega S.A., MEGlobal and a portion of the results of EQUATE Petrochemical Company K.S.C., The Kuwait Olefins Company K.S.C., and the SGC-Dow Group, all joint ventures of the Company.
On June 17, 2010, Dow sold Styron to an affiliate of Bain Capital Partners. Businesses and products sold within the Feedstocks and Energy segment included certain styrene monomer assets, which were reported in the Feedstocks and Energy segment through the date of the divestiture. See Note D to the Consolidated Financial Statements for additional information on this divestiture.
|
| | | | | | | | | | | | | | | |
Feedstocks and Energy | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales | $ | 2,905 |
| | $ | 2,176 |
| | $ | 8,456 |
| | $ | 5,951 |
|
Price change from comparative period | 36 | % | | N/A |
| | 33 | % | | N/A |
|
Volume change from comparative period | (2 | )% | | N/A |
| | 9 | % | | N/A |
|
Volume change, excluding divestitures | (2 | )% | | N/A |
| | 10 | % | | N/A |
|
Equity earnings | $ | 153 |
| | $ | 98 |
| | $ | 446 |
| | $ | 294 |
|
EBITDA | $ | 263 |
| | $ | 154 |
| | $ | 765 |
| | $ | 319 |
|
Certain items impacting EBITDA | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
|
Feedstocks and Energy sales were $2,905 million in the third quarter of 2011, up 34 percent from $2,176 million in the third quarter of 2010. Compared with the same period last year, price increased 36 percent and volume declined 2 percent. Feedstock and energy costs increased significantly during the quarter, resulting in double-digit price increases in all geographic areas and all businesses, except Energy. Sales for the Hydrocarbons business increased 42 percent in the third quarter, with a 41 percent increase in price driven by significant increases in feedstock costs. The Chlor-Alkali/Chlor-Vinyl business reported a 14 percent increase in sales, as a 28 percent increase in price was offset by a 14 percent decline in volume. Caustic soda sales grew, with double-digit increases in all geographic areas, driven by strong demand in the alumina and pulp and paper industries. Vinyl chloride monomer ("VCM") price was up, with double-digit increases in North America, Latin America and EMEA, while volume decreased significantly, primarily due to prior reductions in production capacity in North America. Ethylene Oxide/Ethylene Glycol ("EO/EG") sales were up 23 percent in the third quarter of 2011, driven by a 40 percent increase in price partially offset by a 17 percent decline in volume. Price increased due to higher ethylene costs and tight supply resulting from planned industry turnarounds. Energy sales increased 23 percent in the third quarter of 2011, primarily due to
volume growth in North America.
The Company uses derivatives of crude oil and natural gas as a feedstock in its ethylene facilities. The Company's cost of purchased feedstocks and energy in the third quarter of 2011 increased $1.7 billion compared with the same quarter last year, an increase of 38 percent. Year to date, the cost of purchased feedstocks and energy was up $3.9 billion from the same period last year, an increase of 26 percent.
The Hydrocarbons business transfers materials to Dow's derivative businesses and the Energy business supplies utilities to Dow’s businesses at net cost, resulting in EBITDA that is at or near break-even for these businesses.
For the segment, EBITDA in the third quarter of 2011 was $263 million, up from $154 million in the third quarter of 2010. Despite the significantly higher feedstock and energy costs, EBITDA improved in the third quarter of 2011 primarily due to higher sales prices and increased equity earnings from MEGlobal and The Kuwait Olefins Company K.S.C.
For the first nine months of 2011, sales for Feedstocks and Energy were $8,456 million, up 42 percent from $5,951 million in the same period last year, driven by a 33 percent increase in price and a 9 percent increase in volume. Excluding the impact of the June 17, 2010 divestiture of Styron, volume increased 10 percent. EBITDA for the first nine months of 2011 was $765 million, up significantly from $319 million in the same period last year. EBITDA improved as higher sales prices and volume and higher equity earnings from MEGlobal and The Kuwait Olefins Company K.S.C. more than offset the significant increase in feedstock and energy costs and higher R&D and SG&A expenses.
CORPORATE
Included in the results for Corporate are:
| |
• | results of insurance company operations; |
| |
• | results of Ventures (which includes new business incubation platforms focused on identifying and pursuing new commercial opportunities); |
| |
• | gains and losses on sales of financial assets; |
| |
• | stock-based compensation expense and severance costs; |
| |
• | changes in the allowance for doubtful receivables; |
| |
• | asbestos-related defense and resolution costs; |
| |
• | foreign exchange hedging results; |
| |
• | non-business aligned technology licensing and catalyst activities; |
| |
• | environmental operations; |
| |
• | enterprise level mega project activities; and |
| |
• | certain corporate overhead costs and cost recovery variances not allocated to the operating segments. |
|
| | | | | | | | | | | | | | | |
Corporate | Three Months Ended | | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Sales | $ | 77 |
| | $ | 72 |
| | $ | 251 |
| | $ | 233 |
|
Equity losses | $ | (12 | ) | | $ | (1 | ) | | $ | (27 | ) | | $ | (12 | ) |
EBITDA | $ | (229 | ) | | $ | (432 | ) | | $ | (1,296 | ) | | $ | (1,197 | ) |
Certain items impacting EBITDA | $ | — |
| | $ | (131 | ) | | $ | (513 | ) | | $ | (195 | ) |
Sales for Corporate, which primarily relate to the Company's insurance operations, were $77 million in the third quarter of 2011, up from $72 million the third quarter of 2010. For the first nine months of 2011, sales were $251 million, up from $233 million in the same period of 2010.
EBITDA in the third quarter of 2011 was a loss of $229 million, compared with a loss of $432 million in the third quarter of 2010. Compared with the same period last year, EBITDA was favorably impacted by a decrease in performance-based compensation costs (including stock-based compensation expense, as well as decreased expense related to lower employee participation in the Employees' Stock Purchase Plan), which was partially offset by foreign currency losses. EBITDA in the third quarter of 2010 was reduced by labor-related litigation costs of $50 million, a $46 million loss on the early extinguishment of debt and $35 million of integration costs related to the April 1, 2009 acquisition of Rohm and Haas.
EBITDA for the first nine months of 2011 was a loss of $1,296 million, compared with a loss of $1,197 million in the same period last year. For 2011, year-to-date EBITDA was negatively impacted by a $482 million loss related to the early extinguishment of debt, $31 million of integration costs related to the acquisition of Rohm and Haas and foreign currency losses. EBITDA was favorably impacted by lower performance-based compensation costs (including expenses related to stock-based compensation and decreased participation in the Employees' Stock Purchase Plan), $25 million in dividend income related to the Company's ownership interest in the divested Styron businesses, gains on the sale of various businesses and lower Corporate expenses. EBITDA for the first nine months of 2010 was reduced by integration costs of $98 million related to the acquisition of Rohm and Haas, labor-related litigation costs of $50 million, a $46 million loss on the early extinguishment of debt and a $1 million net adjustment to the 2009 restructuring plan.
|
| | | | | | | | | | | | | | | | | |
Sales Volume and Price by Operating Segment and Geographic Area |
| Three Months Ended | | Nine Months Ended |
| September 30, 2011 | | September 30, 2011 |
Percentage change from prior year | Volume | | Price | | Total | | Volume | | Price | | Total |
Operating segments | | | | | | | | | | | |
Electronic and Functional Materials | 3 | % | | 8 | % | | 11 | % | | 5 | % | | 7 | % | | 12 | % |
Coatings and Infrastructure Solutions | (4 | ) | | 14 |
| | 10 |
| | (3 | ) | | 15 |
| | 12 |
|
Agricultural Sciences | 18 |
| | 9 |
| | 27 |
| | 15 |
| | 5 |
| | 20 |
|
Performance Materials | (3 | ) | | 15 |
| | 12 |
| | (9 | ) | | 14 |
| | 5 |
|
Performance Plastics | 1 |
| | 15 |
| | 16 |
| | (4 | ) | | 15 |
| | 11 |
|
Feedstocks and Energy | (2 | ) | | 36 |
| | 34 |
| | 9 |
| | 33 |
| | 42 |
|
Total | — | % | | 17 | % | | 17 | % | | (1 | )% | | 16 | % | | 15 | % |
Geographic areas | | | | | | | | | | | |
United States | (3 | )% | | 18 | % | | 15 | % | | (1 | )% | | 15 | % | | 14 | % |
Europe, Middle East and Africa | (2 | ) | | 21 |
| | 19 |
| | (2 | ) | | 20 |
| | 18 |
|
Rest of World | 4 |
| | 13 |
| | 17 |
| | 1 |
| | 12 |
| | 13 |
|
Total | — | % | | 17 | % | | 17 | % | | (1 | )% | | 16 | % | | 15 | % |
| | | | | | | | | | | |
| | | | | | | | | | | |
Sales Volume and Price by Operating Segment and Geographic Area Excluding Divestitures (1) |
| Three Months Ended | | Nine Months Ended |
| September 30, 2011 | | September 30, 2011 |
Percentage change from prior year | Volume | | Price | | Total | | Volume | | Price | | Total |
Operating segments | | | | | | | | | | | |
Electronic and Functional Materials | 3 | % | | 8 | % | | 11 | % | | 5 | % | | 7 | % | | 12 | % |
Coatings and Infrastructure Solutions | (4 | ) | | 14 |
| | 10 |
| | — |
| | 15 |
| | 15 |
|
Agricultural Sciences | 18 |
| | 9 |
| | 27 |
| | 15 |
| | 5 |
| | 20 |
|
Performance Materials | (3 | ) | | 15 |
| | 12 |
| | 1 |
| | 16 |
| | 17 |
|
Performance Plastics | 1 |
| | 15 |
| | 16 |
| | 5 |
| | 16 |
| | 21 |
|
Feedstocks and Energy | (2 | ) | | 36 |
| | 34 |
| | 10 |
| | 33 |
| | 43 |
|
Total | — | % | | 17 | % | | 17 | % | | 5 | % | | 17 | % | | 22 | % |
Geographic areas | | | | | | | | | | | |
United States | (3 | )% | | 18 | % | | 15 | % | | 2 | % | | 15 | % | | 17 | % |
Europe, Middle East and Africa | (2 | ) | | 21 |
| | 19 |
| | 7 |
| | 22 |
| | 29 |
|
Rest of World | 4 |
| | 13 |
| | 17 |
| | 7 |
| | 13 |
| | 20 |
|
Total | — | % | | 17 | % | | 17 | % | | 5 | % | | 17 | % | | 22 | % |
| |
(1) | Excludes sales of the acrylic monomer business and a portion of the specialty latex business divested on January 25, 2010, sales of the Powder Coatings business divested on June 1, 2010, and sales of Styron divested on June 17, 2010. |
OUTLOOK
In the third quarter of 2011, the world experienced a reduction in confidence in the pace of global economic recovery. Uneven conditions stemmed from solvency and liquidity concerns in Europe, inflationary pressures in China, and high unemployment in the United States. Despite these challenges, Dow continued to see growth in fast-growing, emerging regions and in recession-resistant end-markets, such as agriculture, food packaging, energy and water.
Consumer sentiment in the United States remains cautious, with continued weakness in construction end-markets and persistently high unemployment. In Europe, ongoing sovereign debt concerns and the ability of governments to implement austerity measures continue to have an impact on overall business conditions and consumer spending. In the emerging regions, the Company continues to see growth, as the underlying factors driving demand remain strong. Inflation concerns in China appear to have peaked with the implementation of monetary policies. In Latin America, robust demand conditions remain in agriculture end-markets, as well as from large infrastructure projects.
Overall, Dow expects solid growth to continue in the rapidly developing emerging regions as a result of the strong demand from the growing middle class, driving demand, particularly as it pertains to infrastructure and urbanization. Looking ahead, Dow sees ongoing volatility in the pace of global economic recovery. Consequently, the Company is prepared for jagged conditions over the near-term.
Feedstock costs are expected to remain volatile with a modest sequential decline estimated in the fourth quarter of 2011. In the United States, the Company expects to continue to benefit from its flexible feedstock position, taking advantage of the relatively low cost of natural gas and the growing supply of natural gas liquids.
In these uncertain times, the Company will continue to implement its strategy, leveraging its diversification across sectors and geographies to take advantage of growth where it occurs around the world. Dow will continue its focused implementation of price and volume actions to manage margins, while commercializing its innovations, strengthening its presence in rapidly growing end-markets and maintaining financial discipline. Dow's enhanced financial flexibility, industry-leading feedstock strength, and diverse and well-balanced portfolio position the Company to continue driving toward its profitability targets with confidence.
CHANGES IN FINANCIAL CONDITION
The Company's cash flows from operating, investing and financing activities, as reflected in the Consolidated Statements of Cash Flows, are summarized in the following table:
|
| | | | | | | |
Cash Flow Summary | Nine Months Ended |
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
|
Cash provided by (used in): | | | |
Operating activities | $ | 1,858 |
| | $ | 2,267 |
|
Investing activities | (1,463 | ) | | 781 |
|
Financing activities | (5,181 | ) | | (2,775 | ) |
Effect of exchange rate changes on cash | (50 | ) | | 58 |
|
Cash assumed in initial consolidation of variable interest entities | 3 |
| | 46 |
|
Net change in cash and cash equivalents | $ | (4,833 | ) | | $ | 377 |
|
In the first nine months of 2011, cash provided by operating activities decreased compared with the same period last year primarily due to increased pension contributions and an increase in working capital requirements that more than offset increased earnings.
Cash was used in investing activities in the first nine months of 2011, reflecting increased capital expenditures in 2011. Cash was provided by investing activities in the first nine months of 2010, primarily due to proceeds from the divestiture of Styron in the second quarter of 2010.
In the first nine months of 2011, cash was used in financing activities primarily for payments on long- and short-term debt including the retirement of $4.8 billion of debt as further discussed below, as well as dividends paid to stockholders. In the first nine months of 2010, cash was used in financing activities primarily for payments on long-term debt and commercial paper, and payments on notes payable related to the monetization of accounts receivable in Europe, as well as dividends paid to stockholders.
The Company had cash and cash equivalents of $2,206 million at September 30, 2011 and $7,039 million at December 31, 2010, of which $1,513 million at September 30, 2011 and $1,139 million at December 31, 2010 was held by foreign subsidiaries. For each of its foreign subsidiaries, the Company makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States. The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. A deferred tax liability has been accrued for the funds that are available to be repatriated to the United States. At September 30, 2011, management believed that sufficient liquidity was available in the United States. However, in the unusual event that additional foreign funds are needed in the United States, the Company has the ability to repatriate additional funds. The repatriation could result in an adjustment to the tax liability after considering available foreign tax credits and other tax attributes.
The Company has undertaken restructuring plans during the past two years as follows (additional details are provided in Note C to the Consolidated Financial Statements):
| |
• | On June 30, 2009, the Board of Directors approved a restructuring plan related to the Company’s acquisition of Rohm and Haas (the “2009 Plan”). The restructuring activities under this plan were substantially completed in the first quarter of 2011, with remaining liabilities primarily related to environmental remediation to be paid over time. |
| |
• | Included in the liabilities assumed with the April 1, 2009 acquisition of Rohm and Haas was a reserve of $122 million for severance and employee benefits for the separation of employees associated with Rohm and Haas’ 2008 restructuring initiatives. The restructuring activities under this plan were completed in the second quarter of 2011. |
The Company expects to incur future costs related to its restructuring activities, as the Company continually looks for ways to enhance the efficiency and cost effectiveness of its operations to ensure competitiveness across its businesses and across geographic areas. Future costs are expected to include demolition costs related to the closed facilities, which will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits and pension plan settlement costs, related to its other optimization activities. These costs cannot be reasonably estimated at this time.
Management expects that the Company will continue to have sufficient liquidity and financial flexibility to meet all of its business obligations.
The following table presents working capital and certain balance sheet ratios:
|
| | | | | | | |
Working Capital In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Current assets | $ | 21,754 |
| | $ | 24,130 |
|
Current liabilities | 12,887 |
| | 13,896 |
|
Working capital | $ | 8,867 |
| | $ | 10,234 |
|
Current ratio | 1.69:1 |
| | 1.74:1 |
|
Days-sales-outstanding-in-receivables | 44 |
| | 43 |
|
Days-sales-in-inventory | 72 |
| | 62 |
|
As shown in the following table, net debt is equal to total gross debt minus “Cash and cash equivalents.” As Dow continues to strengthen its balance sheet and increase financial flexibility, management is principally focused on net debt, as Dow believes this is the best measure of the Company’s financial leverage.
|
| | | | | | | |
Total Debt In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Notes payable | $ | 887 |
| | $ | 1,467 |
|
Long-term debt due within one year | 1,674 |
| | 1,755 |
|
Long-term debt | 17,042 |
| | 20,605 |
|
Gross debt | $ | 19,603 |
| | $ | 23,827 |
|
Cash and cash equivalents | 2,206 |
| | 7,039 |
|
Net debt | $ | 17,397 |
| | $ | 16,788 |
|
Gross debt as a percent of total capitalization | 43.8 | % | | 51.3 | % |
Net debt as a percent of total capitalization | 40.9 | % | | 42.6 | % |
As part of its ongoing financing activities, Dow has the ability to issue promissory notes under its U.S. and Euromarket commercial paper programs. The Company had no commercial paper outstanding at September 30, 2011 or December 31, 2010.
In the event Dow has short-term liquidity needs and is unable to issue commercial paper under these programs for any reason, Dow has the ability to access liquidity through its committed and available $3 billion Three Year Competitive Advance and Revolving Credit Facility Agreement dated June 4, 2010 (the “Revolving Credit Facility”) with various U.S. and foreign banks. The Revolving Credit Facility has a maturity date in June 2013 and provides for interest at a LIBOR-plus rate or Base Rate as defined in the Agreement. At September 30, 2011, the full $3 billion Revolving Credit Facility was available to the Company. On October 18, 2011, the Company entered into a new $5 billion Five Year Competitive Advance and Revolving Credit Facility Agreement with various U.S. and foreign banks. The new agreement, which replaces the previous Revolving Credit Facility, has a maturity date in October 2016 and provides for interest at a LIBOR-plus rate or Base Rate as defined in the Agreement.
As a well-known seasoned issuer, the Company filed an automatic shelf registration for an unspecified amount of mixed securities with the SEC on February 19, 2010. Under this shelf registration, the Company may offer common stock, preferred stock, depositary shares, debt securities, warrants, stock purchase contracts and stock purchase units with pricing and availability dependent on market conditions; and, on February 19, 2010, registered an unlimited amount of securities for issuance under the Company’s U.S. retail medium-term note program (InterNotes). At September 30, 2011, the Company had Euro 5 billion (approximately $6.8 billion) available for issuance under the Company’s Euro Medium Term Note Program, as well as Japanese yen 50 billion (approximately $650 million) of securities available for issuance under a shelf registration renewed with the Tokyo Stock Exchange effective September 8, 2010, which will expire on September 7, 2012.
On March 22, 2011, the Company concluded cash tender offers for $1.5 billion aggregate principal amount of certain notes issued by the Company. As a result of the tender offers, the Company redeemed $1.5 billion of the notes and recognized a $472 million pretax loss on early extinguishment of debt, included in “Sundry income (expense) – net” in the consolidated statements of income and reflected in Corporate.
In the first nine months of 2011, the Company redeemed $800 million of notes that matured on February 1, 2011; Euro 500 million of notes that matured on May 27, 2011 ($707 million equivalent); $250 million of floating rate notes that matured on August 8, 2011; and $1,538 million of InterNotes, and recognized a $10 million pretax loss on early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and reflected in Corporate. Taken together, these actions will reduce the Company's interest expense by more than $250 million on an annual basis going forward.
In the first nine months of 2011, the Company issued $341 million of InterNotes; and approximately $895 million of long-term debt was entered into by consolidated variable interest entities.
Dow’s public debt instruments and documents for its private funding transactions contain, among other provisions, certain covenants and default provisions. The Company’s most significant debt covenant with regard to its financial position is the obligation to maintain the ratio of the Company’s consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Revolving Credit Facility exceeds $500 million. The ratio of the Company’s consolidated indebtedness to consolidated capitalization as defined in the credit agreements was 0.42 to 1.00 at September 30, 2011. At September 30, 2011, management believes the Company was in compliance with all of its covenants and default provisions.
The Company’s credit rating is investment grade. The Company’s long-term credit ratings are BBB with a stable outlook (Standard & Poor’s), Baa3 with a positive outlook (Moody’s) and BBB with a stable outlook (Fitch). In the second quarter of 2011, Standard & Poor’s upgraded the Company’s long-term credit rating from BBB- to BBB, the Company's short-term credit rating from A-3 to A-2, and changed the outlook from positive to stable. Also in the second quarter of 2011, Moody’s upgraded the Company’s outlook from stable to positive. The Company’s short-term credit ratings are A-2 (Standard & Poor’s), P-3 (Moody’s) and F2 (Fitch). If the Company’s credit ratings are downgraded, borrowing costs will increase on certain indentures, and it could have a negative impact on the Company’s ability to access credit markets.
Capital Expenditures
Capital spending was $651 million in the third quarter of 2011, compared with capital spending of $497 million in the third quarter of 2010. Year to date, capital spending was $1,620 million compared with $1,188 million in 2010. The Company expects capital spending in 2011 to be approximately $2.4 billion.
Contractual Obligations
Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest at December 31, 2010 can be found in Notes N, P, Q, R and Y to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010. With the exception of the items noted below, there have been no material changes in the Company’s contractual obligations since December 31, 2010.
The following table represents long-term debt obligations and expected cash requirements for interest at September 30, 2011, reflecting the early redemptions of debt in the first nine months of 2011 (see Note L to the Consolidated Financial Statements).
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Contractual Obligations at September 30, 2011 | Payments Due by Year | | |
In millions | 2011 |
| | 2012 |
| | 2013 |
| | 2014 |
| | 2015 |
| | 2016 and beyond |
| | Total |
|
Long-term debt – current and noncurrent (1) | $ | 37 |
| | $ | 2,800 |
| | $ | 671 |
| | $ | 2,348 |
| | $ | 1,444 |
| | $ | 11,818 |
| | $ | 19,118 |
|
Expected cash requirements for interest | $ | 389 |
| | $ | 1,166 |
| | $ | 1,021 |
| | $ | 908 |
| | $ | 796 |
| | $ | 7,235 |
| | $ | 11,515 |
|
| |
(1) | Excludes unamortized debt discount of $402 million. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Contractual Obligations at December 31, 2010 | Payments Due by Year | | |
In millions | 2011 |
| | 2012 |
| | 2013 |
| | 2014 |
| | 2015 |
| | 2016 and beyond |
| | Total |
|
Long-term debt – current and noncurrent (1) | $ | 1,755 |
| | $ | 2,886 |
| | $ | 943 |
| | $ | 2,548 |
| | $ | 1,574 |
| | $ | 13,112 |
| | $ | 22,818 |
|
Expected cash requirements for interest | $ | 1,382 |
| | $ | 1,332 |
| | $ | 1,187 |
| | $ | 1,061 |
| | $ | 926 |
| | $ | 7,659 |
| | $ | 13,547 |
|
| |
(1) | Excludes unamortized debt discount of $458 million. |
Off-Balance Sheet Arrangements
The Company holds a variable interest in a joint venture accounted for under the equity method of accounting. The Company is not the primary beneficiary of the joint venture and therefore is not required to consolidate the entity (see Note M to the Consolidated Financial Statements). In addition, see Note K to the Consolidated Financial Statements for information regarding the transfer of financial assets.
Guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others if specific triggering events occur. The Company had outstanding guarantees at September 30, 2011 of $939 million, up from $836 million at December 31, 2010. Additional information related to these guarantees can be found in the “Guarantees” section of Note J to the Consolidated Financial Statements.
Fair Value Measurements
The Company’s assets and liabilities measured at fair value are classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation. Assets and liabilities that are traded on an exchange with a quoted price are classified as Level 1. Assets and liabilities that are valued based on a bid or bid evaluation are classified as Level 2. The custodian of the Company’s debt and equity securities uses multiple industry-recognized vendors for pricing information and established processes for validation and verification to assist the Company in its process for determining and validating fair values for these assets. For the Company's interests held in trade receivable conduits, classified as Level 3, the fair value is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that
have not yet been collected. For pension or other post retirement benefit plan assets classified as Level 3, the total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. The sensitivity of fair value estimates is immaterial relative to the assets and liabilities measured at fair value, as well as to the total equity of the Company. See Note I to the Consolidated Financial Statements for the Company’s disclosures about fair value measurements.
Portfolio managers and external investment managers regularly review all of the Company’s holdings to determine if any investments are other-than-temporarily impaired. The analysis includes reviewing the amount of the temporary impairment, as well as the length of time it has been impaired. In addition, specific guidelines for each instrument type are followed to determine if an other-than-temporary impairment has occurred. For debt securities, the credit rating of the issuer, current credit rating trends and the trends of the issuer’s overall sector are considered in determining whether unrealized losses represent an other-than-temporary impairment. For equity securities, the Company’s investments are primarily in Standard & Poor’s (“S&P”) 500 companies; however, the Company also allows investments in companies outside of the S&P 500. The largest holdings are Exchange Traded Funds that represent the S&P 500 index or an S&P sector or subset; the Company also has holdings in Exchange Traded Funds that represent emerging markets. The Company considers the evidence to support the recovery of the cost basis of a security including volatility of the stock, the length of time the security has been in a loss position, value and growth expectations, and overall market and sector fundamentals, as well as technical analysis, in determining impairment. Other-than-temporary impairment write-downs on investments still held by the Company were $6 million in the first nine months of 2011 ($4 million in the first nine months of 2010).
Dividends
On September 15, 2011, the Board of Directors declared a quarterly dividend of $0.25 per common share, payable October 28, 2011, to stockholders of record on September 30, 2011. In the second quarter of 2011, the Board of Directors increased the dividend from $0.15 per common share to $0.25 per common share. The 67 percent increase demonstrates the Board’s commitment to increasingly reward shareholders as the Company continues to grow earnings. Since 1912, the Company has paid a cash dividend every quarter and, in each instance prior to and since February 12, 2009, had maintained or increased the amount of the dividend, adjusted for stock splits. The dividend was reduced in February 2009, for the first time in the 97-year period, due to uncertainty in the credit markets, unprecedented lower demand for chemical products and the global recession. Since 1912, Dow has increased the amount of the quarterly dividend 48 times (approximately 12 percent of the time), reduced the dividend once, and maintained the amount of the quarterly dividend approximately 88 percent of the time.
On September 15, 2011, the Board of Directors declared a quarterly dividend of $85 million to Cumulative Convertible Perpetual Preferred Stock, Series A shareholders of record on September 15, 2011, which was paid on October 3, 2011. Ongoing dividends related to Cumulative Convertible Perpetual Preferred Stock, Series A will accrue at the rate of $85 million per quarter, and are payable quarterly subject to Board of Directors’ approval.
OTHER MATTERS
Recent Accounting Guidance
See Note B to the Consolidated Financial Statements for a summary of recent accounting guidance.
Critical Accounting Policies
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note A to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010 (“2010 10-K”) describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. Dow’s critical accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s 2010 10-K. Since December 31, 2010, there have been no material changes in the Company’s critical accounting policies.
Asbestos-Related Matters of Union Carbide Corporation
Introduction
Union Carbide Corporation (“Union Carbide”), a wholly owned subsidiary of the Company, is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.
Influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation and the prospects of various forms of state and national legislative reform, the rate at which plaintiffs filed asbestos-related suits against various companies, including Union Carbide and Amchem, increased in 2001, 2002 and the first half of 2003. Since then, the rate of filing has significantly abated. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.
The table below provides information regarding asbestos-related claims filed against Union Carbide and Amchem:
|
| | | | | |
| 2011 |
| | 2010 |
|
Claims unresolved at January 1 | 62,582 |
| | 75,030 |
|
Claims filed | 6,050 |
| | 5,525 |
|
Claims settled, dismissed or otherwise resolved | (14,321 | ) | | (17,083 | ) |
Claims unresolved at September 30 | 54,311 |
| | 63,472 |
|
Claimants with claims against both UCC and Amchem | 16,761 |
| | 19,844 |
|
Individual claimants at September 30 | 37,550 |
| | 43,628 |
|
Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.
Estimating the Liability
Based on a study completed by Analysis, Research & Planning Corporation (“ARPC”) in January 2003, Union Carbide increased its December 31, 2002 asbestos-related liability for pending and future claims for the 15-year period ending in 2017 to $2.2 billion, excluding future defense and processing costs. Since then, Union Carbide has compared current asbestos claim and resolution activity to the results of the most recent ARPC study at each balance sheet date to determine whether the accrual continues to be appropriate. In addition, Union Carbide has requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity each November since 2004 to determine the appropriateness of updating the most recent ARPC study.
In November 2009, Union Carbide requested ARPC to review Union Carbide’s 2009 asbestos claim and resolution activity and determine the appropriateness of updating its then most recent study completed in December 2008. In response to that request, ARPC reviewed and analyzed data through October 31, 2009. In December 2009, ARPC stated that an update of its study would not provide a more likely estimate of future events than the estimate reflected in its study of the previous year and, therefore, the estimate in that study remained applicable. Based on Union Carbide’s own review of the asbestos claim and resolution activity and ARPC’s response, Union Carbide determined that no change to the accrual was required. At December 31, 2009, Union Carbide’s asbestos-related liability for pending and future claims was $839 million.
In November 2010, Union Carbide requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity and determine the appropriateness of updating its December 2008 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2010. The resulting study, completed by ARPC in December 2010, stated that the undiscounted cost of resolving pending and future asbestos-related claims against Union Carbide and Amchem, excluding future defense and processing costs, through 2025 was estimated to be between $744 million and $835 million. As in its earlier studies, ARPC provided estimates for a longer period of time in its December 2010 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time.
In December 2010, based on ARPC’s December 2010 study and Union Carbide’s own review of the asbestos claim and resolution activity, Union Carbide decreased its asbestos-related liability for pending and future claims to $744 million, which covered the 15-year period ending 2025, excluding future defense and processing costs. The reduction was $54 million and was shown as “Asbestos-related credits” in the consolidated statements of income. At December 31, 2010, the asbestos-related liability for pending and future claims was $728 million. At December 31, 2010, approximately 21 percent of the recorded liability related to pending claims and approximately 79 percent related to future claims.
Based on Union Carbide’s review of 2011 activity, Union Carbide determined that no adjustment to the accrual was required at September 30, 2011. Union Carbide’s asbestos-related liability for pending and future claims was $690 million at September 30, 2011. Approximately 18 percent of the recorded liability related to pending claims and approximately 82 percent related to future claims.
Defense and Resolution Costs
The following table provides information regarding defense and resolution costs related to asbestos-related claims filed against Union Carbide and Amchem:
|
| | | | | | | | | | | |
Defense and Resolution Costs | Nine Months Ended | | Aggregate Costs to Date as of |
|
In millions | Sep 30, 2011 |
| | Sep 30, 2010 |
| | Sep 30, 2011 |
|
Defense costs | $ | 58 |
| | $ | 58 |
| | $ | 832 |
|
Resolution costs | $ | 38 |
| | $ | 40 |
| | $ | 1,561 |
|
The average resolution payment per asbestos claimant and the rate of new claim filings has fluctuated both up and down since the beginning of 2001. Union Carbide’s management expects such fluctuations to continue in the future based upon a number of factors, including the number and type of claims settled in a particular period, the jurisdictions in which such claims arose and the extent to which any proposed legislative reform related to asbestos litigation is being considered.
Union Carbide expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $30 million in the third quarter of 2011 ($22 million in the third quarter of 2010) and $58 million in the first nine months of 2011 ($58 million in the first nine months of 2010), and was reflected in “Cost of sales” in the consolidated statements of income.
Insurance Receivables
At December 31, 2002, Union Carbide increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion, substantially exhausting its asbestos product liability coverage. The insurance receivable related to the asbestos liability was determined by Union Carbide after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which Union Carbide and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The Wellington Agreement and other agreements with insurers are designed to facilitate an orderly resolution and collection of Union Carbide’s insurance policies and to resolve issues that the insurance carriers may raise.
In September 2003, Union Carbide filed a comprehensive insurance coverage case, now proceeding in the Supreme Court of the State of New York, County of New York, seeking to confirm its rights to insurance for various asbestos claims and to facilitate an orderly and timely collection of insurance proceeds (the “Insurance Litigation”). The Insurance Litigation was filed against insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place with Union Carbide regarding their asbestos-related insurance coverage, in order to facilitate an orderly resolution and collection of such insurance policies and to resolve issues that the insurance carriers may raise. Since the filing of the case, Union Carbide has reached settlements with several of the carriers involved in the Insurance Litigation, including settlements reached with two significant carriers in the fourth quarter of 2009. The Insurance Litigation is ongoing.
Union Carbide’s receivable for insurance recoveries related to its asbestos liability was $50 million at September 30, 2011 and $50 million at December 31, 2010. At September 30, 2011 and December 31, 2010, all of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.
In addition to the receivable for insurance recoveries related to its asbestos liability, Union Carbide had receivables for defense and resolution costs submitted to insurance carriers that have settlement agreements in place regarding their asbestos-related insurance coverage.
The following table summarizes Union Carbide’s receivables related to its asbestos-related liability:
|
| | | | | | | |
Receivables for Asbestos-Related Costs In millions | Sep 30, 2011 |
| | Dec 31, 2010 |
|
Receivables for defense costs – carriers with settlement agreements | $ | 20 |
| | $ | 12 |
|
Receivables for resolution costs – carriers with settlement agreements | 166 |
| | 236 |
|
Receivables for insurance recoveries – carriers without settlement agreements | 50 |
| | 50 |
|
Total | $ | 236 |
| | $ | 298 |
|
After a review of its insurance policies, with due consideration given to applicable deductibles, retentions and policy limits, and after taking into account the solvency and historical payment experience of various insurance carriers; existing insurance settlements; and the advice of outside counsel with respect to the applicable insurance coverage law relating to the terms and conditions of its insurance policies, Union Carbide continues to believe that its recorded receivable for insurance recoveries from all insurance carriers is probable of collection.
Summary
The amounts recorded by Union Carbide for the asbestos-related liability and related insurance receivable described above were based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of disposing of each such claim, coverage issues among insurers, and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries for Union Carbide to be higher or lower than those projected or those recorded.
Because of the uncertainties described above, Union Carbide’s management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. Union Carbide’s management believes that it is reasonably possible that the cost of disposing of Union Carbide’s asbestos-related claims, including future defense costs, could have a material adverse impact on Union Carbide’s results of operations and cash flows for a particular period and on the consolidated financial position of Union Carbide.
It is the opinion of Dow’s management that it is reasonably possible that the cost of Union Carbide disposing of its asbestos-related claims, including future defense costs, could have a material adverse impact on the Company’s results of operations and cash flows for a particular period and on the consolidated financial position of the Company.
|
|
The Dow Chemical Company and Subsidiaries PART I – FINANCIAL INFORMATION |
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
Dow’s business operations give rise to market risk exposure due to changes in foreign exchange rates, interest rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies, which enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as hedges per the accounting guidance related to derivatives and hedging activities, where appropriate. A secondary objective is to add value by creating additional non-specific exposure within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not material to the Company’s results.
The global nature of Dow’s business requires active participation in the foreign exchange markets. As a result of investments, production facilities and other operations on a global basis, the Company has assets, liabilities and cash flows in currencies other than the U.S. dollar. The primary objective of the Company’s foreign exchange risk management is to optimize the U.S. dollar value of net assets and cash flows, keeping the adverse impact of currency movements to a minimum. To achieve this objective, the Company hedges on a net exposure basis using foreign currency forward contracts, over-the-counter option contracts, cross-currency swaps, and nonderivative instruments in foreign currencies. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities. The largest exposures are denominated in European currencies, the Japanese yen and the Canadian dollar, although exposures also exist in other currencies of Asia Pacific, Latin America, and India, Middle East and Africa.
The main objective of interest rate risk management is to reduce the total funding cost to the Company and to alter the interest rate exposure to the desired risk profile. Dow uses interest rate swaps, “swaptions,” and exchange-traded instruments to accomplish this objective. The Company’s primary exposure is to the U.S. dollar yield curve.
Dow has a portfolio of equity securities derived primarily from the investment activities of its insurance subsidiaries. This exposure is managed in a manner consistent with the Company’s market risk policies and procedures.
Inherent in Dow’s business is exposure to price changes for several commodities. Some exposures can be hedged effectively through liquid tradable financial instruments. Feedstocks for ethylene production and natural gas constitute the main commodity exposures. Over-the-counter and exchange traded instruments are used to hedge these risks when feasible.
Dow uses value at risk (“VAR”), stress testing and scenario analysis for risk measurement and control purposes. VAR estimates the maximum potential loss in fair market values, given a certain move in prices over a certain period of time, using specified confidence levels. The VAR methodology used by the Company is a historical simulation model which captures co-movements in market rates across different instruments and market risk exposure categories. The historical simulation model uses a 97.5 percent confidence level and the historical scenario period includes at least six months of historical data. The September 30, 2011, 2010 year-end and 2010 average daily VAR for the aggregate of all positions are shown below. These amounts are immaterial relative to the total equity of the Company:
|
| | | | | | | | | | | |
Total Daily VAR | | | 2010 |
In millions | At September 30, 2011 |
| | Year-end | | Average |
|
Foreign exchange | $ | 2 |
| | $ | 1 |
| | $ | 3 |
|
Interest rate | $ | 211 |
| | $ | 251 |
| | $ | 211 |
|
Equities | $ | 26 |
| | $ | 15 |
| | $ | 12 |
|
Commodities | $ | 3 |
| | $ | 1 |
| | $ | 2 |
|
Composite | $ | 254 |
| | $ | 252 |
| | $ | 218 |
|
The Company’s daily VAR for the aggregate of all positions increased slightly from a composite VAR of $252 million at December 31, 2010 to a composite VAR of $254 million at September 30, 2011. Equities VAR increased due to an increase in volatility. Interest rate VAR decreased principally due to a decrease in the amount of debt outstanding.
See Note H to the Consolidated Financial Statements for further disclosure regarding market risk.
|
|
The Dow Chemical Company and Subsidiaries PART I – FINANCIAL INFORMATION |
ITEM 4. CONTROLS AND PROCEDURES.
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out an evaluation, under the supervision and with the participation of the Company’s Disclosure Committee and the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 or 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.
Changes in Internal Control Over Financial Reporting
There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that was conducted during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
|
|
The Dow Chemical Company and Subsidiaries PART II – OTHER INFORMATION |
ITEM 1. LEGAL PROCEEDINGS.
Asbestos-Related Matters of Union Carbide Corporation
No material developments regarding this matter occurred during the third quarter of 2011. For a summary of the history and current status of this matter, see Note J to the Consolidated Financial Statements; and Management’s Discussion and Analysis of Financial Condition and Results of Operations, Asbestos-Related Matters of Union Carbide Corporation.
Rohm and Haas Pension Plan Matters
In December 2005, a federal judge in the U.S. District Court for the Southern District of Indiana (the “District Court”) issued a decision granting a class of participants in the Rohm and Haas Pension Plan (the “Rohm and Haas Plan”) who had retired from Rohm and Haas, now a wholly owned subsidiary of the Company, and who elected to receive a lump sum benefit from the Rohm and Haas Plan, the right to a cost-of-living adjustment (“COLA”) as part of their retirement benefit. In August 2007, the Seventh Circuit Court of Appeals (the "Seventh Circuit") affirmed the District Court’s decision, and in March 2008, the U.S. Supreme Court denied the Rohm and Haas Plan’s petition to review the Seventh Circuit’s decision. The case was returned to the District Court for further proceedings. In October 2008 and February 2009, the District Court issued rulings that have the effect of including in the class all Rohm and Haas retirees who received a lump sum distribution without a COLA from the Rohm and Haas Plan since January 1976. These rulings are subject to appeal, and the District Court has not yet determined the amount of the COLA benefits that may be due to the class participants. The Rohm and Haas Plan and the plaintiffs entered into a settlement agreement that, in addition to settling the litigation with respect to the Rohm and Haas retirees, provides for the amendment of the complaint and amendment of the Rohm and Haas Plan to include active employees in the settlement benefits. The District Court preliminarily approved the settlement on November 24, 2009 and, following a hearing on March 12, 2010, issued a final order approving the settlement on April 12, 2010. A group of objectors to the settlement filed an appeal from the final order. In November 2010, the District Court issued an order approving class counsel’s fee award petition in an amount consistent with the terms of the settlement. The same objectors also appealed this order. On September 2, 2011, the Seventh Circuit affirmed the approval of the settlement and the award of attorneys' fees. A lone objector filed a petition for rehearing, which was denied on October 17, 2011.
A pension liability associated with this matter of $185 million was recognized as part of the acquisition of Rohm and Haas on April 1, 2009. The liability, which was determined in accordance with the accounting guidance for contingencies, recognized the estimated impact of the above described judicial decisions on the long-term Rohm and Haas Plan obligations owed to the applicable Rohm and Haas retirees and active employees. The Company had a liability associated with this matter of $186 million at September 30, 2011 and $186 million at December 31, 2010.
ITEM 1A. RISK FACTORS.
The factors described below represent the Company's principal risks.
Global Economic Conditions: The Company operates in a global, competitive environment, which gives rise to operating and market risk exposure.
The Company sells its broad range of products and services in a competitive, global environment, and competes worldwide for sales on the basis of product quality, price, technology and customer service. Increased levels of competition could result in lower prices or lower sales volume, which could have a negative impact on the Company's results of operations.
Economic conditions around the world and in certain industries in which the Company does business also impact sales prices and volume. As a result, an economic downturn in the geographic areas or industries in which Dow sells its products could reduce demand for these products and result in decreased sales volume, which could have a negative impact on Dow's results of operations.
In addition, volatility and disruption of financial markets could limit customers' ability to obtain adequate financing to maintain operations, which could result in a decrease in sales volume and have a negative impact on Dow's results of operations. The Company's global business operations also give rise to market risk exposure related to changes in foreign exchange rates, interest rates, commodity prices and other market factors such as equity prices. To manage such risks, Dow enters into hedging transactions pursuant to established guidelines and policies. If Dow fails to effectively manage such risks, it could have a negative impact on the Company's results of operations.
The economic environment impacts the fair value of pension and insurance assets, which could trigger increased future funding requirements of the pension trusts and could result in other-than-temporary impairment losses for certain insurance assets.
Financial Obligations and Credit Markets: Market conditions could reduce the Company's flexibility to respond to changing business conditions or fund capital needs.
Interest and dividend payments could increase the Company's vulnerability to adverse economic conditions and reduce the Company's flexibility to respond to changing business and economic conditions or to fund capital expenditures or working capital needs. In addition, the economic environment could result in a contraction in the availability of credit in the marketplace and reduce sources of liquidity for the Company. This could result in higher borrowing costs.
Raw Materials: Availability of purchased feedstocks and energy and the volatility of these costs impact Dow's operating costs and add variability to earnings.
The Company purchases hydrocarbon raw materials including liquefied petroleum gases, crude oil, naphtha, natural gas and condensate. The Company also purchases electric power, benzene, ethylene and propylene to supplement internal production, as well as other raw materials. If the Company's key suppliers are unable to provide the raw materials required for production, it could have a negative impact on Dow's results of operations.
Purchased feedstock and energy costs account for a substantial portion of the Company's total production costs and operating expenses. While the Company uses its feedstock flexibility and financial and physical hedging programs to lower overall feedstock costs, when these costs increase the Company is not always able to immediately raise selling prices; and, ultimately, the ability to pass on underlying cost increases is greatly dependent on market conditions. Conversely, when these costs decline, selling prices decline as well. As a result, volatility in these costs could negatively impact the Company's results of operations.
Supply/Demand Balance: Earnings generated by the Company's basic chemical and plastic products vary based in part on the balance of supply relative to demand within the industry.
The balance of supply relative to demand within the industry may be significantly impacted by the addition of new capacity, especially for basic commodities where capacity is generally added in large increments as world-scale facilities are built. This may disrupt industry balances and result in downward pressure on prices due to the increase in supply, which could negatively impact the Company's results of operations.
Litigation: The Company is party to a number of claims and lawsuits arising out of the normal course of business with respect to commercial matters including product liability, governmental regulation and other actions.
Certain of the claims and lawsuits facing the Company purport to be class actions and seek damages in very large amounts. All such claims are contested. With the exception of the possible effect of the asbestos-related liability of Union Carbide Corporation (“Union Carbide”), described below, it is the opinion of the Company's management that the possibility is remote that the aggregate of all such claims and lawsuits will have a material adverse impact on the Company's consolidated financial statements.
Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. At September 30, 2011, Union Carbide's asbestos-related liability for pending and future claims was $690 million ($728 million at December 31, 2010) and its receivable for insurance recoveries related to the asbestos liability was $50 million ($50 million at December 31, 2010). At September 30, 2011, Union Carbide also had receivables of $186 million ($248 million at December 31, 2010) for insurance recoveries for defense and resolution costs. It is the opinion of the Company's management that it is reasonably possible that the cost of Union Carbide disposing of its asbestos-related claims, including future defense costs, could have a material adverse impact on the Company's results of operations and cash flows for a particular period and on the consolidated financial position of the Company.
Environmental Compliance: Actual or alleged violations of environmental laws or permit requirements could result in restrictions or prohibitions on plant operations, substantial civil or criminal sanctions, as well as the assessment of strict liability and/or joint and several liability.
The Company is subject to extensive federal, state, local and foreign laws, regulations, rules and ordinances relating to pollution, protection of the environment, and the generation, storage, handling, transportation, treatment, disposal and remediation of hazardous substances and waste materials. At September 30, 2011, the Company had accrued obligations of $666 million ($607 million at December 31, 2010) for probable environmental remediation and restoration costs, including $64 million ($59 million at December 31, 2010) for the remediation of Superfund sites. This is management's best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although the ultimate cost with respect to these particular matters could range up to approximately twice that amount. Costs and capital expenditures relating to environmental, health or safety matters are subject to evolving regulatory requirements and depend on the timing of the promulgation and enforcement of specific standards which impose the requirements. Moreover, changes in environmental regulations could inhibit or interrupt the Company's operations, or require modifications to its facilities. Accordingly, environmental, health or safety regulatory matters could result in significant unanticipated costs or liabilities.
Chemical Safety: Increased concerns regarding the safe use of chemicals in commerce and their potential impact on the environment have resulted in more restrictive regulations from local, state and federal governments and could lead to new regulations.
Concerns regarding the safe use of chemicals in commerce and their potential impact on health and the environment reflect a growing trend in societal demands for increasing levels of product safety and environmental protection. These concerns could manifest themselves in stockholder proposals, preferred purchasing and continued pressure for more stringent regulatory intervention. These concerns could also influence public perceptions, the viability of the Company's products, the Company's reputation and the cost to comply with regulations. In addition, terrorist attacks and natural disasters have increased concerns about the security and safety of chemical production and distribution. These concerns could have a negative impact on the Company's results of operations.
Local, state and federal governments continue to propose new regulations related to the security of chemical plant locations and the transportation of hazardous chemicals, which could result in higher operating costs and interruptions in normal business operations.
Operational Event: A significant operational event could negatively impact the Company's results of operations.
As a diversified chemical manufacturing company, the Company's operations, the transportation of products, or severe weather conditions and other natural phenomena (such as drought, hurricanes, earthquakes, tsunamis, floods, etc.) could result in an unplanned event that could be significant in scale and could negatively impact operations, neighbors or the public at large, which could have a negative impact on the Company's results of operations.
In the past, major hurricanes have caused significant disruption in Dow's operations on the U.S. Gulf Coast, logistics across the region, and the supply of certain raw materials, which had an adverse impact on volume and cost for some of Dow's products. Due to the Company's substantial presence on the U.S. Gulf Coast, similar severe weather conditions or other natural phenomena in the future could negatively affect Dow's results of operations.
Company Strategy: Implementing certain elements of the Company's strategy could negatively impact the Company's financial results.
The Company has entered into an agreement to form a new joint venture and is evaluating the formation of other joint ventures in emerging geographies to build and operate integrated, world-scale facilities. Large projects like these, as well as other proposed and existing projects of varying size in these geographies, are accompanied by uncertainty and risks including: navigating different government regulatory environments; relationships with new, local partners; project funding commitments and guarantees; war, terrorism and political instability; uninsurable risks; and determining raw material supply and other details regarding product movement. If the implementation of these projects is not successful, it could adversely affect the Company's financial condition and results of operations.
Goodwill: An impairment of goodwill would negatively impact the Company's financial results.
The April 1, 2009 acquisition of Rohm and Haas Company increased the Company's goodwill by $9.7 billion. At least annually, the Company assesses goodwill for impairment. If an initial qualitative assessment identifies that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is performed. If the quantitative testing indicates that goodwill is impaired, the carrying value of goodwill is written down to fair value with a charge against earnings. Since the Company utilizes a discounted cash flow methodology to calculate the fair value of its reporting units, continued weak demand for a specific product line or business could result in an impairment. Accordingly, any determination requiring the write-off of a significant portion of goodwill could negatively impact the Company's results of operations.
Implementation of ERP system: The Company's implementation of a new enterprise resource planning (“ERP”) system may adversely affect the Company's business and results of operations or the effectiveness of internal control over financial reporting.
During the first quarter of 2011, the Company began implementing a new ERP system that will deliver a new generation of work processes and information systems. ERP implementations are complex and time-consuming projects that involve substantial expenditures on system software and implementation activities that take several years. ERP implementations also require transformation of business and financial processes in order to reap the benefits of the ERP system. If the Company does not effectively implement the ERP system as planned or if the system does not operate as intended, it could adversely affect financial reporting systems, the Company's ability to produce financial reports, and/or the effectiveness of internal control over financial reporting.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
Issuer Purchases of Equity Securities
The Company does not currently have a share repurchase program, and there were no purchases of the Company's common stock by the Company during the three months ended September 30, 2011.
ITEM 6. EXHIBITS.
See the Exhibit Index on page 76 of this Quarterly Report on Form 10-Q for exhibits filed with this report.
|
|
The Dow Chemical Company and Subsidiaries Trademark Listing |
The following trademarks or service marks of The Dow Chemical Company and certain affiliated companies of Dow appear in this report: ACRYSOL, ACUDYNE, ACULYN, ACUMER, ACuPLANE, ACRYLIGARD, ACUSOL, ADCOTE, ADSORBSIA, ADVALUBE, ADVAPAK, ADVASTAB, AERIFY, AFFINITY, AIRSTONE, AMBERCHROM, AMBERJET, AMBERLITE, AMBERLYST, AMPLIFY, ANGUS, AR, ASC METATIN, ASPUN, ATTANE, AQUA-LAM, AQUASET, AQUCAR, AUROLECTROLESS, AUTOMATE, AVANSE, BETAFOAM, BETAFORCE, BETAMATE, BETASEAL, BETATECH, BIOBAN, CARBITOL, CARBOWAX, CARBOWAX SENTRY, CELLOSIZE, CELLOSOLVE, CLEAR+STABLE, COMPAXX, CONTINUUM, COPPER GLEAM, CYCLOTENE, D.E.H., D.E.N., D.E.R., DIPRANE, DOW, DOWANOL, DOWEX, DOWFAX, DOWFROST, DOWLEX, DOWTHERM, DUOLITE, DURAGREEN, DURAMAX, DURAMOULD, DURAPLUS, DURAPOSIT, DURELAST, ECHELON, ECOSMOOTH, ECOSOFT, ECOSURF, ELASTENE, ENFORCER, ENGAGE, ENHANCER, ENLIGHT, ELITE, EPIC, ETHOCEL, EVOQUE, FILMTEC, FORTEGRA, FROTH-PAK, GLUTEX, GREAT STUFF, HYPERKOTE, HYPERLAST, HYPOL, IMPAXX, INFUSE, INSPIRE, INSTA-STIK, INTEGRAL, INTERVIA, ISONATE, KATHON, KLARIX, LITHOJET, METEOR, METHOCEL, MOR-FREE, NEOLONE, NORDEL, NYLOPAK, OPTICITE, OPTIDOSE, OPTIPORE, OPTOGRADE, OPULYN, OROTAN, PAPI, PARALOID, POLYOX, POWERHOUSE, PRIMACOR, PRIMAL, PRIMENE, PROCITE, PROGLYDE, PROLOGIC, PURAGUARD, REDI-LINK, RHOPLEX, ROBOND, ROMAX, ROPAQUE, SARAN, SARANEX, SATISFIT, SEALUTION, SERFENE, SHAC, SI-LINK, SILVADUR, SOFTCAT, SOLTERRA, SOLTEX, SPECFLEX, STYROFOAM, SUNSPHERES, SURECEL, SYMBIO, SYNALOX, TAMOL, TERGITOL, THERMAX, TILE BOND, TRAFFIDECK, TRENCHCOAT, TRITON, TRYCITE, TUFLIN, TYBRITE, TYMOR, TYRIN, UCAR, UCARE, UCARHIDE, UCON, UNIGARD, UNIPOL, UNIVAL, VENPURE, VERDISEAL, VERSENE, VERSIFY, VINYZENE, VISIONPAD, VORACOR, VORACTIV, VORAFORCE, VORALUX, VORAMER, VORANATE, VORANOL, VORASURF, VORATEC, VORATHERM, VORATRON, WALOCEL, WALSRODER, WEATHERMATE
The following trademarks or service marks of Dow AgroSciences LLC and certain affiliated companies of Dow AgroSciences LLC appear in this report: BRODBECK, CLINCHER, DAIRYLAND, DELEGATE, DITHANE, FORTRESS, GARLON, GLYPHOMAX, GRANITE, HERCULEX, KEYSTONE, LAREDO, LONTREL, LORSBAN, MILESTONE, MUSTANG, MYCOGEN, NATURALYTE, NEXERA, PHYTOGEN, PROFUME, RENZE, SENTRICON, SIMPLICITY, STARANE, TELONE, TORDON, TRACER, TRIUMPH, VIKANE, WIDESTRIKE
The following trademark of Agromen Sementes Agricolas Ltda appears in this report: AGROMEN
The following trademark of Antaria Limited appears in this report: ZinClear
The following trademark of Monsanto Technology LLC appears in this report: SmartStax. SmartStax multi-event technology developed by Dow AgroSciences LLC and Monsanto
|
|
The Dow Chemical Company and Subsidiaries Signature |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
THE DOW CHEMICAL COMPANY
Registrant
Date: November 1, 2011
|
|
/s/ RONALD C. EDMONDS |
Ronald C. Edmonds |
Vice President and Controller |
|
|
The Dow Chemical Company and Subsidiaries Exhibit Index |
|
| | |
EXHIBIT NO. | | DESCRIPTION |
| |
3(ii) | | The Bylaws of The Dow Chemical Company, as amended and re-adopted in full on October 12, 2011, effective October 12, 2011, incorporated by reference to Exhibit 99.1 to The Dow Chemical Company Current Report on Form 8-K filed on October 13, 2011. |
| | |
12.1 | | Computation of Ratio of Earnings to Fixed charges. |
| |
23 | | Analysis, Research & Planning Corporation’s Consent. |
| |
31(a) | | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
31(b) | | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| |
32(a) | | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| |
32(b) | | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| |
101.INS | | XBRL Instance Document |
| |
101.SCH | | XBRL Taxonomy Extension Schema Document |
| |
101.CAL | | XBRL Taxonomy Extension Calculation Linkbase Document |
| |
101.DEF | | XBRL Taxonomy Extension Definition Linkbase Document |
| |
101.LAB | | XBRL Taxonomy Extension Label Linkbase Document |
| |
101.PRE | | XBRL Taxonomy Extension Presentation Linkbase Document |